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Abstract 
The BDyn device is a bilateral posterior dynamic stabilisation spinal implant used to treat 
degenerative disc disease. The BDyn device consists of a polycarbonate urethane (PCU) 
component, a silicone component, a mobile titanium alloy rod, a fixed titanium alloy rod and it 
is fixed to the vertebrae by titanium alloy pedicle screws.  
The viscoelastic properties, chemical structure and surface morphological changes of the 
untreated, in vitro degraded and in vivo degraded were compared. The macro and micro-scale 
viscoelastic properties, chemical structure and surface morphology of five long-term implantable 
PCU biomaterials, which were in vitro degraded by four separate degradation methods were 
also investigated. 
No resonant frequencies were reported for the untreated and in vitro degraded components 
and devices however, resonance was detected in the frequency sweep test of BDyn Explant 2 
with the sharp increase of the loss stiffness occurred at 4 Hz; this highlights the importance of 
evaluating orthopaedic devices with frequency dependent mechanical testing techniques. The 
biomaterials were viscoelastic throughout the frequency range tested and were significantly 
different at specific frequencies when comparing untreated specimens to specimens degraded 
by a specific degradation method; this further highlights the need to evaluate elastomeric 
biomaterials with frequency dependent mechanical testing techniques. 
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1 Introduction 
Vibration is simply defined as an oscillating motion (Steidel, 1989). One of the earliest studies 
of oscillating motion is Galileo’s work, in 1584, when he created the principle of the 
isochronous pendulum (Steidel, 1989). The published work of John William Strutt, also known 
as Lord Rayleigh, relating to vibration helped to develop the theory and the field of mechanical 
vibration (Steidel, 1989). 
Alongside heavy and frequent lifting, long term vibration exposure was stated as a high risk 
factor of low back pain (Magnusson et al., 1996). Studies have evaluated the in vivo response of 
the spine to sinusoidal vibrations at different frequencies (Panjabi et al., 1986; Wilder et al., 
1982). Panjabi et al. (1986) recorded the average in vivo lumbar vertebrae resonant frequency at 
4.4 Hz for the axial direction with the person in the seated position (sitting upright 
unsupported). Wilder et al. (1982) recorded the greatest transmissibility (recorded from 
accelerometers in the seat and the head helmet) in the male and female lumbar spine of 4.9 Hz 
and 4.75 Hz, respectively; these resonant frequencies are similar to the frequencies recorded by 
Panjabi et al. (1986). Further, Wilder et al. (1982) recorded second and third resonant 
frequencies at 9.5 Hz and 12.7 Hz for both genders.  
Knowledge and understanding the resonance or natural frequencies of the spine is important in 
relation to reducing exposure to these potentially harmful frequencies (Panjabi et al., 1986). 
Further, design and mechanical testing of spinal devices should assess the behaviour of such 
devices at spinal resonant frequencies. Motion preserving spinal devices have recently emerged 
as a new treatment of cervical and lumbar degenerative disorders (Kurtz et al., 2009). However, 
little work has been undertaken to analyse the frequency dependent response of spinal devices 
and the frequency dependent behaviour of the biomaterials used in such implants; to design 
structures that function properly, it is imperative that that the mechanical behaviour of a 
material is understood (Gere and Timoshenko, 1997). Any resonance of the device, at any 
frequency, is a limitation of the device as the resonance may damage the device and in a worst-
case scenario, the device may fail. Further, these materials degraded and assessing the 
mechanical response of these degraded materials, and the implants they are used in, is lacking.  
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The aim of this thesis was to investigate the biostability of the BDyn posterior dynamic 
stabilisation (PDS) orthopaedic (spinal) device elastomeric biomaterials and the biostability of 
potential replacement polycarbonate urethane (PCU) biomaterials, which could be used, for 
this PDS device. The specific objectives were: 
 To investigate the effect of in vitro degradation (oxidation and hydrolysis) on the in vitro 
biostability of five potential replacement PCU biomaterials. The micro-scale and macro-
scale viscoelastic properties, the polymer chemical structure and surface morphology 
were analysed to assess changes due to in vitro degradation.  
 To assess the biostability of the BDyn PDS device elastomeric biomaterials. The 
viscoelastic properties, the polymer chemical structure, macro and surface morphology 
were analysed to assess differences between the control, in vitro degraded (oxidation) 
and in vivo degraded BDyn PDS components.  
By investigating the in vitro biostability of polymers used in orthopaedics, and used in 
cardiovascular applications, these findings will influence the selection of biomaterials for future 
implantable devices. Assessing the differences between the untreated, in vitro degraded 
(oxidation) and in vivo degraded BDyn PDS components will develop the understanding of the 
implant’s performances in the biological environment and the ability of the in vitro oxidative 
degraded method to replicate changes comparable to in vivo degraded specimens.  Further, by 
investigating the failure of the explanted BDyn devices, findings will help biomedical engineers 
to design and test future spinal implants. 
Chapter 2 provides the relevant background information beginning with the mechanics of 
elastic, viscous and viscoelastic materials. Next, information of the human spinal column and 
orthopaedic devices used for degenerative diseases is provided. Finally, background of the 
biostability of polyurethane biomaterials, which includes brief examination of published 
retrieval studies and information of in vitro biodegradation experiments, is provided. 
Chapter 3 provides information about the general materials and methods used in this thesis. 
This chapter focuses generally on the long-term implantable biomaterials, the biomaterials used 
for a posterior dynamic stabilisation device, in vitro oxidative and in vitro hydrolytic degradation 
methods, hyperspectral chemical imaging (HCI) and attenuated total reflectance Fourier 
transform infra-red (ATR-FTIR) spectroscopy methods, micro-scale (µDMA) and macro-scale 
dynamic mechanical analysis (DMA) methods, scanning electron microscopy (SEM) and 
statistical analyses used.  
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Chapter 4 investigates the in vitro biostability of five commercially available, long-term 
implantable polycarbonate urethane (PCU) biomaterials. This chapter provides study specific 
materials and methods used and investigates the changes in viscoelasticity (µDMA and DMA), 
PCU chemical structure (HCI) and surface morphology (SEM).   
Chapter 5 compares the viscoelastic response of the BDyn devices and its individual 
elastomeric components. Further, this chapter compares the viscoelasticity of the untreated, in 
vitro and in vivo degraded BDyn components and the BDyn device assembled with degraded 
components. The chapter provides study specific materials and methods used and investigates 
the changes in viscoelasticity (DMA), PCU chemical structure (HCI and ATR-FTIR), macro-
morphological plastic deformation and surface morphology (SEM). The work in this chapter 
has been published in the Journal of Mechanical Behaviour of Biomedical Materials (Lawless et 
al., 2016) and the Journal of Biomedical Materials Research Part B: Applied Biomaterials 
(Lawless et al., 2018). 
Chapter 6 provides an overall discussion, future research necessary to further develop our 
understanding of the biostability of elastomeric orthopaedic devices and biomaterials and 
general conclusions of this thesis.   
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Background  
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2 Background 
2.1 Introduction 
This chapter provides information to understand subsequent chapters in this thesis. This 
chapter explains the mechanics of materials (section 2.2), the human vertebral column (section 
2.3), orthopaedic spinal devices, and more specifically, elastomeric posterior dynamic 
stabilisation devices (section 2.4), and the biostability of these biomaterials (section 2.5). 
2.2 Mechanics of materials 
When a force (F) is applied to a specimen, the specimen may deform due to this applied force 
(Figure 2-1). If deformation occurs and the original length (Lo) of the specimen alters to a new 
length (L), this deformation (ΔL) can be calculated and the stiffness (k) of the structure can be 
determined from: 
𝒌 =  
𝑭
𝑳𝑶−𝑳
 =  
𝑭
𝜟𝑳
    Equation 2.1 
 
Figure 2-1: Compression of a rectangular cross sectional area piece. Compressive force 
(F), original length (Lo) and length (L), after an applied force, are highlighted. 
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Further, this deformation (ΔL) can be expressed as a function of the initial length (Lo); this is 
known as strain (ε). A conventional description of strain (ε) is commonly known as nominal, 
engineering or Cauchy strain: 
𝝐 =
𝑳𝑶−𝑳
𝑳𝑶
=  
𝜟𝑳
𝑳𝑶
   Equation 2.2 
As the ratio is length versus length, strain is a dimensionless parameter.  
For the example above (Figure 2-1), the force, F, is applied over the entire area, A, of the 
surface (highlighted in Figure 2-1 in red). The applied force, over this area, induces a stress (σ) 
and is described by:  
𝛔 =  
𝑭
𝑨
      Equation 2.3 
Stress and strain are two of the most fundamental parameters used to describe the mechanics of 
materials (Gere and Timoshenko, 1997) and the stress that acts perpendicular to the surface 
(see Figure 2-1) is known as normal stress. For Figure 2-1, the strain calculated is axial strain. It 
can be witnessed in Figure 2-1 that the width and depth dimensions, of the squared specimen, 
have expanded as the specimen was compressed. The negative ratio of the lateral strain (εL) to 
the axial strain (ε) is known as Poisson’s ratio (Gere and Timoshenko, 1997). 
𝛖 = − 
𝝐𝑳
𝝐
      Equation 2.4 
The Poisson’s ratio of titanium alloys is 0.33 while the Poisson’s ratio of rubber ranges between 
0.45 and 0.5 (Gere and Timoshenko, 1997). The theoretical upper limit for Poisson’s ratio is 
0.5 for homogenous, isotropic materials and rubber comes close to this limit (Gere and 
Timoshenko, 1997). Studies (Briscoe et al., 1998; de Lima et al., 2015; Herbert et al., 2008) 
have assumed that materials have a specific Poisson’s ratio. However, the Poisson’s ratio is 
physically capable of exhibiting time dependent behaviour (Herbert et al., 2008).  
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2.2.1 Elasticity 
Scientist Robert Hooke (1635–1703) was one of the first people to investigate the elastic 
behaviour of materials (Gere and Timoshenko, 1997). Hooke’s description ut tensio sic vis 
(Blatz and Ko, 1962), which translates to “as the extension, so the force”, established the linear 
relationship between the applied load and resulting deformation (Gere and Timoshenko, 
1997). Hooke’s Law holds for linear-elastic materials in the linear-elastic region (see Figure 2-2). 
From the origin of the stress-strain curve for structural steel (Figure 2-2), the ratio of the stress 
and strain is linear in behaviour up to the proportional limit (Point A; Figure 2-2); the slope of 
this straight line is the Young’s Modulus (E).  
𝑬 =  
𝛔
𝝐
      Equation 2.5 
Past the proportional limit, the increment of stress per increment of strain reduces and the 
stress reaches a point where the specimen yields. At this point (Point B), the stress is known as 
the yield stress of the material. The specimen continues to yield i.e. there is an increase in the 
strain while there is minimal change in the stress (Point B to Point C).  
 
Figure 2-2: Typical stress-strain curve for structural steel. (A) Proportional limit, (B) yield 
stress (yield strength), (C) beginning of strain harden, (D) ultimate Tensile stress 
(ultimate strength) and (E) fracture point. The four regions are (i) linear, (ii) yielding, 
(iii) strain hardening and (iv) necking. Adapted from (Gere and Timoshenko, 1997). 
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At point C, the steel begins to undergo changes in the crystalline structure and these changes 
continue until the ultimate tensile stress (Point D); this region (iii) is known as strain hardening. 
Post the ultimate tensile strength point (Point D), the material begins to neck (region (iv)) and 
the specimen finally fractures (Point E).  
At the beginning of Point C, the cross-sectional area of specimen begins to decrease with 
increasing strain. If it is possible to measure the actual cross-sectional area and elongation, the 
true stress and true strain of the material can be calculated and the true stress at fracture (Point 
F); this stress is different to the engineering stress at fracture (Point E) as the engineering stress 
uses the cross-sectional area at the beginning of the tension test. 
For isotropic materials in the linear elastic region, the shear modulus (G) can be calculated 
from the Young’s modulus (E) and the Poisson’s ratio (𝛖): 
𝑬 = 𝟐𝐆(𝟏 +  𝝊)   Equation 2.6 
2.2.2 Viscosity 
Nine years after Robert Hooke’s discovery, Isaac Newton (1643–1727) published Philosophiae 
Naturalis Principia Mathematica (Barnes et al., 1989). Along with Newton’s Laws of motion in 
Principia, Newton postulated the idea of a viscous liquid; “The resistance which arises from the 
lack of slipperiness of the parts of the liquid, other things being equal, is proportional to the 
velocity with which the parts of the liquid are separated from one another” (Barnes et al., 1989). 
Today, the “lack of slipperiness”, or sometimes quoted in earlier translations as “the want of 
lubricity” (Franco and Partal, 2010), is known as viscosity and is a measure of the resistance to 
flow (Barnes et al., 1989). 
With Newton’s concept, when a layer of fluid moves with respect to another layer (Figure 2-3), 
the greater the internal friction, to promote movement, the greater the force and induced stress 
(Franco and Partal, 2010). In the nineteenth century, Claude-Louis Navier and George Gabriel 
Stokes independently described the three dimensional theory of the motion of a fluid and this 
led to the formation of Newton’s Law (Barnes et al., 1989; Franco and Partal, 2010). Similar to 
Hooke’s Law, Newton’s Law is a linear Law i.e., it assumes proportionality between shear stress 
(τ) and shear rate (?̇?) (Barnes et al., 1989). This proportionality between the shear stress and 
shear rate is the viscosity (μ) of the fluid: 
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𝝉 =  𝝁 
𝒅𝒖
𝒅𝒚
    Equation 2.7 
  
Figure 2-3: Newton’s Law of viscosity. The stationary layer, the moving layer, velocity (u) 
of the fluid, the shear stress (τ) and y position which is perpendicular to the flow. 
 
Fluids that have a shear stress linearly proportional to the shear rate are known as Newtonian 
fluids and one example of this is water. However, many fluids are considered non-Newtonian 
(Figure 2-4); i.e. the fluid does not follow Newton’s Law of viscosity. Non-Newtonian fluid 
behaviour can be characterised into different types: 
 Shear thickening (rheopectic); increase in viscosity with increase of shear rate  
 Shear thinning (thixotropic); decrease in viscosity with increase of shear rate 
 Bingham plastic; the fluid requires a specific shear stress before it begins to flow  
Fluids that are non-Newtonian include liquid body armour (shear thickening), paint (shear 
thinning), blood (shear thinning) and toothpaste (Bingham plastic). 
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Figure 2-4: Viscosity of a Newtonian fluid and the viscosity three different non-Newtonian 
fluids (shear thinning, shear thickening and Bingham plastic). Shear stress (τ) and shear 
rate (ẏ).  
The behaviour of some materials falls in between the classical Hookean elastic response and 
Newtonian viscous response; these materials are known as viscoelastic materials and the 
behaviour of these materials have been described by the term viscoelasticity.  
2.2.3 Viscoelasticity 
Viscoelastic materials exhibit both elastic and vicious properties (Haddad, 1995). They are 
characterised by a certain level of rigidity of an elastic body but, at the same time, the same body 
flows and dissipates energy by frictional losses as a viscous fluid (Haddad, 1995). This flow and 
dissipation of energy is due to internal mechanisms such as bond breakage, formation and 
dislocations (Haddad, 1995). A material’s viscoelastic properties can be quantified by quasi-
statically (creep, stress relaxation) and dynamically (dynamic mechanical analysis).  
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2.2.3.1 Quasi-static viscoelasticity 
Unlike elastic and viscous materials, when a load is applied to a viscoelastic material, a stress is 
induced and the deformation (ΔL; see Equation 2.2) does not stop at a constant value (Figure 
2-5). Instead, the deformation continues or ‘creeps’ over time until the strain equilibrates at a 
final displacement.  
 
Figure 2-5: Comparison of (a) induced stress versus strain response for (b) an elastic, (c) 
a viscous and (d) a viscoelastic material. Adapted from (Haddad, 1995) 
Once the load is removed, the residual strain reduces over time and it may disappear entirely 
(Haddad, 1995) thus, creating a hysteresis loop (see Figure 2-6). This hysteresis loops is caused 
by the viscoelastic nature of polymers (Menard, 2008) as under cyclical loading and unloading, 
viscoelastic material exhibit a phase lag which leads to a dissipation of mechanical energy (Liu 
and Qi, 2010). The area within the hysteresis loops represents the dissipated energy per 
volume, in a viscoelastic material, per cycle (Carbone and Persson, 2005; Li and Xu, 2007; Liu 
and Qi, 2010). 
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Figure 2-6: Hysteresis loop; Loading (Red) and Unloading (Blue) highlighted 
In contrast, when a deformation is applied to a viscoelastic material, the induced stress does not 
stop at a constant value. Instead, the stress ‘relaxes’ over time until the stress equilibrates at a 
final displacement (Figure 2-7). Depending on the vicious property of a viscoelastic material, the 
induced stress may decay to zero or equilibrate at a finite value (Haddad, 1995). 
 
Figure 2-7: (a) creep and (b) stress relaxation. Stress in (a) and the strain in (b) are 
plotted to a nominal value of ‘1’. 
 
 
  
Loading 
Unloading 
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2.2.3.2 Dynamic Mechanical Analysis (DMA) 
Unlike conventional creep and stress relaxation tests, Dynamic Mechanical Analysis (DMA) is a 
dynamic testing method used to determine the viscoelastic properties of a material or multi-
component structure. For DMA, the viscoelastic properties are measured following the 
application of an oscillating force to a specimen and analysis of the out-of-phase displacement 
response (Menard, 2008). The sinusoidal load and displacement timed data are recorded 
(Figure 2-8): 
 
Figure 2-8: Load and displacement sinusoidal waves 
Fourier analyses, of the displacement and load sinusoidal waves (Figure 2-8) are performed. 
From these analyses, the magnitude of the load (F*), the magnitude of the displacement (d*), 
the actual frequency (f) and the phase lag (δ) are measured. As seen on the plots below (Figure 
2-9), the magnitude of the displacement (d*) and the magnitude of the load (F*) are found at 
the major peak of the displacement and load fast Fourier transform plots (Figure 2-9), 
respectively. The peaks, in these plots, have been normalised by the dataset length. The actual 
frequency (f) is measured at the position of the major peak. The phase angles of the force and 
displacement, at the respective major peaks, are calculated and the units are radians. The 
difference between these phase angles equates the phase lag (δ).  
 15 
 
 
Figure 2-9: Fast Fourier transform plots of (left) displacement and (right) load. The 
magnitude of the displacement (d*) and the magnitude of the load (F*) are illustrated. 
With the magnitudes of the load (F*) and displacement (d*), from the Fourier analyses, the 
complex (dynamic) stiffness (k*) is then calculated: 
𝒌∗ =
𝑭∗
𝒅∗
     Equation 2.8 
A viscoelastic structure can be characterised in terms of storage and loss stiffness. The storage 
stiffness represents the elastic portion of the viscoelastic structure and it describes the ability of a 
structure to store (recoverable) energy, while the loss stiffness characterises the ability of the 
structure to dissipate (irrecoverable) energy through heat and internal motions (Menard, 2008; 
Placet and Foltête, 2010). Further, the storage stiffness is also referred to as the ‘real’ portion of 
k* while the loss stiffness is referred to as the ‘imaginary’ portion of k* (Haddad, 1995). By 
using the phase lag (δ) and the complex (dynamic) stiffness (k*), the storage stiffness (k’) and 
loss stiffness (k”) can be calculated: 
𝒌′ = 𝒌∗ 𝐜𝐨𝐬(𝜹)   Equation 2.9 
𝒌′′ = 𝒌∗ 𝐬𝐢𝐧(𝜹)   Equation 2.10 
  
d* 
F* 
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A shape factor (SF) is calculated to account for specimen geometry. SF normalises the load and 
displacement in terms of cross-sectional area and length, respectively. Therefore, the complex 
(dynamic) modulus (E*) can be calculated from the complex (dynamic) stiffness, thus, the 
viscoelastic properties of the specific material, instead of the structure, can be quantified. 
Further, by dividing the storage and loss stiffness by the shape factor SF, the storage (E’) and loss 
(E”) moduli, of the material, can be calculated: 
𝑬∗ =
𝒌∗
𝑺𝑭
     Equation 2.11 
𝑬′ =
𝒌′
𝑺𝑭
     Equation 2.12 
𝑬′′ =
𝒌′′
𝑺𝑭
     Equation 2.13 
When a viscoelastic material is subjected to a sinusoidal load, the strain response is neither in 
phase with the induced stress or out of phase by 90̊ (Ferry, 1980); being in phase the stress or 
out of phase by 90̊ would imply a perfectly elastic solid or viscous liquid (Figure 2-10). Thus, as 
the phase angle increases to 90̊, the stored energy becomes negligible compared to the 
dissipation of energy (Ferry, 1980). The tangent, tan(δ), is a useful parameter to understand the 
ratio of the dissipation of energy to the storage of energy in a material:  
𝐭𝐚𝐧 (𝜹) =
𝑬′′
𝑬′
     Equation 2.14 
 
Figure 2-10: Vectorial relationship between the complex (E*), storage (E’) and loss (E’’) 
moduli. A phase angle (δ ) close to 0° implies a more elastic solid material reponse. 
Adapted from (Ferry, 1980). 
 
 δ 
 17 
 
Frequency sweep viscoelastic experiments are commonly used to study polymer melt 
behaviour; however, for other applications, frequency sweep viscoelastic studies are the most 
neglected experiments (Menard, 2008). By using DMA, many biological materials have been 
shown to be frequency dependent viscoelastic materials. These materials include bladder 
(Barnes et al., 2015), bladder tumours (Barnes et al., 2016), articular cartilage (Cooke et al., 
2018a, 2018b; Espino et al., 2014; Lawless et al., 2017; Temple et al., 2016), cardiovascular 
tissue (Burton et al., 2017; Constable et al., 2018) and intervertebral discs (Gadd and Shepherd, 
2011; Leahy and Hukins, 2001; Zhou et al., 2014).   
2.3 Human Vertebral Column 
The human vertebral column is a complex, non-linear structure. The main functions of the 
vertebral column (Figure 2-11) are to provide support to the head, neck and trunk, to transfer 
forces to the lower limbs and to protect the spinal cord and cauda equina (Martini et al., 2012). 
Usually, the vertebral column consists of 33 irregular bones called vertebrae and these vertebrae 
are divided into five distinct regions: cervical (7), thoracic (12), lumbar (5), sacrum (5) and 
coccyx (4). The sacral and coccygeal vertebrae are fused while the cervical, thoracic and lumbar 
vertebrae are known as articulating vertebrae. 
 
Figure 2-11: Vertebal column. Illustration is in the public domain; plate 111 (Gray, 1918). 
 
Cervical 
Thoracic 
Lumbar 
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Each vertebra (Figure 2-12) consists of three parts: the vertebral body, the vertebral arch and the 
articular processes. The vertebral body is located anteriorly to the spinal canal and it transfers 
load along the axis of the vertebral column (Martini et al., 2012). The vertebral body itself 
comprises mainly of trabecular bone which is surrounded and supported by a thin layer of 
cortical bone. A thin, porous hyaline cartilage and fibrocartilage endplate is at the cranial and 
caudal ends of the vertebral body. Posterior to the vertebral body is the vertebral arch. The 
vertebral arch consists of the pedicles, the laminae, the spinous and transverse processes. The 
pedicles extend posteriorly from the vertebral body and connect to the laminae to create the 
vertebral foramina. The vertebral foramen, which begins at the atlas vertebra and ends at the L5 
lumbar vertebra, encloses the spinal cord and spinal meninges. Where the laminae meet, the 
spinous process projects posteriorly while the transverse processes projects laterally from where 
the pedicles and laminae connect. Also, where the pedicles and the laminae meet, the articular 
processes are located. Each articular process has a smooth surface, covered in hyaline cartilage, 
called an articular facet. At the facet joint, the superior articular facet, of the inferior vertebra, 
articulates with the inferior articular facet, of the superior vertebra (Martini et al., 2012). 
  
Figure 2-12: (left) Lumbar vertebrae and (right) sagittal section of the lumbar vertebra. 
Illustrations are in the public domain; plates 83 (left) and 92 (right) from (Gray, 1918) 
Between the vertebral bodies of the articulating vertebrae lies the intervertebral disc (IVD) 
(Figure 2-13). In total, there are 23 IVDs. The IVDs keep the vertebral bodies separated and 
contribute in the movement of the spinal column. The IVD is a frequency dependent 
viscoelastic structure (Gadd and Shepherd, 2011; Leahy and Hukins, 2001; Zhou et al., 2014) 
which comprises an annulus fibrosus (AF) and nucleus pulposus (NP) core. The AF is layered 
with orientated collagen fibre layers and it surrounds the NP. The NP is a gelatinous core 
consisting of collagen fibrils, proteoglycan and noncollagenous proteins (Kurtz and Edidin, 
2006). The NP compresses and displaces to facilitate in the movement of the vertebral column 
(Martini et al., 2012). The IVD is connected to the vertebral body endplates, called the 
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symphyseal joint, and the IVD acquires nutrients and fluids through the endplates (Figure 2-13 
(A)). 
 
Figure 2-13: Sagittal section views of lumbar vertebrae, intervertebral discs and 
ligaments. (A) sagittal view of the intervertebral disc and (B) sagittal view of two lumbar 
vertebrae, ligaments and intervertebral discs. Illustrations are in the public domain; plates 
298 (left) and 301 (right) from (Gray, 1918). 
In the vertebral column, seven different ligaments connect adjacent vertebrae (Martini et al., 
2012); these ligaments are the anterior longitudinal ligament, posterior longitudinal ligament, 
intertransverse ligaments, ligamentum flavum, facet capsular ligaments, interspinous ligament 
and supraspinous ligament. Ligaments are uniaxial structures and their functions are to stabilise 
the vertebral column (Martini et al., 2012), assist in movement and not to allow hyper-
movements of the vertebral column. Vertebral column muscles are grouped into three different 
groups: superficial layer, deep layer and spinal flexors. The purpose of the vertebral column 
muscles are to contract during vertebral column movements, make delicate adjustments of 
individual vertebrae and stabilise adjacent vertebrae (Martini et al., 2012).  
The spinal cord is part of the central nervous system. Its purpose is to transmit neurological 
signals from the brain to the peripheries (Martini et al., 2012). The spinal cord is surrounded by 
the spinal meninges. The spinal meninges are comprised of the dura mater, the arachnoid 
mater and the pia mater. The spinal meninges protect the neural tissues from the bony 
structures of the vertebral canal, provide physical stability, protect the blood vessels that deliver 
nutrients and oxygen to the spinal cord (Martini et al., 2012).   
(A) 
(B) 
Nucleus pulposus 
Annulus fibrosus 
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2.4 Orthopaedic Spinal Devices 
In England, approximately 80% of the population, at some point in their lives, will seek 
healthcare advice on spinal pain (NHS England, 2013). Of this 80%, the majority of people can 
be managed by primary care but approximately 5%, of the population, will endure long-term 
pain which will affect their quality of life (NHS England, 2013). Low back pain may be caused 
by one or multiple spinal structures. However, one of the structures commonly associated as a 
leading cause of low back pain is degeneration of the IVD (Palepu et al., 2012).  
The structure and composition of the IVD changes with age (Kurtz and Edidin, 2006) and 
degeneration of the IVD is part of ageing (Palepu et al., 2012) (Figure 2-14). However, the 
distinguishing effects of normal ageing and degeneration disc disease (DDD) of the IVD are 
hard to differentiate (Kurtz and Edidin, 2006). Biochemical changes, that occurs with ageing of 
the IVD, cause proteoglycans to become fragmented (Adams, 2004) which leads to dehydration 
of the NP. This results in biomechanical loading changes of the IVD and posterior elements 
(Pollintine et al., 2004) which can lead to further biochemical and cellular changes that result in 
the progression of the disc degeneration (Kurtz and Edidin, 2006). The aetiology of DDD is 
not fully understood (Kurtz and Edidin, 2006), but DDD is linked to multiple factors such as 
ageing, genetics, occupational factors, accidental back injuries, whole body vibration exposure, 
smoking and obesity (Battié et al., 2004; Kurtz and Edidin, 2006; Lumoa et al., 1998). Surgical 
intervention may be required for chronic back pain due to DDD and over 90% of spinal 
surgery procedures are due to degenerative issues (An et al., 2004; Palepu et al., 2012). 
(A)   (B)  
(C)   (D)  
Figure 2-14: IVD degeneration. (A) Healthy, non-degraded IVD, (B) moderately degraded 
IVD, (C) severely degraded IVD and (D) extremely degraded IVD. Reproduced from Kurtz 
and Edidin (2006) with a license agreement from Elsevier; this image in Kurtz and Edidin 
(2006) was adapted from Adams (2002). 
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2.4.1 Current Devices 
Spinal arthrodesis (fusion) is the standard surgical treatment for patients with a variety of 
degenerative, spinal disorders (Chamoli et al., 2014). In England, 3,559 primary lumbar 
fusions/disc replacements were performed in 2010-11 (NHS England, 2013) while in the U.S., 
488,000 spinal fusions were performed in 2011 (Weiss et al., 2014). Between 1998 and 2008, 
US hospital charges, for spinal fusion, increased from $4.3 billion to $33.9 billion (Rajaee et al., 
2012).  
Spinal fusion is the gold standard surgical treatment of low back pain caused by degenerative 
disorders (Schwarzenbach et al., 2010; Sengupta, 2004; van den Broek et al., 2012b) even 
though many problems such as prolonged recuperation time, adjacent segment degeneration 
and pseudarthrosis are associated with it (Serhan et al., 2011). To alleviate these problems, non-
fusion techniques have been suggested as an alternative (Cunningham et al., 2010; Serhan et al., 
2011). These non-fusion techniques have been developed with the assumption that maintaining 
biomechanical segment motion is better, for the vertebral column, than eliminating it with 
fusion (Cunningham et al., 2010). One rapidly evolving non-fusion technique, used for spine 
surgery, are pedicle screw fixation Posterior Dynamic Stabilisation (PDS) devices (Khoueir et 
al., 2007; Serhan et al., 2011). Many of these pedicle fixation PDS devices comprise of one or 
more viscoelastic components: BDyn (S14 Implants, Pessac, France), Dynesys (Zimmer Spine, 
Warsaw, IN, USA), CD HORIZON BalanC (Medtronic Sofamor Danek, Memphis, TN, 
USA), Elaspine (Spinelab, Winterthur, Switzerland), NFlex (Synthes Spine Inc., West Chester, 
PA, USA) and Transition (Globus Medical, Audubon, PA, USA). Even though the main 
function is similar, i.e. to limit the biomechanical movements of the fixated spinal segment 
(Palepu et al., 2012), these PDS devices are designed differently, and comprise of different 
biomaterials, to restrict spinal movement. 
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2.4.2 BDyn  
The BDyn device (S14 Implants, Pessac, France) is a PDS device that provides an alternative to 
fusion. This bilateral PDS device is designed to preserve intersegmental range of motion, 
reduce intradiscal pressure and alleviate loading of the facet joints. It can be used in the bridging 
of one segment level (vertebra-disc-vertebra) or multiple segment levels. The BDyn device 
consists of two elastomeric components, a mobile titanium alloy rod, a fixed titanium alloy rod, 
and it is fixed to the vertebrae by titanium alloy pedicle screws (Figure 2-15). The interaction of 
the mobile rod and the elastomeric components allow partial three-dimensional spinal 
movement.  
 
Figure 2-15: BDyn 1 level device fixed to the vertebrae (left) [Reproduced with kind 
permission from S14 Implants, Pessac, France. © S14 Implants], cross sectional view of 
the BDyn device (centre) and elastomeric components (right). The polycarbonate 
urethane (PCU) ring and silicone cushion components, along with the mobile and fixed 
rods, are highlighted. 
The BDyn device has been used in the treatment of degenerative lumbar spondylolisthesis 
(Gille et al., 2014) and an in vitro study has shown that the device can successfully limit the 
range of motion following a laminectomy of L4-L5 segment (Guerin et al., 2011). To date, it 
has been implanted in approximately 2,000 patients (S14 Implants, 2017). Recently, the BDyn 
device was incorporated in a novel dynamic growing rod proposed for use as a surgical 
treatment of early onset scoliosis (Gonzalez Alvarez et al., 2018). 
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2.4.3 Other polymeric posterior dynamic stabilisation devices 
The Dynesys dynamic stabilisation system (Zimmer Spine, Warsaw, IN, USA) is one of the first 
dynamic stabilisation systems (Wilke et al., 2009) and one of the most widespread PDS devices 
used (Schmoelz et al., 2012). In 2011, it was reported that Dynesys had been implanted in 
more than 42,000 patients (Shen et al., 2011). It comprises of a PCU spacer, a polyethylene 
terephthalate (PET) cord and titanium alloy pedicle screws (Bothmann et al., 2008; 
Cunningham et al., 2010; Lee et al., 2008; Welch et al., 2007). The interaction between the 
PCU spacer and the PET cord allow for restricted spinal movement. Similar to BDyn, Dynesys 
is a bilateral PDS device that can be instrumented over one or multi-spinal segments.  
In 2012, CD HORIZON BalanC (Medtronic Sofamor Danek, Memphis, TN, USA), a 
dynamic stabilisation system made of and polyetheretherketone (PEEK) and a silicone block, 
was launched. The silicone block is positioned between the pedicle screws and it is partially 
surrounded by PEEK. CD HORIZON BalanC is a bilateral system and has been successful 
used as a hybrid stabilisation system (Formica et al., 2015). 
The Elaspine device (Spinelab, Winterthur, Switzerland) comprises pedicle screws and a PCU 
rod. The PCU rod is connected to the pedicle screws by a locking clip mechanism. Elaspine 
device was designed to allow relatively homogenous load transmission for all spinal loading 
directions (Schmoelz et al., 2012).  
The NFlex stabilisation system (Synthes Spine Inc., West Chester, PA, USA) comprises 
titanium alloy pedicle screws and a PCU spacer. The PCU spacer is semi-rigid and in parts, it is 
surrounded by a titanium ring which the pedicle screws are locked to (Coe et al., 2012). The 
NFlex device can be used for single level or multiple spinal levels (Coe et al., 2012). 
The Transition stabilisation system (Globus Medical, Audubon, PA, USA) is somewhat similar 
to Dynesys device as it comprises of titanium alloy pedicle screws, PET cord and PCU spacers 
(Sengupta et al., 2013). The difference with the Dynesys device is that the Transition device 
consists of two PCU spacers; one spacer at the instrumented level between the pedicle screws 
while the other spacer is above the superior pedicle screw. The design and positioning of the 
PCU spacers is to allow a natural compression across the spinal segment and reduce the 
possibility of screw breakage (Sengupta et al., 2013).  
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2.5 Biostability 
2.5.1 Biostability of polyurethane-based biomaterials  
The human body is an aggressive environment for biomaterials (Ramakrishna et al., 2001; 
Stokes et al., 1995). Once a device is implanted, the human body reacts to the implanted 
specimen with a foreign body attack and the body’s response is to attack and destroy the foreign 
body (Christenson et al., 2007). At the implantation site, monocytes migrate to the area and 
differentiate into macrophages (Christenson et al., 2007). The implant is too large to be 
phagocytosed (the process, the macrophages adhere and fuse to form foreign body giant cells 
(FBGCs) (Christenson et al., 2007). Adherent macrophages and FBGCs, to the surface of the 
biomaterial, are known to lead the biodegradation of biomaterials and subsequent clinical 
device failure (Anderson et al., 2008). At the cell membrane-biomaterial surface interface, the 
macrophages and FBGCs release degradative agents such as reactive oxygen intermediates 
(oxygen free radicals), enzymes and acid (Anderson et al., 2008; Christenson et al., 2007; 
Heiple et al., 1990; Sheikh et al., 2015; Wright and Silverstein, 1983); this has been described 
as frustrated phagocytosis (Anderson et al., 2008; Henson, 1971a, 1971b). The susceptibility of 
a biomaterial to degradation, due to these agents at the cell-biomaterial interface, is dictated by 
the chemical structure of the biomaterial (Anderson et al., 2008; Sheikh et al., 2015).  
Since the 1950s, polyurethanes (PUs) have been investigated for numerous biomedical 
applications (Ghanbari et al., 2009) due to its biocompatibility, biostability, flexibility and 
toughness (Chandy et al., 2009). The chemical composition of PUs allow it to be tailored to 
specific requirements (Kanyanta and Ivankovic, 2010) which makes it a suitable material for 
various types of implantable devices (Chandy et al., 2009). Over the years, numerous hard and 
soft segment combinations have been utilised for a specific purpose, i.e. increasing the 
biostability of the biomaterial. The earliest application of PUs was in cardiovascular applications 
(Akutsu et al., 1959; St John, 2014) and these early PUs utilised a polyester soft segment 
(Ghanbari et al., 2009; Griesser, 1991). Due to the hydrolytic instability of polyester urethanes, 
the more stable polyether soft segment was used (Griesser, 1991; Stokes et al., 1987).  
Polyether urethanes (PEU) were used in many biomedical applications such as artificial heart 
valves, pacemaker leads, blood pumps and catheters (Ratner et al., 1988; Thoma and Phillips, 
1987; Zhao et al., 1991). Along with increased biostability over polyester urethane, PEU offered 
high tensile strength and resistance to flex fatigue (Ratner et al., 1988). However, in the late 
1980s, PEU pacemaker leads clinically failed (Anderson et al., 2008; Stokes, 1988; Stokes et al., 
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1995; Thoma and Phillips, 1987). Explanted PEU leads displayed long term biodegradation 
with the presence of environmental stress cracks (ESCs) and metal ion oxidation (MIO) 
(Anderson et al., 2008; Kao et al., 1994; Sheikh et al., 2015; Thoma and Phillips, 1987; Zhao et 
al., 1993). These ESCs are caused by interaction of macrophages and FBGCs, by frustrated 
phagocytosis, at the cell-biomaterial interface (Anderson et al., 2008; Christenson et al., 2007; 
Kao et al., 1994; Zhao et al., 1991, 1993). While MIO of the PEU pacemaker leads was caused 
by the interaction of the metallic component and oxidation catalysed by corrosion products 
(Stokes, 1988; Stokes et al., 1995). To increase the biostability, polycarbonate urethanes (PCU) 
were suggested to provide oxidative and hydrolytic stability (Stokes et al., 1995). Laboratory 
experiments have demonstrated that PCU is more biostable than PEU (Christenson et al., 
2004a; Tanzi et al., 1997; Wiggins et al., 2004). Due to this superiority in biostability, PCU 
components have been used in cardiovascular (Chandy et al., 2009; Dang et al., 2014; Hartford, 
2013) and orthopaedic (Cipriani et al., 2013; Gille et al., 2014; Schmoelz et al., 2003) 
applications. 
2.5.2 Explanted devices and specimens (in vivo degradation) 
From the mid-1990s, PCUs have been used in various orthopaedic devices especially in 
dynamic spinal fixation (Ward and Jones, 2011); see sections 2.4.2 and 2.4.3. As the body 
breaks down biomaterials by numerous degradation methods, which includes oxidative, 
hydrolytic and enzymatic, it is important to examine explanted implants by a retrieval analysis. 
A retrieval analysis gives insight into the implant’s performances and investigates whether the 
implant, and its material components, has been affected from the biological environment (Kurtz 
et al., 2009).  
In relation to polymeric posterior dynamic stabilisation devices, Dynesys has been one of the 
most investigated devices with regards to retrieval studies (Cipriani et al., 2013; Ianuzzi et al., 
2010; Neukamp et al., 2015; Shen et al., 2011; Trommsdorff et al., 2004a, 2004b). By analysing 
the chemical structure, retrieval studies of explanted Dynesys devices have demonstrated 
biological oxidative degradation of the PCU components (Cipriani et al., 2013; Ianuzzi et al., 
2010; Neukamp et al., 2015). This oxidation of PCU components was not a surprise as 
Christenson et al. (2006a) demonstrated that PCU is vulnerable to in vivo oxidative degradation. 
To assess the effect of the in vivo degradation mechanisms on these biomaterials, studies have 
attempted to replicate the biodegradation in an in vitro set-up.  
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2.5.3 Biodegradation methods (in vitro degradation) 
In vitro biostability studies are useful for relativistic comparisons between implantable 
biomaterials and to provide directional guidance for in vivo studies (Wilkoff et al., 2015); these 
in vitro studies include enzymatic, oxidative and hydrolytic degradation. At the cell/biomaterial 
interface, adherent macrophages and FBGCs generate localised concentrations of reactive 
oxygen intermediates (oxygen free radicals), enzymes and acid (Anderson et al., 2008; 
Christenson et al., 2007; Heiple et al., 1990; Sheikh et al., 2015; Wright and Silverstein, 1983). 
Studies identified cholesterol esterase (CE) as the most active enzyme in polyurethane 
degradation (Christenson et al., 2006b; Labow et al., 1999). CE was used to degrade a 
commercially available PEU (Elasthane 80A) and a PCU (Bionate 80A) and this study 
concluded that oxidation, rather than enzymatic hydrolysis, is the primary mechanism for the 
degradation of PEUs and PCUs (Christenson et al., 2006b).  
Two common degradation methods, that are used to evaluate polymeric materials of an 
implantable device, are oxidation and hydrolysis. Oxidative degradation is defined as (ISO, 
2010): 
“scission of chemical bonds in a polymer by the attack of one or more oxidising agents” 
Numerous in vitro oxidation methods have been described in the literature: Hydrogen peroxide 
with silver nitrate (Thoma and Phillips, 1987), silver nitrate and lactic acid sodium salt solution 
(Takahara et al., 1991), hydrogen peroxide and nitric acid (Tanzi et al., 1997), nitric acid 
(Erdodi et al., 2010; Kang et al., 2010) and mixtures of hydrogen peroxide with cobalt chloride 
(see Table 2-1). 
A popular method of degrading polymers in an in vitro scenario is by using hydrogen peroxide 
(H2O2) and cobalt (II) chloride (CoCl2). Over the years, numerous quantities of H2O2 and 
CoCl2 have been examined (see Table 2-1). These methods have used various temperatures, 
quantities of hydrogen peroxide, cobalt chloride, and time period (Table 2-1). 
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Table 2-1: Published in vitro degradation methods. Number of days per solution changes 
(days); Mean temperature (Temp). [1] Pre-treated with human plasma (α-macroglobulin) 
at 37°C for 7 days; [2] Solution was in a spongy glass wool; [3] Stated that the degradation 
method was based on Zhao et al. (1995) method but degraded for 3 months; [4] Time of 
experiment read from a graph. Also, changes of solution varied (which is seen from the 
graph); [5] Specimens were treated with 0.5%, 1%, 2%, 3%, 10%, 20% and 50% H2O2; [6] 
Some specimens were pre-treated with human plasma (α-macroglobulin) at 37°C for 7 
days or glass wool. 
Lead author Year H2O2 CoCl2 Time Days  Temp(°C) 
K. Stokes (1987) 3% - 6 m 2-3 37 
B.D Ratner (1988) 3% - 1 d - 37 
B.D Ratner (1988) 3% - 7 d  2 37 
J.R Frautschi (1993) 3% - 180 d 2-3 37 
Q.H Zhao [1] (1993) 10% 0.1 M 10 d 3 50 
G.F Meijs (1993) 25% - 1 d - 100 
G.F Meijs (1993) 25% - 4 & 14 d 2 100 
Q.H. Zhao [2] (1995) 1.63 M 0.05 M  1 m 3-4 37 
M.A Schubert [1] (1995) 10% 0.1 M 9, 12 & 15 d 3 37 
M. Tanzi (1997) 20% - 21 d 3-4  50 
M.A Schubert (1997) 20% 0.1 M 12 d 3  37 
D. Martin [1] (2001) 10% 0.1 M 10 & 20 d 2-3  50 
E.M Christenson (2004b) 20% 0.1 M 24 d 3  37 
I. Khan (2005a) 3% - 3 m 7 37 
I. Khan [3] (2005a) 1.63 M 0.05 M 3 m 3-4 37 
E.M Christenson (2005) 20% 0.1 M 36 d 3  37 
E.M Christenson (2006b) 20% 0.1 M 24 d 3 37 
B. Ward (2006) 3% - 105 & 252 d 2-3  37 
D. Sarkar (2007) 5% 10% 20% 0.1 M 3, 7, 15 & 22 d  7 37 
J. McBane (2007) 20% - 1 & 3 d 1 37 
R. Hernandez (2008) 20% 0.1 M 24, 48 & 72 d 3 37 
T. Chandy (2009) 20% 0.1 M 1, 3, 5, 7, 10 m 3-4 37 
S. Jewrajka (2009) 20% 0.1 M 40 3-4 50 
J. Kang [4] (2010) 20% 0.1 M 100 d approx. Varied 37 
G.N Arjun (2012) 20% 0.1 M 90 d 7 45 
Y. Andriani (2013) 20% 0.1 M 28 & 49 d 4 37 
N. Arora (2013) 20% 0.1 M 7 d - 37 
D.K Dempsey (2014) 3% - 365 d 7 37 
D.K Dempsey (2014) 20% 0.1 M 36 d 3 37 
A. Weems [5] (2017) Varied - 36, 45,140 d 3 37 
A. Weems [5] (2017) 20% 0.1 M Varied 3 37 
G. Gallagher [6]
 
(2017) 20% - 72 d 3-4 37 
G. Gallagher [6] (2017) 20% 0.1 M 72 d 3-4 37 
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The mixture of H2O2 and CoCl2 induces a Haber-Weiss reaction that creates hydroxyl radicals. 
This mixture and creation of these hydroxyl radicals have been deemed sufficient in the in vitro 
degradation of polymer as these radicals are present at the cellular/polymer interface of the 
biomaterial; this is similar to the oxygen radicals that are present in vivo (Christenson et al., 
2007). 
𝐶𝑜++ +  𝐻2𝑂2  →  𝐶𝑜
+++ +  𝐻𝑂− +  𝐻𝑂●  
The most popular of these H2O2 and CoCl2 methods (Table 2-1) to replicate oxidation is the 
20% H2O2 and 0.1M CoCl2 solution at 37°C (Andriani et al., 2013; Arora et al., 2013; Chandy 
et al., 2009; Christenson et al., 2006b, 2005, 2004a; Dempsey et al., 2014; Gallagher et al., 
2017; Hernandez et al., 2008; Kang et al., 2010; Sarkar and Lopina, 2007; Schubert et al., 1997; 
Weems et al., 2017). The reason for this is that the H2O2 and CoCl2 method accurately 
reproduces the in vivo effect, after one year, in 24 days (Christenson et al., 2006b). This in vitro 
method has been shown to reproduce chemical and physical degradation similar to in vivo 
oxidative degradation of PEU and PCU after one year in a Sprague-Dawley rat model 
(Christenson et al., 2006a).  
To standardise oxidative degradation of polymeric materials, the International Organisation for 
Standardisation (ISO) published an in vitro oxidative degradation method. A test solution 
suggested for oxidation is the use of 3% H2O2  at 37 ± 1 °C for up to one year (ISO, 2010) and 
this 3% H2O2 method has been used previously (see Table 2-1). A recent study by Dempsey et 
al. (2014) degraded commercially available PCU and PCU with silicone biomaterials and 
compared the ISO 3% H2O2 method to the 20% H2O2  and 0.1 M  CoCl2 method. For the 
degradation of PCU, Dempsey et al. (2014) concluded that the 3% H2O2 method does not 
simulate an oxidative environment and that the 20% H2O2  / 0.1 M  CoCl2 method should be 
used for predicting oxidative stability of segmented polyurethanes.  
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Hydrolytic degradation is defined as (ISO, 2010): 
“scission of chemical bonds in a polymer by the attack of water” 
Water is a very loose term for the definition as it can have a “neutral, acidic of alkaline pH 
value and can contain additional chemical compounds or ions”  (ISO, 2010). In ISO 10993-13, 
there are two hydrolytic degradation methods: Real-time degradation test and accelerated 
degradation test. The recommended solution for both degradation tests is the same with either 
(ISO, 2010):  
 Grade 2 water for analytical laboratory use in accordance with ISO 3696 
 Buffer; see ISO 13781 for examples. 
Phosphate buffer saline (PBS) solution is one particular buffer listed in ISO 13781 and this 
buffer has been used in previous studies in the degradation of segmented polyurethanes 
(Chaffin et al., 2014, 2012; Khan et al., 2005a; Mishra et al., 2015). However, the difference 
between the real-time and accelerated degradation tests is the temperature at which the solution 
should be; real-time solution temperature is 37 ± 1°C while accelerated solution temperature is 
70 ± 2°C (ISO, 2010). By utilising a higher temperature, the accelerated method allows the 
prediction of the effect of ageing. A common method is the assumption that the rate of ageing is 
increased by a factor (Hukins et al., 2008):  
𝒇 = 𝟐
𝜟𝑻
𝟏𝟎⁄      Equation 2.15 
where, 
𝜟𝑻 = 𝑻 −  𝑻𝒓𝒆𝒇    Equation 2.16 
For equation 2.16, T refers to the elevated temperature the biomaterial is degraded at while Tref 
refers to the reference temperature i.e. the temperature of the human body. As an example, for 
equation 2.15 and 2.16, if a biomaterial is degraded at 70°C for 76 days, this is equivalent to just 
over 2 years in the body at 37°C. 
  
 30 
 
Studies have used elevated temperatures (Tref > 37°C) to predict properties of hydrolytically 
degraded biomaterials (Chaffin et al., 2014, 2012; Mahomed et al., 2015; Mishra et al., 2015; 
Pretsch et al., 2009). However, recently, Padsalgikar et al. (2015) highlighted issues in using the 
accelerated degradation tests as the predicted long-term in vitro performance did not correlate 
to the in vivo performance. 
This correlation issue between in vitro predictions and in vivo assessment was seconded by 
Wilkoff et al. (2015). Optim (OPT) cardiac lead insulation (St. Jude Medical, USA), which is 
sometimes referred to as ElastEon 2A (E2A) biomaterial (AorTech, Surrey, UK), is segmented 
polyurethane with polydimethylsiloxane (PDMS) and polyhexamethylene oxide (PHMO) soft 
segments. After 4-5 years in vivo implantation, Wilkoff et al. (2015) discovered that the 
molecular weight of OPT decreased by approximately 20% while Chaffin et al. (2012) in vitro 
accelerated treatment, at 85°C approximated to six years at 37°C, of E2A would lose over 50% 
of its molecular weight. Further, OPT ultimate tensile strength (UTS) decreased by 
approximately 20-25% after 4-5 years of implantation (Wilkoff et al., 2015) while the 
accelerated in vitro predicted a decrease, in the UTS, by over 50% (Chaffin et al., 2012).  
To accurately predict the changes of a biomaterial at 37°C by utilising a higher temperature and 
a short degradation time period, i.e. applying the Time Temperature Superposition, the 
biomaterial in question must respond equally to temperature in the temperature range being 
tested (Han and Kim, 1993; Padsalgikar et al., 2015). Temperature independence can be 
illustrated with the use of Dynamic Mechanical Temperature Analysis (DMTA) and 
investigating the linearity of storage (E’) and loss (E’’) moduli in a log-log plot (Han and Kim, 
1993; Padsalgikar et al., 2015). 
 
  
 31 
 
2.6 Chapter Summary 
In summary: 
 The human vertebral column is a complex, non-linear, multi-component structure. 
 The viscoelastic behaviour of different biological structures, like the intervertebral disc, 
is frequency dependent.  
 Unlike creep and stress relaxation, dynamic mechanical analysis is a dynamic method to 
quantify the frequency dependent viscoelastic properties of a multi-component structure 
or material.  
 To alleviate problems associated with spinal fusion, the gold standard surgical treatment 
of low back pain, non-fusion techniques, such as posterior dynamic stabilisation devices, 
have been suggested as an alternative.  
 Some of these posterior dynamic stabilisation devices have elastomeric biomaterial 
components.  
 These elastomeric components have been shown to be susceptible to oxidative and 
hydrolytic degradation in the human body. 
 The understanding of the effect of degradation on the frequency dependent viscoelastic 
properties of these elastomeric posterior dynamic stabilisation devices, and its 
biomaterials, is unknown. 
Information about the materials and methods used in this thesis is provided in the next chapter. 
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Chapter 3 
 
Materials and methods  
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3 Materials and methods  
This chapter provides detailed information about the materials (sections 3.1 and 3.2), 
degradation protocols (sections 3.3 and 3.4), chemical structure characterisation (section 3.5), 
viscoelastic testing (sections 3.6 and 3.7), surface morphology characterisation (section 3.8) and 
statistical analyses (section 3.9) methods used in this thesis. Study specific methods are 
discussed in the materials and methods sections (sections 4.2 and 5.2) in subsequent chapters 
(Chapters 4 and 5).  
3.1 Long-term implantable biomaterials 
3.1.1 Biomaterials 
Five different commercially available, long-term implantable polycarbonate urethane (PCU) 
biomaterials were used for testing: 
 Bionate II 80A (DSM Biomedical, Exton, PA, USA)  
 Quadrathane ARC 80A (Biomerics, Salt Lake City, UT, USA) 
 Quadrathane ARC 80A-B20 (Biomerics, Salt Lake City, UT, USA) 
 ChronoFlex C 80A (AdvanSource Biomaterials, Wilmington, MA, USA) 
 ChronoSil AL 80A 5% (AdvanSource Biomaterials, Wilmington, MA, USA) 
Bionate II is an aromatic PCU with a hard segment of methylene di(p-phenyl isocyanate) (MDI) 
and butane diol (BDO) and a polycarbonate glycol soft segment (Dempsey et al., 2014). 
Quadrathane and Quadrathane B20 are aromatic PCUs that have an MDI/BDO hard segment 
and a polycarbonate based soft segment (Mishra et al., 2015). The difference between 
Quadrathane and Quadrathane B20 is that Quadrathane B20 is compounded with a 
radiopacifier (20%, by weight, barium sulfate).  
ChronoFlex C 80A is an aromatic PCU that has a MDI/BDO hard segment and a 
polycarbonate based soft segment (Mishra et al., 2015). The only biomaterial, out of the five 
being analysed in this thesis that is not aromatic is ChronoSil AL 80A 5%. ChronoSil 5% is an 
aliphatic PCU with a 5% silicone additive; the addition of silicone has been shown to increase 
the biostability of PCUs (Christenson et al., 2005).  
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3.1.2 Specimen Manufacturing 
All of the biomaterials were purchased in pellet form and they were injection moulded to the 
specific manufacturer’s recommendations at the Warwick Manufacturing Group (University of 
Warwick, Coventry, UK). The pellets were moulded in 150 mm × 150 mm sized plaques (ISO, 
2014) with a thickness of 3 mm ± 0.2 mm. As per implantation protocols, the plaques were 
sterilised by Ethylene Oxide (EtO) (Steriservices, Bernay, France). The EtO sterilisation 
process involves 3 cycles with an EtO concentration of 600 mg/L for 4 hours at 43°C. No 
separate aeration was performed as it is performed in the sterilisation chamber. The plaques 
were labelled for the oxidation or hydrolysis studies; this was to ensure no batch differences. 
Next, ASTM D1708 specimen shaped dumbbells were cut (ASTM, 2013) by using a die cutter 
(Wallace Instruments, Cambridge, UK) on a Wallace Hand Operated Specimen Cutting Press 
(Wallace Instruments, Cambridge, UK) (Figure 3-1 (A) and (B)). From each plaque, 23 
specimens were cut (Figure 3-1 (C)). 
 
Figure 3-1: (A) Wallace Hand Operated Cutting Press, (B) Quadrathane 80A-B20 before 
dumbbell specimen cutting and (C) Quadrathane 80A after specimen cutting. 
  
(A) 
(B) 
 
 
 
 
 
  (C) 
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Once a plaque was cut into 23 specimens, the specimens were numbered and an Excel random 
order generator function (Microsoft, Redmond, Washington, USA) was used to separate the 
specimens into three groups; Control (n = 6), Degradation Group A (n = 6) and Degradation 
Group B (n = 6); information on these degradation groups can be found in sections 3.3 and 3.4. 
The ASTM D1708 standard specimen shaped dumbbells (see Figure 3-2 and section 8.1 
Appendix A) were used for Chapter 4 - Biostability of PCU biomaterials; this specimen shape 
has been widely used in previous biostability studies (Chaffin et al., 2012; Christenson et al., 
2006a; Dempsey et al., 2014; Schubert et al., 1997, 1995; Stokes et al., 1987; Wiggins et al., 
2004; Wilkoff et al., 2015). 
 
Figure 3-2: Tensile ASTM D1708 dumbbell specimens of the five different long-term 
implantable biomaterials. From left to right; Quadrathane ARC 80A, ChronoFlex C ARC 
80A, Bionate II 80A, Quadrathane ARC 80A-B20 (radiopacifier additive) and ChronoSil AL 
80A 5%.  
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3.2 BDyn 
The BDyn posterior dynamic stabilisation device (S14 Implants, Pessac, France) consists of two 
elastomeric components, a mobile titanium alloy rod, a fixed titanium alloy rod, and it is fixed 
to the vertebrae by titanium alloy pedicle screws (Figure 2-15). The titanium alloy used for the 
mobile rod, the fixed rod, the housing is Ti-6Al-4V. The two elastomeric components are a 
PCU ring (Bionate II 80A, DSM Biomedical, Exton, PA, USA) and a silicone cushion (MED 
4770, NuSil Technology LLC, Carpinteria, CA, USA) (Figure 3-3 and section 8.2 Appendix B).  
Both elastomeric components are ion treated. This ion treatment has been shown to increase 
scratch resistance of polymers by increasing the hardness of the surface layer (Kondyurin and 
Bilek, 2015; Shi et al., 2001) and it has been shown to improve the tribological properties of 
ultra-high molecular weight polyethylene (UHMWPE), high-density polyethylene (HDPE) and 
low-density polyethylene (LDPE) used in total joint replacements (Abdul-Kader et al., 2010; Shi 
et al., 2001; Sze and Tay, 2006). As per implantation protocols, the BDyn device was sterilised 
by EtO (Steriservices, Bernay, France). Similar to the EtO sterilisation process described in 
section 3.1.2, the sterilisation process involves 3 cycles with an EtO concentration of 600 mg/L 
for 4 hours at 43°C. No separate aeration was performed as it is performed in the sterilisation 
chamber. 
 
Figure 3-3: From left to right; The BDyn 1 level device, PCU ring (Bionate II 80A) and  
silicone cushion (MED 4770). The housing, mobile and fixed rods are all titanium alloy 
(Ti-6Al-4V).     
 
Mobile rod 
Housing 
Silicone cushion 
PCU ring 
Fixed rod 
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3.3 In vitro oxidation 
To prepare the oxidative solutions, 30% Hydrogen Peroxide (H2O2) (Fisher Scientific, 
Loughborough, UK) and 0.1 M cobalt (II) chloride hexahydrate (CoCl2.6H2O) (CoCl2) (Sigma 
Aldrich, Gillingham, Dorset, UK) were used. The 30% H2O2 was diluted, using deionised 
water, to 3% H2O2 and 20% H2O2 concentration levels. All mass measurements of H2O2, 
deionised water and solution to be added to each tube was measured using an A&D EK-2000i 
top pan balance (A&D Instruments, Abingdon, Oxfordshire, UK). An Ohaus GA200D 
analytical balance (Ohaus Corporation, Parsippany, NJ, USA) was used for the mass 
measurements of CoCl2. The in vitro oxidative degradation of all biomaterials and BDyn 
components were performed in 50 mL medical grade polypropylene tubes (Corning, 
Wiesbaden, Germany) (Figure 3-4).  
For the 3% method, the oxidation of the biomaterials was performed at 37 ± 1°C in a water bath 
(JB5 Water Bath, Grant Instruments, Cambridgeshire, UK). The solution was changed every 7 
days for 52 weeks (Dempsey et al., 2014). The 20% H2O2/0.1 M CoCl2 accelerated ageing of 
the biomaterials were performed at 37 ± 1°C in a water bath (JBN18 Water Bath, Grant 
Instruments, Cambridgeshire, UK). To maintain a relative constant concentration of radicals 
(Dempsey et al., 2014; Hernandez et al., 2008), the solution was changed every 3 days and the 
degradation period lasted 24 days. After the 3% (52 weeks) and 20% H2O2/0.1 M CoCl2 (24 
days) degradation periods, the specimens were rinsed with deionised water and were vacuum 
dried for 48 hours at room temperature. 
            
Figure 3-4: (A) 3% H2O2 (B) 20% H2O2/0.1 M CoCl2 and (C) BDyn silicone component in the 
20% H2O2/0.1 M CoCl2 solution. 
 
(A) (B) (C) 
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3.4 In vitro hydrolysis 
Phosphate buffer saline (PBS) tablets (Sigma Aldrich, Gillingham, Dorset, UK) were used to 
prepare the hydrolytic solutions. The PBS tablets were diluted, using deionised water, to the 
appropriate concentration levels; one tablet dissolved in 200 mL of deionised water. This yields 
a solution of 0.01 M phosphate buffer, 0.0027 M potassium chloride (KCl) and 0.137 M 
sodium chloride (NaCl) at pH 7.4 which is similar to the buffer solution recommended in ISO 
13781:2017 (ISO, 2017); this buffer is suggested for hydrolytic degradation in ISO 10993-13 
(ISO, 2010). All mass measurements of the PBS solution, which was individually added to each 
tube, were measured using either an Ohaus Emerald 500 portable balance (Ohaus 
Corporation, Parsippany, NJ, USA) or an A&D EK-2000i top pan balance (A&D Instruments, 
Abingdon, Oxfordshire, UK). Similar to the in vitro oxidation experiments (section 3.3), in vitro 
hydrolytic degradation experiments of all biomaterials were performed in 50 mL medical grade 
polypropylene tubes (Corning, Wiesbaden, Germany) (Figure 3-4). 
Both real-time and accelerated degradation tests of the biomaterials were performed in separate 
JBN18 water baths (JBN18 Water Bath, Grant Instruments, Cambridgeshire, UK) with real-
time and accelerated temperatures of 37 ± 1°C and 70 ± 2°C (ISO, 2010), respectively. The 
solution was changed every 7 days for 52 weeks. After the degradation period the specimens 
were rinsed with deionised water and were vacuum dried for 48 hours at room temperature. 
3.5 Spectroscopy 
3.5.1 Infra-red spectroscopy 
Infra-red spectroscopy is used to identify and quantify the chemical structure of solids, liquids 
or gases. The chemical structures of such materials are quantified by the interaction of infra-red 
radiation with the matter. Alongside mass spectrometry (MS) and nuclear magnetic resonance 
(NMR) spectroscopy, Fourier transform infra-red (FTIR) spectroscopy is one of the three 
recommended techniques to quantify the chemical structure of polymers (Dorrepaal et al., 
2018; ISO, 2009) and one widely used FTIR technique is attenuated total reflectance Fourier 
transform infra-red (ATR-FTIR). 
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3.5.2 Attenuated total reflectance Fourier transform infra-red (ATR-FTIR) 
For attenuated total reflectance Fourier transform infra-red (ATR-FTIR) spectroscopy, the 
infra-red beam passes through the ATR crystal, which is in contact with the surface of the 
specimen, and reflects off the surface. An evanescent wave is due to the reflection and this wave 
penetrates into the specimen (approximately 2 µm). The beam exits the ATR crystal and is 
collected by the detector. ATR-FTIR has been used in characterising degradation of: 
 Explanted orthopaedic (spinal) devices (Cipriani et al., 2013; Ianuzzi et al., 2010; 
Neukamp et al., 2015; Shen et al., 2011; Trommsdorff et al., 2004b);  
 Explanted cardiac leads insulation (Wiggins et al., 2001; Wilkoff et al., 2015);  
 Explanted biomaterials from animal models (in vivo degradation) (Christenson et al., 
2006a, 2004b, Simmons et al., 2008, 2004);  
 Degradation of biomaterials from laboratory experiments (in vitro degradation) 
(Dempsey et al., 2014; Hernandez et al., 2008; Lawless et al., 2018; Mahomed et al., 
2010; Padsalgikar et al., 2015; Schubert et al., 1997). 
ATR-FTIR point spectroscopy was performed using a Bruker LUMOS spectrometer (Bruker 
Optics, Billerica, MA, USA). Spectra were recorded in absorbance mode with a Germanium 
ATR crystal. Twenty spectra, with a spectral resolution of 2 cm-1 between 600 and 4000 cm-1, 
were acquired and mean averaged to obtain each spectrum (Simmons et al., 2004). This point 
spectroscopy method was utilised for the in vitro oxidation of the BDyn components (chapter 5 
- Biostability of the BDyn Posterior Dynamic Stabilisation device) and further information of 
the chemical structure characterisation can be found in section 5.2.2.1. All other chemical 
structure characterisation was performed with hyperspectral chemical imaging (HCI).  
3.5.3 Hyperspectral chemical imaging (HCI) 
Hyperspectral chemical imaging (HCI) combines spectroscopy with imaging and it enables the 
acquisition of spatially localised spectra across the surface of a material (Dorrepaal et al., 2018; 
Gowen and Dorrepaal, 2016; Mukherjee and Gowen, 2015). HCI is a technique that has been 
utilised for biochemical processes at the cellular level (Kuimova et al., 2009) and the evaluation 
of the molecular state of polymer matrices for drug release (Chan and Kazarian, 2006). 
Recently, a study, in which I am co-first author, demonstrated that ATR-FTIR HCI reveals 
spatial variations in the degradation of polymer biomaterials (Dorrepaal et al., 2018). Further, 
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the use of HCI in biodegradation of biomaterials is a more objective technique, than 
conventional point ATR-FTIR spectroscopy methods (Dorrepaal et al., 2018). 
HCI by ATR-FTIR was performed using a Thermo-Scientific Nicolet iN10Mx infra-red 
microscope (Thermo-Fisher Scientific, Madison, WI, USA). Spectra were recorded in 
absorbance mode with a slide-on Germanium ATR micro tip crystal. Imaging factors such as, 
aperture size, spatial resolution, distance between each pixel, etc. are study specific and further 
information of these parameters are in chapters 4 - Biostability of PCU biomaterials and 
chapter 5 - Biostability of the BDyn Posterior Dynamic Stabilisation device (sections 4.2.2 and 
5.2.2, respectively). The scale bars on all hyperspectral chemical images and hyperspectral 
chemical maps (HCMs) are arbitrary units (AU). 
3.6 Micro-dynamic mechanical analysis (μDMA) 
The micro-level viscoelastic properties of all biomaterials, undegraded and degraded by 
oxidation and hydrolysis, were measured using a customised nano-indenter testing machine 
(Chavan et al., 2012), with a commercial interferometer (OP1550, Optics11, Amsterdam, The 
Netherlands) running customised LabVIEW 16.0 software (Figure 3-5); the nano-indenter 
testing machine used is similar to the PIUMA Nano-indenter (Optics11, Amsterdam, The 
Netherlands). 
 
Figure 3-5: Customised nano-indenter testing set-up 
  
LabVIEW 
OP1550 Interferometer  
Stage 
Z-axis 
manipulator 
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Before μDMA testing, a customised probe was manufactured. For the manufacturing of the 
probe, a 3 mm × 3 mm × 7 mm glass ferrule (VitroCom, Mountain Lakes, New Jersey, USA) 
(Figure 3-6 (A)) was mounted on a diamond wire cutter and a ridge (500 μm × ~400 μm) was 
removed (Figure 3-6 (B)). A rectangular glass ribbon 30 μm [thickness] × 300 μm [width] 
(VitroCom, Mountain Lakes, New Jersey, USA) was sputter coated with a 10 nm thick 
chromium layer followed by a 100 nm thick gold layer to make it reflective and was 
subsequently bonded to the glass ferrule (Figure 3-6 (C)).  
  
   
    
Figure 3-6: (A-F) Manufacturing of the probe, (G) finished probe and (H) zoomed in 
section of the the indenter. Dimensions of the probe can be found in and section 8.3 
Appendix C. 
  
(A)      (B)               (C) 
 
 
(D)      (E)               (F) 
 
 
(G)                           (H)    
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A micrometre precision screw stage was used to accurately set the desired length of the glass 
ribbon, then, laser ablation was performed to cut off excess ribbon (Figure 3-6 (D)). Next, a 
borosilicate glass sphere, with a radius of 37 μm (Figure 3-6 (E) and section 8.3 Appendix C), 
was bonded (Norland 68 Ultra-Violet Curing Adhesive, Norland Products Inc., Cranbury, NJ, 
USA) to the cantilever tip. Finally, a standard single mode 125 μm optical fibre was cleaved, to 
create more back reflections which were needed to create one of the two light signals in the 
interference pattern, and bonded to the ferrule facing the cantilever (Figure 3-6 (F)). The 
stiffness of the probe was subsequently measured using a custom-built calibration rig; the probe 
stiffness was 480 ± 13 N/m and further information on the custom-built calibration rig and 
calibration procedure can be found in Beekmans and Iannuzzi (2015). 
Experimental factors such as applied sinusoidal load, investigated frequencies, etc. are study 
specific and further information of these parameters are detailed in chapter 4 - Biostability of 
PCU biomaterials (sections 0). 
3.7 Dynamic Mechanical Analysis (DMA) 
The viscoelastic properties of all components, BDyn implants and biomaterials were measured 
using a Bose ElectroForce 3200 testing machine running WinTest 4.1 DMA software (Bose 
Corporation, Electroforce Systems Group, Minnesota, USA; now, TA Instruments, New 
Castle, DE, USA). The DMA technique, machine and software have been used to quantify the 
viscoelastic properties of various biological tissues (Barnes et al., 2016; Constable et al., 2018; 
Cooke et al., 2018a; Fulcher et al., 2009; Lawless et al., 2017; Temple et al., 2016), implantable 
biomaterials (Mahomed et al., 2009a, 2009b, 2008; Murata et al., 2000), degraded biomaterials 
(Mahomed et al., 2015, 2010) and mineralised hydrogels (Majumdar et al., 2018; Wands et al., 
2008). 
All testing was performed in air at 37°C ± 1°C in a custom-built chamber (Figure 3-7 and 8.4 
Appendix D) in which water was pumped around the chamber by a Cole Parmer water 
circulating bath and pump with digital control (Model: 12107-15, Cole Parmer, St Neots, 
Cambridgeshire, UK). The air temperature was monitored throughout the frequency sweep 
with a SLS digital thermometer (Scientific Laboratory Supplies (SLS), Wilford, Nottingham, 
UK) (Figure 3-7). 
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(A)   
(B)  
Figure 3-7: (A) Bose ElectroForce 3200 testing machine with custom built chamber and 
water circulating pump and (B) custom built chamber with thermometer. 
Other experimental factors such as applied sinusoidal load, requested frequencies (and actual 
tested frequencies; Table 3-1), machine fixtures used, etc. are study specific and further 
information of these parameters are detailed in chapter 4 - Biostability of PCU biomaterials and 
chapter 5 - Biostability of the BDyn Posterior Dynamic Stabilisation device (sections 4.2.4 and 
5.2.3, respectively). 
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Table 3-1: Requested (Hz) and actual (Hz) tested frequencies for a Bose 3200 machine 
running 4.1 DMA software 
Requested (Hz) Actual (Hz) Requested (Hz) Actual (Hz) Requested (Hz) Actual (Hz) 
0.01 0.01 0.4 0.4 10 10 
0.02 0.02 0.5 0.5 15 15 
0.03 0.03 0.75 0.75 20 20 
0.04 0.04 1 1 25 24 
0.05 0.05 2 2 30 29 
0.1 0.1 3 3 35 34 
0.2 0.2 4 4 40 39 
0.3 0.3 5 5 45 44 
    50 49 
 
3.8 Scanning Electron Microscopy (SEM) 
The surface morphology of all biomaterials and BDyn components investigated in the thesis, 
was examined using the Hitachi TM3030 Scanning Electron Microscope (SEM) (Chiyoda, 
Tokyo, Japan). The specimens were examined with back-scatter detector at a 15 kV accelerating 
voltage. 
3.9 Statistical analysis 
All statistical analysis was performed using SigmaPlot (Systat Software Inc., San Jose, California, 
USA). Specific regression analyses, statistical hypotheses tests comparing groups, etc. are study 
specific and further information of these parameters are detailed in chapter 4 - Biostability of 
PCU biomaterials and chapter 5 - Biostability of the BDyn Posterior Dynamic Stabilisation 
device (sections 4.2.6 and 5.2.5, respectively). Statistical results with p < 0.05 were considered 
significant. 
3.10 Chapter Summary 
In summary, this chapter provided detailed information about the five different commercially 
available biomaterials, degradation protocols, chemical structure characterisation methods, 
viscoelastic testing methods, surface morphology characterisation techniques and statistical 
analyses used in this thesis. Study specific methods are discussed in the materials and methods 
sections of subsequent chapters (Chapters 4 and 5). 
The biostability of the five biomaterials is investigated in the next chapter.  
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Biostability of PCU 
biomaterials  
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4 Biostability of PCU biomaterials 
4.1 Introduction 
In 2016, the biomaterials market was worth $70.9 billion (Marketsandmarkets.com, 2016). 
Broadly, biomaterials fall into four main categories: metallic, ceramic, polymeric and natural 
(biological) biomaterials. Polymeric biomaterials are commonly used in medical device 
applications and one of the highest performing medical-grade polymers are polyurethanes (PU) 
(Khan et al., 2005a). PU biomaterials have a unique combination of suitable mechanical and 
biological properties, such as durability, elasticity, flexibility, toughness, biocompatibility and 
biostability (Chandy et al., 2009; Jaganathan et al., 2014; Khan et al., 2005a); a brief background 
about PU biomaterials and the biostability of PUs can be found in section 2.5. 
Due to its increase in biostability over polyester urethanes and polyether urethanes (see section 
2.5), PCU has been widely used in cardiovascular (Chandy et al., 2009; Dang et al., 2014; 
Hartford, 2013) and orthopaedic (Cipriani et al., 2013; Gille et al., 2014; Schmoelz et al., 2003) 
applications. PCU components have been shown to degrade due to implantation (Cipriani et 
al., 2013; Ianuzzi et al., 2010; Neukamp et al., 2015) and the degradation mechanism, that PCU 
components have been susceptible to, is oxidative degradation (Christenson et al., 2006a). 
In vitro biostability studies do not fully reproduce degradation that happens in vivo (ISO, 2010; 
Wilkoff et al., 2015). However, in vitro biostability studies are useful to provide directional 
guidance for in vivo studies and are useful as a biomaterial screening method (Wilkoff et al., 
2015). Numerous studies have evaluated the effect of in vitro degradation of PCU biomaterials 
(Arjun and Ramesh, 2012; Dempsey et al., 2014; Faré et al., 1999; Hernandez et al., 2008; 
Mishra et al., 2015; Tanzi et al., 1997; Wiggins et al., 2004). To understand how the 
degradation affects the mechanical behaviour of biomaterials, some studies focussed on quasi-
static tensile properties of the in vitro degradation specimens (Arjun and Ramesh, 2012; 
Dempsey et al., 2014; Mishra et al., 2015; Wiggins et al., 2004). While, some studies focussed 
on the viscoelastic response of these biomaterials by performing a temperature sweep; i.e. 
performing dynamic mechanical temperature analysis (DMTA) (Arjun and Ramesh, 2012; 
Hernandez et al., 2008; Wiggins et al., 2004).  
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As will be shown in this chapter, these biomaterials are frequency dependent viscoelastic 
materials; the applied strain rate has an effect on the biomaterials response. A detailed 
assessment of these biomaterials’ viscoelasticity, both macro-level and micro-level viscoelastic 
properties, is currently absent. 
The aim of this chapter is to provide a detailed investigation of the effect of in vitro 
biodegradation on the viscoelasticity of five long-term implantable, commercially available, 
PCU. In total, four degradation protocols, two oxidation and two hydrolytic methods, were used 
to evaluate the in vitro biostability of the five PCU biomaterials. Between the untreated (control) 
and in vitro degraded (oxidation and hydrolysis) specimens, this chapter will: 
 Quantify frequency dependent macro viscoelastic properties of the five PCU 
biomaterials by using DMA; 
 Quantify frequency dependent micro viscoelastic properties of the five PCU 
biomaterials by using µDMA; 
 Investigate the effect of four in vitro degradation methods on the micro-level and 
macro-level viscoelasticity of the five biomaterials; 
 Compare the chemical structure changes of the untreated (control) and in vitro 
degraded (oxidation and hydrolysis) specimens, for the five biomaterials, by using HCI;  
 Compare the macro morphological and surface morphological changes of the untreated 
(control) and in vitro degraded (oxidation and hydrolysis) specimens. 
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4.2 Materials and Methods 
4.2.1 Biomaterials 
The five different commercially available, long-term implantable PCU biomaterials 
(Quadrathane ARC 80A B20, Bionate II 80A, Quadrathane ARC 80A, ChronoFlex C 80A 
and ChronoSil 80A 5%; see section 3.1.1) were used to analyse the effect of in vitro 
biodegradation. Further information about the manufacturing of these PCU pellets, ethylene 
oxide (EtO) sterilisation of these injected moulded ISO plaques and die cutting the plaques into 
ASTM D1708 shaped specimens can be found in section 3.1.2. 
Once the first plaque was die cut into ASTM D1708 shaped specimens, the specimens were 
numbered and an Excel random order generator (Microsoft, Redmond, Washington, USA) 
was used to separate the specimens into three groups to assess the effect of in vitro oxidative 
degradation; Control (n = 6), 3% H2O2 degraded (n = 6) and 20% H2O2 / 0.1 M CoCl2 (n = 6) 
groups. A second plaque was die cut ASTM D1708 shaped specimens and randomly grouped 
into three groups to assess the effect of in vitro hydrolytic degradation; Control (n = 6), real-time 
degraded (n = 6) and accelerated degraded (n = 6) groups (see Table 4-1). Further information 
about the in vitro oxidative degradation methods (3% H2O2 and 20% H2O2 / 0.1 M CoCl2) can 
be found in section 3.3 while further information about the in vitro hydrolytic degradation 
methods (real-time [37 ± 1°C] and accelerated [70 ± 2°C]) can be found in section 3.4. 
Table 4-1: Biomaterial grouping information. The number of specimens, per biomaterial, 
that were degraded in the two different studies (Oxidation and Hydrolysis) is stated. 
 
4.2.2 Spectroscopy - HCI 
Attenuated total reflectance Fourier transform infra-red hyperspectral chemical imaging (HCI) 
was performed on the untreated (control) and in vitro degraded (3% H2O2, 20% H2O2 / 0.1 M 
CoCl2, real-time [37 ± 1°C] and accelerated [70 ± 2°C]) groups. The light aperture size of 200 
µm (in the x and y dimension) was selected which implies that the single point detector was 50 
Biomaterials Plaque 1: Oxidation  Plaque 2: Hydrolysis 
 Control 3% H2O2 / CoCl2  Control Real-time Accelerated 
Quadrathane B20 Six Six Six  Six Six Six 
Bionate II Six Six Six  Six Six Six 
Quadrathane Six Six Six  Six Six Six 
ChronoFlex C Six Six Six  Six Six Six 
ChronoSil Six Six Six  Six Six Six 
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µm (a fourfold decrease). For HCI of the in vitro biodegraded specimens, a grid of data points 
was selected and the distance between each pixel was 50 µm; this creates a spatially contiguous 
image (Dorrepaal et al., 2018). 
Twenty spectra with a spectral resolution of 2 cm-1
 
between 675 and 4000 cm-1 were acquired 
and mean averaged to obtain each spectrum (Simmons et al., 2004). The PCU spectra were cut 
between 750 and 2000 cm-1 and spectra of the four aromatic PCU biomaterials were 
normalised to the internal reference around 819 cm-1 peak, the stable aromatic C–H out of 
plane bending peak (Dorrepaal et al., 2018). Linear baseline correction was performed 
subsequent to the internal reference normalisation and followed by a baseline shift of one 
arbitrary unit (Dorrepaal et al., 2018). A secondary normalisation method, the Savitzky Golay 
(SG) technique (Savitzky and Golay, 1964), was also performed to understand the changes of 
the wavelengths of the five biomaterials. The SG window size was 31 wave measurements (a 
buffer size of 15 on either side of the centre point), the fit was a second order polynomial and a 
second order derivative. Spectral assignments and wavenumbers (cm-1) are listed in Table 4-2. 
Table 4-2: Spectral assignment and wavenumber (Christenson et al., 2004a, 2004b; 
Cipriani et al., 2013; Dorrepaal et al., 2018; Hernandez et al., 2008; Shen et al., 2011; 
Smith, 1998; B. Ward et al., 2006; R. Ward et al., 2006) 
Spectral assignment Wavenumber (cm-1) 
C=O stretching vibration of free carbonate 1740-1737 
C=O stretching vibration of hydrogen-bonded carbonate 1720 
C=O stretching vibration of hydrogen-bonded urethane 1705-1701 
NH2 free aromatic amine 1650 
Aromatic C=C stretching vibration  1598-1596 
CH2 bending vibration 1466 
O-C-O stretching vibration of carbonate  1254-1246 
N–H bending and C–N stretching vibration of urethane 1223-1220 
C-C crosslinking (branched ether) 1174 
C-O 1110 
C-O-C of urethane 
C-H bending in plane aromatic ring 
O-H bending or bending of aliphatic CO2H 
1079 
1018 
930-931 
C-H bending out of plane aromatic ring 816-819 
 
4.2.3 Micro-Dynamic Mechanical Analysis (µDMA) 
Micro-scale viscoelastic response of the untreated and degraded (oxidation and hydrolysis) five 
biomaterials was measured by using a customised nano-indenter testing machine running 
customised LabVIEW 16.0 software and customised probe; see section 3.6 and Figure 4-1. 
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Figure 4-1: Customised probe used in µDMA testing 
For µDMA, firstly, double sided tape was placed on the base of the glass petri dish and six 
specimens were placed on the tape; placing the specimens on double-sided tape prevented 
specimens from floating. As spherical probes can be adhesive to specimen surfaces (van Hoorn 
et al., 2016), the specimens were immersed with 5% wt. Bovine Serum Albumin (BSA) (Sigma 
Aldrich, Dorset, UK) in Dulbecco’s PBS solution for 30 minutes at room temperature (van 
Hoorn et al., 2016). After 30 minutes, the BSA was poured out of the petri dish and the 
specimens were immersed in Dulbecco’s PBS solution. Both the specimens and the probe 
were fully submerged and allowed to stabilise for 30 minutes (Figure 4-2).  
(A)  (B)  
Figure 4-2: (A) Specimens, in a petri dish, on the nano-indentor testing stage and (B) 
Specimens, held to the base of the petri dish by double side tape, immersed in Dulbecco’s 
PBS solution. All specimens are Bionate II 80A but vary on degradation; (from left to 
right) control from oxidation plaque, 3% H2O2 degraded, 20% H2O2 / 0.1 M CoCl2 
degraded, control from hydrolysis plaque,  real-time degraded and accelerated degraded. 
For (B), the customised probe is over the B20 specimen. 
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All tests were performed using indentation control (displacement control). From preliminary 
testing of control specimens, it was decided that a 5 μm indentation with 100 nm amplitude 
would be used to characterise the viscoelastic response of the untreated and degraded 
specimens; this is within the 10 μm depth from the surface which has been stated to be where 
most of the observed surface changes occur (Cipriani et al., 2013). From the number of 
specimens degraded per group (Table 4-1), one specimen was randomly selected with the Excel 
random order generator (Microsoft, Redmond, Washington, USA).  In total, six different 
specimens, of the same biomaterial, were tested per day (see Figure 4-2 (B)) and each specimen 
was tested at six different locations which were 100 μm apart along the gauge of the specimen; 
this ensured that the viscoelastic characterisation occurred at a non-contacted location (Mattei et 
al., 2015).  
At each location, the probe was not in contact at the beginning of the test. Once the test was 
started, a ramp of 5 μm was performed in 2 seconds. Once the probe made contact with the 
surface, the data acquisition began recording and the probe continued in ramp control until it 
indented the surface by 5 μm. This 5 μm indentation was held for 60 seconds and allowed the 
removal of stress-relaxation, which was determined from preliminary testing; it is important to 
measure the viscoelastic properties on a relaxed sample so enough time should be given to 
ensure constant indentation depth over time (Beekmans, 2018). The viscoelastic response was 
measured for five different frequencies between 0.1 and 10 Hz (0.1, 0.316, 1, 3.16 and 10 Hz). 
Once the frequency sweep was finished, the probe went back to its initial, starting position (not 
in contact with the biomaterial’s surface) and the data acquisition finished. The testing location 
was moved 100 μm and the μDMA test procedure began again.  
All tested locations were performed in Dulbecco’s Phosphate Buffer Saline (PBS) solution at 
room temperature and the stage was enclosed within a custom-built sound proof chamber 
(Figure 4-3).   
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Figure 4-3: Test set-up with sound proof chamber; see Figure 3-5 for test set-up without 
sound proof chamber  
4.2.4 Dynamic Mechanical Analysis (DMA) 
To enable macro-viscoelasticity comparisons between specimens, the method used to 
characterise the viscoelastic properties of control and in vitro degraded (oxidation and 
hydrolysis) ASTM D1708 shaped specimens were kept consistent. The experimental factors 
such as the applied sinusoidal load, investigated frequencies, machine fixtures used, etc. 
discussed henceforth were kept consistent unless stated otherwise.  
A sinusodially varying tension load of 1 N to 10 N was applied to each specimen (this applied 
load range was selected from preliminary testing – see 8.10 Appendix J - section 8.10.1) and the 
storage and loss stiffness were calculated for 25 different frequencies between 49 Hz to 0.01 Hz; 
see section 2.2.3.2 for more information on how this storage and loss stiffness is calculated by 
dynamic mechanical analysis (DMA). All devices and components were tested in air at 37°C ± 
1°C and the temperature was monitored throughout the frequency sweep (see section 3.7, 
Figure 3-7, Figure 4-4 and 8.4 Appendix D). 
 
Figure 4-4: Testing of a Quadrathane with a radiopacifier (barium sulfate)  
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As one specimen was randomly selected with the Excel random order generator (Microsoft, 
Redmond, Washington, USA) for the micro-dynamic mechanical analysis (see section 0), this 
left five specimens per degradation group per biomaterial remaining from the initial number of 
specimens degraded; the number of specimens degraded per group can be found in Table 4-1. 
For the in vitro oxidative degradation groups, all five specimens were used to quantify the 
macro-viscoelastic properties; Control (n = 5), 3% H2O2 degraded (n = 5) and 20% H2O2 / 0.1 
M CoCl2 (n = 5) groups.  
For the in vitro hydrolytic degradation groups, three specimens were used to quantify the 
macro-viscoelastic properties; Control (n = 3), 3% H2O2 degraded (n = 3) and 20% H2O2 / 0.1 
M CoCl2 (n = 3) groups; these specimens were randomly selected with the Excel random order 
generator and this sample size (n = 3) is the minimum number of test specimens stated in ISO 
10993-13 (ISO, 2010).  
DMA of in vitro oxidation groups and DMA of the in vitro hydrolysis groups were separated; 
however, the order of specimen testing was randomised by using the Excel Random Function. 
4.2.5 Scanning electron microscopy 
After DMA, scanning electron micrographs of the control and in vitro degraded (oxidation and 
hydrolysis) were gathered to investigate surface morphological changes due to degradation. By 
using the ASTM D1708 die cutter (Wallace Instruments, Cambridge, UK), a 5 mm × 5 mm × 3 
mm cube was die cut from the ASTM D1708 specimen gauge (Figure 4-5).   
(A)  (B)  (C)  
Figure 4-5: (A)  3% H2O2 degraded ChronoFlex C 80A specimen, (B) isolating the 5 mm × 
5 mm × 3 mm cube from the specimen gauge and (C) finished cube. 
In total, one specimen was randomly selected per degradation group per biomaterial with the 
Excel random order generator (Microsoft, Redmond, Washington, USA). These cubed 
specimens were attached to an SEM stub and each SEM stub contained cubes from the 
untreated oxidation control, 3% H2O2 degraded, 20% H2O2 / 0.1 M CoCl2 degraded, 
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untreated hydrolysis control, real-time degraded and accelerated degraded of one specific 
biomaterial (Figure 4-6 (A)). The stubs, with attached cubed specimens, were sputter coated 
(Figure 4-6 (B) and (C)) with ~25 nm layer of gold by using an Emscope SC500 sputter coater 
(Emscope Laboratories, Kent, UK). 
(A)   (B)  
(C)  
Figure 4-6: (A)  Five different biomaterials on five different stubs; (top row, left to right) 
Quadrathane ARC B20 80A, Bionate II 80A and Quadrathane ARC 80A and (bottom row, 
left to right) ChronoFlex C 80A and ChronoSil 80A 5%. On each specific stub (top row, left 
to right) the untreated oxidation control, 3% H2O2 degraded, 20% H2O2 / 0.1 M CoCl2 
degraded and (bottom row, left to right) untreated hydrolysis control, real-time degraded 
and accelerated degraded. (B) Sputter coating of  a SEM stub with attached cubes and (C) 
sputted coated cubed specimens. 
Scanning electron micrographs of the control and degraded specimens were gathered at x1.2k 
and x2.0k magnification. ImageJ 1.48v (National Institutes of Health, Bethesda, MD, USA) was 
used to measure surface pits. The scale bar on a specific SEM image was used to calibrate the 
image. As the pits were irregular in shape, the major diameters, of numerous pits, were 
recorded and a range of pit sizes, in micrometres, was reported.    
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4.2.6 Statistical analysis 
All statistical analyses were performed using SigmaPlot 13.0 (SYSTAT, San Jose, CA, USA). 
The median storage and loss stiffness of the untreated (control) and in vitro degraded 
specimens were plotted, with respect to the natural logarithmic frequency, with error bars; the 
error bars are specified, with the particular sample size, in the figure captions. Further, the 
median storage and loss stiffness of the untreated biomaterials were plotted in a similar fashion 
to the comparison of the untreated (control) and in vitro degraded specimens. Regression 
analyses were performed to evaluate the significance of the curve fit (equation 4.1 and 4.2): 
𝒌′ = 𝑨 𝐥𝐧(𝒇) + 𝑩 for  𝟎. 𝟎𝟏 ≤ 𝒇 ≤ 𝟒𝟗  Equation 4.1 
𝒌′′ = 𝑪 𝐥𝐧(𝒇) + 𝑫 for  𝟎. 𝟎𝟏 ≤ 𝒇 ≤ 𝟒𝟗  Equation 4.2 
where f is frequency (independent variable), A and C are coefficients and B and D are the 
constants of the logarithmic regression. 
Kruskal-Wallis one-way analysis of variance (ANOVA) on ranks tests were performed to 
evaluate: 
 Micro-level viscoelastic differences among the untreated and degraded biomaterial 
specimens (n = 6); 
 Micro-level viscoelastic differences among the untreated biomaterial specimens (n = 6); 
 Macro viscoelastic differences among the untreated biomaterial specimens (n = 5); 
 Macro viscoelastic differences among the untreated and oxidative degraded biomaterial 
specimens (n = 5). 
 Macro viscoelastic differences among the untreated and hydrolytic degraded biomaterial 
specimens (n = 3). 
For all Kruskal-Wallis ANOVA tests, if the tests showed significant differences (p < 0.05), the 
multiple comparison Tukey test was used to evaluate significant differences (p < 0.05). It must 
be noted that findings and conclusions made from the micro-level viscoelastic data is limited by 
statistical pseudo-replication, i.e. multiple observations on the same unit. Thus, findings and 
conclusions are specific to the surface of the specific biomaterials evaluated so, it may not give a 
fair representation of a wider comparison of all biomaterials; this limitation is discussed further 
in section 4.4.   
All statistical results with p < 0.05 were considered significant.   
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4.3 Results  
4.3.1 Oxidation  
Figure 4-7 shows the discolouration between the (A) untreated biomaterials, (B) biomaterials 
treated for 52 weeks with the ISO 10993-13 3% H2O2 degradation protocol and (C) 
biomaterials treated for 24 days with the 20% H2O2 / 0.1 M CoCl2 degradation protocol: 
 
Figure 4-7: The five different biomaterials in three different groups; (A) Untreated 
(Control), (B) 3% H2O2 degraded and (C) 20% H2O2 / 0.1 M CoCl2 groups. 
 
  
    (A)            (B)             (C)       
Quadrathane ARC B20 80A 
Bionate II 80A 
Quadrathane ARC 80A 
ChronoFlex C ARC 80A 
ChronoSil 80A 5% 
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4.3.1.1 HCI 
The ATR-FTIR spectrum of the untreated and oxidative degraded biomaterials is illustrated in 
Figure 4-8.  
Evidence of PCU oxidative degradation has been established as new absorbance peaks were 
observed at 930 cm-1 (O-H bending or bending of aliphatic CO2H) and 1174 cm-1 (C-C 
crosslinking) for all in vitro H2O2/CoCl2 degraded Quadrathane ARC 80A-B20 (with 
radiopacifier), Bionate II 80A and Quadrathane ARC 80A specimens (6 out of 6 specimens). 
New absorbance peaks were observed at 930 cm-1 and 1174 cm-1 for 5 out of 6 in vitro 
H2O2/CoCl2 degraded ChronoFlex C 80A. Hyperspectral chemical images (Figure 4-9 and 
Figure 4-10) demonstrated that the new peaks at 930 cm-1 and 1174 cm-1, for the H2O2/CoCl2 
degraded specimens, varied regionally. The variation of the height of the 1174 cm-1 absorbance 
peak can be analysed by examining the range of the peak height across the specimens; see the 
scale bar adjacent to HCIs. For example, the variation (approximate range) of the untreated 
Chronoflex C 80A specimen (Figure 4-10 (J)) is low (1.52-1.67 AU) compared to in vitro 
H2O2/CoCl2 degraded specimen (range of Figure 4-10 (L) is approximately 1.6-2.6 AU). HCIs 
provide further evidence of the PCU oxidative degradation spatial variation as high absorbance 
peak heights, for the new absorbance peaks at 930 cm-1 and 1174 cm-1, is regionalised for the 
Bionate II 80A and ChronoFlex C 80A H2O2/CoCl2 degraded specimens; Figure 4-9 (F) and 
(L) for variation of 930 cm-1 peak height and Figure 4-10 (F) and (L) for variation of 1174 cm-1 
peak height.  
In comparison to the H2O2/CoCl2 degraded specimens, no new absorbance peaks were 
observed at 930 cm-1 and 1174 cm-1 for the untreated and 3% H2O2 degraded specimens 
(Figure 4-8). Further, no new absorbance peaks at 930 cm-1 and 1174 cm-1 were observed for 
the untreated, 3% H2O2 degraded and the H2O2/CoCl2 degraded Chronosil specimens (Figure 
4-8). 
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(A) (B)  
(C)  (D)  
(E)  
Figure 4-8: Stacked ATR-FTIR spectra of untreated and in vitro oxidative degraded five 
biomaterials; (A) Quadrathane ARC 80A B20, (B) Bionate II 80A, (C) Quadrathane ARC 
80A, (D) ChronoFlex C 80A and (E) ChronoSil 80A 5%. Absorbance units are arbitrary 
units (AU). 
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(A)  (B)  
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Figure 4-9: Spatial variation of the new peak witnessed at approximately 930 cm-1 for the 
PCU biomaterials; (A, D, G, J, M) untreated, (B, E, H, K, N) in vitro oxidative degradation 
ISO 10993-13 3% H2O2 method (3% H2O2) and (C, F, I, L, O) in vitro accelerated oxidation 
20% H2O2 and 0.1 M CoCl2 method (H2O2/ CoCl2) of the five biomaterials; (A-C) 
Quadrathane ARC 80A B20, (D-F) Bionate II 80A, (G-I) Quadrathane ARC 80A, (J-L) 
ChronoFlex C 80A and (M-O) ChronoSil 80A 5%.  
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Figure 4-10: Spatial variation of the new peak witnessed at approximately 1174 cm-1 for 
the PCU biomaterials; (A, D, G, J, M) untreated, (B, E, H, K, N) in vitro oxidative 3% H2O2 
method (3% H2O2) and (C, F, I, L, O) in vitro 20% H2O2 and 0.1 M CoCl2 method (H2O2/ 
CoCl2) of the five biomaterials; (A-C) Quadrathane ARC 80A B20, (D-F) Bionate II 80A, (G-
I) Quadrathane ARC 80A, (J-L) ChronoFlex C 80A and (M-O) ChronoSil 80A 5%. 
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From the HCI, a wide spatial variation in absorbance peak intensity around 1248 cm-1 was 
observed (Figure 4-11); this peak is indicative of the O-C-O carbonate bonds (Dorrepaal et al., 
2018; Smith, 1998). For Bionate II 80A in vitro H2O2/CoCl2 degraded specimen (Figure 4-11 
(F), a specific region, on the right of the HCI, was highlighted to have a low absorbance peak 
intensity (1248 cm-1) when compared to the rest of the specimen; this highlights a specific area 
where the soft segment of this PCU biomaterial has degraded which provides evidence of 
spatial variation of degradation of a biomaterial.   
The new absorbance peak at 1650 cm-1 (NH2 free aromatic amine) has been stated to provide 
evidence of hard segment chain scission. All six Bionate II 80A in vitro H2O2/CoCl2 degraded 
specimens demonstrated a new peak at 1650 cm-1. However, isolated acquisitions of the 
untreated Bionate II 80A specimens also demonstrated a new peak at 1650 cm-1. Further, 2 
(out of 6) Bionate II 80A 3% H2O2 degraded specimens demonstrated isolated new peaks at 
1650 cm-1. The untreated Quadrathane 80A-B20 and Quadrathane 80A specimens had peaks 
around 1635-1640 cm-1. Comparing the untreated Quadrathane 80A-B20 and Quadrathane 
80A specimens to the H2O2/CoCl2 degraded specimens (Figure 4-8), this peak around 1635-
1640 cm-1 shrunk; this can be further seen with the change of the range of 1650 cm-1 
absorbance intensity range (comparing range of Figure 4-12 (A) to Figure 4-12 (C) and Figure 
4-12 (G) to Figure 4-12 (I)). The ChronoFlex C 80A in vitro H2O2/CoCl2 degraded HCI 
(Figure 4-12 (L)) demonstrated a regional variation pattern comparable to the HCI at 930 cm-1 
(Figure 4-9 (L)) and 1174 cm-1 (Figure 4-10 (L)). No new absorbance peaks at 1650 cm-1 was 
observed for the untreated, 3% H2O2 degraded and the H2O2/CoCl2 degraded Chronosil 
specimens (Figure 4-8 and Figure 4-12 (M) to Figure 4-12 (O)). 
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Figure 4-11: Spatial variation of the new peak witnessed at approximately 1248 cm-1 for 
the PCU ; (A, D, G, J, M) untreated, (B, E, H, K, N) in vitro oxidative 3% H2O2 method (3% 
H2O2) and (C, F, I, L, O) in vitro accelerated oxidative 20% H2O2 and 0.1 M CoCl2 method 
(H2O2/ CoCl2) of the five biomaterials; (A-C) Quadrathane ARC 80A B20, (D-F) Bionate II 
80A, (G-I) Quadrathane ARC 80A, (J-L) ChronoFlex C 80A and (M-O) ChronoSil 80A 5%  
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Figure 4-12: Spatial variation of the new peak witnessed at approximately 1650 cm-1 for 
the PCU ; (A, D, G, J, M) untreated, (B, E, H, K, N) in vitro oxidative 3% H2O2 method (3% 
H2O2) and (C, F, I, L, O) in vitro accelerated oxidation 20% H2O2 and 0.1 M CoCl2 method 
(H2O2/ CoCl2) of the five biomaterials; (A-C) Quadrathane ARC 80A B20, (D-F) Bionate II 
80A, (G-I) Quadrathane ARC 80A, (J-L) ChronoFlex C 80A and (M-O) ChronoSil 80A 5% 
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4.3.1.2 µDMA 
As stated in the materials and methods (section 0), the testing procedure is shown in Figure 
4-13. The indenter position was held at 5 μm for 60 seconds to allow the removal of stress-
relaxation response (see Load in Figure 4-13) and next, the viscoelastic response was measured 
for five different frequencies between 0.1 and 10 Hz (0.1, 0.316, 1, 3.16 and 10 Hz).  
 
Figure 4-13: Removal of stress relaxation and subsequent frequency sweep. This example 
is of a measurement of a position on the surface of the Chronoflex C 80A (untreated) 
The micro-level viscoelastic frequency dependent trends of the storage and loss stiffness of the 
five biomaterials are shown in Figure 4-14. For each specific biomaterial, the storage stiffness 
was larger than the loss stiffness for all frequencies tested. 
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(A)   (B)  
Figure 4-14: Comparison of the micro-level, surface viscoelastic properties (A) storage 
stiffness and (B) loss stiffness of the five long-term implantable polymers (untreated) 
(median ± 95% confidence intervals). 
Table 4-3 provides the multiple comparison test results and the frequencies at which the 
untreated five long-term implantable PCU biomaterials were significantly different. Both, the 
micro-scale storage and the loss stiffness of the comparison between Quadrathane B20 – 
Bionate II and Bionate II – Quadrathane were significantly different for all frequencies (p < 
0.05). There were no significant differences (p > 0.05), for the storage stiffness and the loss 
stiffness, between Quadrathane B20 – Quadrathane, Quadrathane B20 – Chronosil, Bionate II 
– Chronoflex C and Quadrathane – Chronosil, for all frequencies tested. The micro-level, 
surface viscoelastic properties for other groupings were significantly different (p < 0.05) at 
specific frequencies (Table 4-3). 
Table 4-3: Multiple comparison test results for the micro-level, surface viscoelastic 
properties of the five long-term implantable, untreated polymers. The frequencies stated 
indicates that the comparison were significantly different (p < 0.05). 
Multiple Comparison Test Storage Stiffness Loss Stiffness 
Quadrathane B20 – Bionate II 0.1 to 10 Hz 0.1 to 10 Hz 
Quadrathane B20 – Quadrathane - - 
Quadrathane B20 – Chronoflex C - 1 to 10 Hz 
Quadrathane B20 - Chronosil - - 
Bionate II – Quadrathane 0.1 to 10 Hz 0.1 to 10 Hz 
Bionate II – Chronoflex C - - 
Bionate II – Chronosil 0.1 to 10 Hz 10 Hz 
Quadrathane – Chronoflex C - 0.1 to 0.316 Hz 
Quadrathane – Chronosil - - 
Chronoflex C - Chronosil 0.1 to 10 Hz - 
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Figure 4-15 and Figure 4-16 presents the storage stiffness and loss stiffness, respectively, of the 
(A) Quadrathane ARC 80A B20, (B) Bionate II 80A, (C) Quadrathane ARC 80A, (D) 
Chronoflex C 80A and (E) Chronosil 80A 5%, for normal and the in vitro oxidative degraded 
biomaterials. The majority of storage stiffness trends increased logarithmically in relation to 
frequency (p < 0.05) (equation 4.1, where A is a coefficient and B is a constant, and 8.5 
Appendix E- Table 8-1 to Table 8-5). Similarly to the storage stiffness, the majority of the loss 
stiffness trends increased logarithmically in relation to frequency (p < 0.05) (equation 4.2, where 
C is a coefficient and D is a constant, and 8.5 Appendix E- Table 8-1 to Table 8-5). All six 
storage stiffness and five (out of six) loss stiffness frequency dependent trends of the Bionate II 
80A specimen, degraded with the 3% H2O2 method, were not logarithmic in behaviour (p > 
0.05).  
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(A)  (B)  
(C)  (D)  
(E)  
Figure 4-15: Comparison of the micro-level, surface storage stiffness of the untreated, in 
vitro ISO 10993-13 3% H2O2 oxidation method (3% H2O2) and the in vitro accelerated 
oxidation 20% H2O2 and 0.1 M CoCl2 method (H2O2/ CoCl2) of the five biomaterials; (A) 
Quadrathane ARC 80A B20, (B) Bionate II 80A, (C) Quadrathane ARC 80A, (D) ChronoFlex 
C 80A and (E) ChronoSil 80A 5% (median ± 95% confidence intervals) 
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(A)  (B)  
(C)  (D)  
(E)  
Figure 4-16: Comparison of the micro-level, surface loss stiffness of the untreated, in vitro 
ISO 10993-13 3% H2O2 oxidation method (3% H2O2) and the in vitro accelerated 
oxidation 20% H2O2 and 0.1 M CoCl2 method (H2O2/ CoCl2) of the five biomaterials; (A) 
Quadrathane ARC 80A B20, (B) Bionate II 80A, (C) Quadrathane ARC 80A, (D) ChronoFlex 
C 80A and (E) ChronoSil 80A 5% (median ± 95% confidence intervals) 
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The median untreated and in vitro degraded storage stiffness (see Figure 4-15) ranged, for the 
five biomaterials (Table 4-4). 
Table 4-4: Median range of storage stiffness (N/mm) values per biomaterial  
Biomaterial Group Range 
Quadrathane B20 
UNT 12.91 (0.1 Hz) to 16.23 (10 Hz)  
3% H2O2 15.46 (0.1 Hz) to 17.88 (10 Hz) 
H2O2/CoCl2 11.39 (0.1 Hz) to 14.01 (10 Hz) 
Bionate II 
UNT 23.69 (0.1 Hz) to 27.64 (10 Hz) 
3% H2O2 20.02 (0.316 Hz) to 22.56 (10 Hz) 
H2O2/CoCl2 20.75 (0.1 Hz) to 26.64 (10 Hz) 
Quadrathane 
UNT 13.84 (0.316 Hz) to 16.65 (10 Hz) 
3% H2O2 11.58 (0.1 Hz) to 14.36 (10 Hz) 
H2O2/CoCl2 12.32 (0.1 Hz) to 14.95 (10 Hz) 
Chronoflex C 
UNT 18.15 (0.1 Hz) to 21.83 (10 Hz) 
3% H2O2 16.32 (0.1 Hz) to 20.57 (10 Hz) 
H2O2/CoCl2 18.78 (0.1 Hz) to 23.36 (10 Hz) 
Chronosil 
UNT 9.75 (0.1 Hz) to 13.28 (10 Hz) 
3% H2O2 10.96 (0.1 Hz) to 15.34 (10 Hz) 
H2O2/CoCl2 9.72 (0.1 Hz) to 14.14 (10 Hz) 
While, the median untreated and in vitro degraded loss stiffness (see Figure 4-16) ranged, for 
the five biomaterials (Table 4-5). 
Table 4-5: Median range of loss stiffness (N/mm) values per biomaterial 
Biomaterial Group Range 
Quadrathane B20 
UNT 0.78 (0.1 Hz) to 3.77 (10 Hz)  
3% H2O2 0.86 (0.1 Hz) to 4.16 (10 Hz) 
H2O2/CoCl2 0.77 (0.1 Hz) to 2.93 (10 Hz) 
Bionate II 
UNT 1.69 (0.1 Hz) to 10.01 (10 Hz) 
3% H2O2 1.63 (0.316 Hz) to 5.31 (10 Hz) 
H2O2/CoCl2 1.62 (0.1 Hz) to 8.45 (10 Hz) 
Quadrathane 
UNT 0.74 (0.1 Hz) to 4.50 (10 Hz) 
3% H2O2 0.52 (0.1 Hz) to 3.60 (10 Hz) 
H2O2/CoCl2 0.66 (0.1 Hz) to 4.08 (10 Hz) 
Chronoflex C 
UNT 1.33 (0.1 Hz) to 7.06 (10 Hz) 
3% H2O2 0.93 (0.1 Hz) to 6.05 (10 Hz) 
H2O2/CoCl2 1.33 (0.1 Hz) to 6.89 (10 Hz) 
Chronosil 
UNT 1.07 (0.1 Hz) to 4.60 (10 Hz) 
3% H2O2 1.00 (0.1 Hz) to 5.49 (10 Hz) 
H2O2/CoCl2 1.14 (0.1 Hz) to 5.13 (10 Hz) 
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The multiple comparison test results, that compared the untreated and in vitro oxidative 
degraded biomaterials, are shown in Table 4-6; the frequencies at which significant differences 
were detected (p < 0.05) are stated. The comparison of micro-scale viscoelastic properties of the 
untreated group to the H2O2/CoCl2, were not significantly different (p > 0.05) for all 
frequencies except for the viscous property (loss stiffness) at 1 Hz for Quadrathane B20. The 
storage and loss stiffness of the Chronosil groups were not significantly different for all 
frequencies (p > 0.05). Between the untreated and in vitro oxidative degraded Quadrathane 
ARC 80A specimens (Quadrathane in Table 4-6), the loss stiffness at 0.1 Hz was the only 
comparison that was significantly different (p < 0.05). The storage and loss stiffness of Bionate 
II and Chronoflex C biomaterials were significantly different at specific frequencies (p < 0.05). 
Table 4-6: Multiple comparison test results for the micro-level, surface viscoelastic 
properties of the untreated and oxidative degraded long-term implantable polymers. The 
frequencies stated indicates that the comparison were significantly different (p < 0.05) 
between the untreated, in vitro ISO 10993-13 3% H2O2 oxidation method (3% H2O2) and 
the in vitro accelerated oxidation 20% H2O2 and 0.1 M CoCl2 method (H2O2/ CoCl2) of the 
specific biomaterial. 
Biomaterial Multiple Comparison Test Storage Stiffness Loss Stiffness 
Quadrathane B20 
UNT – 3% H2O2 - - 
UNT – H2O2/CoCl2 - 1 Hz 
3% H2O2 – H2O2/CoCl2 0.1 to 10 Hz 0.316 to 10 Hz 
Bionate II 
UNT – 3% H2O2 0.316 to 10 Hz 0.316 to 10 Hz 
UNT – H2O2/CoCl2 - - 
3% H2O2 – H2O2/CoCl2 1 to 10 Hz 10 Hz 
Quadrathane 
UNT – 3% H2O2 - 0.1 Hz 
UNT – H2O2/CoCl2 - - 
3% H2O2 – H2O2/CoCl2 - - 
Chronoflex C 
UNT – 3% H2O2 0.1 Hz 0.1, 0.316 and 3.16 Hz 
UNT – H2O2/CoCl2 - - 
3% H2O2 – H2O2/CoCl2 0.1 Hz 0.1 to 0.316 Hz 
Chronosil 
UNT – 3% H2O2 - - 
UNT – H2O2/CoCl2 - - 
3% H2O2 – H2O2/CoCl2 - - 
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4.3.1.3 DMA 
The macro viscoelastic frequency dependent trends of the storage and loss stiffness of the five 
biomaterials are shown in Figure 4-17. Similar to the micro-viscoelastic response of the five 
biomaterials, the storage stiffness was larger than the loss stiffness, for all frequencies tested, for 
each specific biomaterial. 
(A)  (B)  
Figure 4-17: Comparison of the macro viscoelastic properties (A) storage stiffness and (B) 
loss stiffness of the five long-term implantable polymers (untreated) (median ± 95% 
confidence intervals). 
Table 4-7 provides the multiple comparison test results and the frequencies at which the 
untreated five long-term implantable PCU biomaterials were significantly different. Similarly to 
the micro-viscoelastic properties (Table 4-3), both, the storage and the loss stiffness of the 
comparison between Bionate II – Quadrathane were significantly different for all frequencies (p 
< 0.05).  
There were no significant differences (p > 0.05), for the storage stiffness and the loss stiffness, 
between Quadrathane B20 – Quadrathane, Quadrathane B20 – Chronosil and Bionate II – 
Chronoflex C, across all frequencies tested (Table 4-7); this is similar to the micro-viscoelastic 
properties (Table 4-3).  
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Table 4-7: Multiple comparison test results for the macro viscoelastic properties of the 
five long-term implantable, untreated polymers. The frequencies stated indicates that the 
comparison were significantly different (p < 0.05). 
Multiple Comparison Test Storage Stiffness Loss Stiffness 
Quadrathane B20 – Bionate II - 0.01 to 29, 39 to 49 Hz 
Quadrathane B20 – Quadrathane - - 
Quadrathane B20 – Chronoflex C - - 
Quadrathane B20 - Chronosil - - 
Bionate II – Quadrathane 0.01 to 49 Hz 0.01 to 49 Hz 
Bionate II – Chronoflex C - - 
Bionate II – Chronosil 0.01 to 49 Hz - 
Quadrathane – Chronoflex C 24 to 49 Hz 0.01 to 0.1, 15 and 29 Hz 
Quadrathane – Chronosil - 0.2 to 24 and 49 Hz 
Chronoflex C - Chronosil 0.01 to 10 Hz - 
 
There were no significant differences (p > 0.05), for the storage stiffness and the loss stiffness, 
between Quadrathane B20 – Chronoflex C, for all frequencies tested (Table 4-7). The 
viscoelastic properties for other groupings were significantly different (p < 0.05) at specific 
frequencies (Table 4-7). 
Figure 4-18 and Figure 4-19 presents the macro storage stiffness and loss stiffness, respectively, 
of the control (untreated) and the in vitro oxidative degraded biomaterials; (A) Quadrathane 
ARC 80A B20, (B) Bionate II 80A, (C) Quadrathane ARC 80A, (D) Chronoflex C 80A and 
(E) Chronosil 80A 5%. For the frequency range tested, the storage stiffness was larger than the 
loss stiffness for all frequencies tested for each specific biomaterial tested. Unlike the micro-
viscoelastic properties regression analyses, all of the storage stiffness trends increased 
logarithmically in relation to frequency (p < 0.05) for all biomaterials (equation 4.1, where A is a 
coefficient and B is a constant; see 8.6 Appendix F - Table 8-6 and Table 8-10). Further, all of 
the frequency dependent loss stiffness trends increased logarithmically with respect to frequency 
(p < 0.05) (equation 4.2, where C is a coefficient and D is a constant; see 8.6 Appendix F - 
Table 8-6 and Table 8-10).   
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(A)  (B)  
(C)  (D)  
(E)  
Figure 4-18: Comparison of the macro storage stiffness of the untreated, in vitro ISO 
10993-13 3% H2O2 oxidation method (3% H2O2) and the in vitro accelerated oxidation 
20% H2O2 and 0.1 M CoCl2 method (H2O2/ CoCl2) of the five biomaterials; (A) 
Quadrathane ARC 80A B20, (B) Bionate II 80A, (C) Quadrathane ARC 80A, (D) ChronoFlex 
C 80A and (E) ChronoSil 80A 5% (median ± 95% confidence intervals) 
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(A)  (B)  
(C)  (D)  
(E)  
Figure 4-19: Comparison of the macro loss stiffness of the untreated, in vitro ISO 10993-
13 3% H2O2 oxidation method (3% H2O2) and the in vitro accelerated oxidation 20% H2O2 
and 0.1 M CoCl2 method (H2O2/ CoCl2) of the five biomaterials; (A) Quadrathane ARC 80A 
B20, (B) Bionate II 80A, (C) Quadrathane ARC 80A, (D) ChronoFlex C 80A and (E) 
ChronoSil 80A 5% (median ± 95% confidence intervals) 
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The median untreated and in vitro degraded macro storage stiffness (see Figure 4-18) ranged, 
for the five biomaterials (Table 4-8). 
Table 4-8: Median range of storage stiffness (N/mm) values per biomaterial  
Biomaterial Group Range 
Quadrathane B20 
UNT 8.94 (0.01 Hz) to 13.83 (49 Hz)  
3% H2O2 9.27 (0.01 Hz) to 14.07 (49 Hz) 
H2O2/CoCl2 8.68 (0.01 Hz) to 13.69 (49 Hz) 
Bionate II 
UNT 14.21 (0.01 Hz) to 22.58 (49 Hz) 
3% H2O2 15.09 (0.01 Hz) to 23.80 (49 Hz) 
H2O2/CoCl2 14.33 (0.01 Hz) to 22.32 (49 Hz) 
Quadrathane 
UNT 7.83 (0.01 Hz) to 11.48 (49 Hz) 
3% H2O2 8.04 (0.01 Hz) to 11.78 (49 Hz) 
H2O2/CoCl2 7.69 (0.01 Hz) to 11.26 (49 Hz) 
Chronoflex C 
UNT 12.53 (0.01 Hz) to 19.87 (49 Hz) 
3% H2O2 13.48 (0.01 Hz) to 21.28 (49 Hz) 
H2O2/CoCl2 12.38 (0.01 Hz) to 19.97 (49 Hz) 
Chronosil 
UNT 5.28 (0.01 Hz) to 12.29 (49 Hz) 
3% H2O2 5.93 (0.01 Hz) to 12.58 (49 Hz) 
H2O2/CoCl2 5.39 (0.01 Hz) to 11.38 (49 Hz) 
While, the median untreated and in vitro degraded macro loss stiffness (Figure 4-19) ranged, 
for the five biomaterials (Table 4-9). 
Table 4-9: Median range of loss stiffness (N/mm) values per biomaterial 
Biomaterial Group Range 
Quadrathane B20 
UNT 0.50 (0.01 Hz) to 1.79 (49 Hz) 
3% H2O2 0.52 (0.01 Hz) to 1.80 (49 Hz) 
H2O2/CoCl2 0.47 (0.01 Hz) to 1.82 (49 Hz) 
Bionate II 
UNT 0.68 (0.01 Hz) to 4.13 (49 Hz) 
3% H2O2 0.70 (0.01 Hz) to 3.94 (49 Hz) 
H2O2/CoCl2 0.68 (0.01 Hz) to 3.81 (49 Hz) 
Quadrathane 
UNT 0.36 (0.01 Hz) to 1.49 (24 Hz) 
3% H2O2 0.36 (0.01 Hz) to 1.48 (49 Hz) 
H2O2/CoCl2 0.34 (0.01 Hz) to 1.30 (49 Hz) 
Chronoflex C 
UNT 0.67 (0.01 Hz) to 3.15 (49 Hz) 
3% H2O2 0.68 (0.01 Hz) to 3.20 (29 Hz) 
H2O2/CoCl2 0.65 (0.01 Hz) to 3.31 (49 Hz) 
Chronosil 
UNT 0.49 (0.01 Hz) to 3.20 (49 Hz) 
3% H2O2 0.44 (0.01 Hz) to 3.07 (49 Hz) 
H2O2/CoCl2 0.43 (0.01 Hz) to 2.84 (49 Hz) 
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The multiple comparison test results, that compared the macro viscoelastic response of the 
untreated and in vitro oxidative degraded biomaterials, are shown in Table 4-10. The 
frequencies stated in Table 4-10 imply significant differences were detected (p < 0.05) between 
the stated groups. Similarly to the comparison of micro-scale viscoelastic properties of the 
untreated group to the H2O2/CoCl2, the macro-scale viscoelastic properties of Bionate II and 
Chronoflex C were not significantly different (p > 0.05) for all frequencies for this multiple 
comparison test. The macro-viscoelastic response (storage and loss stiffness) of the specific 
groups of Chronosil, Quadrathane B20 and Quadrathane were significantly different at specific 
frequencies (p < 0.05). 
Table 4-10: Multiple comparison test results for the macro viscoelastic properties of the 
untreated and oxidative degraded long-term implantable polymers. The frequencies 
stated indicates that the comparison were significantly different (p < 0.05) between the 
untreated, in vitro ISO 10993-13 3% H2O2 oxidation method (3% H2O2) and the in vitro 
accelerated oxidation 20% H2O2 and 0.1 M CoCl2 method (H2O2/ CoCl2) of the specific 
biomaterial. 
Biomaterial Multiple Comparison Test Storage Stiffness Loss Stiffness 
Quadrathane 
B20 
UNT – 3% H2O2 0.01, 0.75 and 1 Hz 0.03 to 0.1 Hz 
UNT – H2O2/CoCl2 - 0.3 Hz 
3% H2O2 – H2O2/CoCl2 0.01 to 15, 29 Hz 0.01 to 0.2, 0.4 Hz 
Bionate II 
UNT – 3% H2O2 0.01 to 10, 20 and 29 Hz - 
UNT – H2O2/CoCl2 - - 
3% H2O2 – H2O2/CoCl2 29, 39 to 49 Hz - 
Quadrathane 
UNT – 3% H2O2 3 to 15 and 29 Hz 0.5 to 1, 5 Hz 
UNT – H2O2/CoCl2 - 20 Hz 
3% H2O2 – H2O2/CoCl2 0.01 to 10, 20, 24, 34 to 49 Hz 0.01 to 10, 20, 34, 49 Hz 
Chronoflex C 
UNT – 3% H2O2 24 Hz - 
UNT – H2O2/CoCl2 - - 
3% H2O2 – H2O2/CoCl2 0.01 to 10 and 20 Hz 0.01 Hz 
Chronosil 
UNT – 3% H2O2 0.01 to 0.03 Hz - 
UNT – H2O2/CoCl2 - 0.01 to 0.5 Hz 
3% H2O2 – H2O2/CoCl2 0.01 to 0.05 Hz - 
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4.3.1.4 SEM  
Figure 4-20 to Figure 4-24 shows representative SEM images of the surfaces of the five 
biomaterials; Quadrathane ARC 80A B20 (Figure 4-20), Bionate II 80A (Figure 4-21), 
Quadrathane ARC 80A (Figure 4-22), Chronoflex C 80A (Figure 4-23) and Chronosil 80A 5% 
(Figure 4-24). For all SEM figures (Figure 4-20 to Figure 4-24), images (A), (C) and (E) are 
recorded at x1.2k magnification while images (B), (D) and (F) are at x2.0k magnification. 
Further, for all SEM images of the biomaterials’ surfaces, (A) and (B) are Untreated 
biomaterial, (C) and (D) are biomaterials treated with 3% H2O2 at 37°C and (E) and (F) are 
biomaterials treated with 20% H2O2/0.1M CoCl2 at 37°C. 
There was no evidence of surface pitting, or any other surface morphology changes, between 
the untreated and 3% H2O2 degraded for Quadrathane B20, Bionate II and Chronoflex C. On 
the surface of the 3% H2O2 degraded Quadrathane specimen, one pit was identified (Figure 
4-22 (C) and (D)). The surface morphology of Chronosil (Figure 4-24) untreated, 3% H2O2 
degraded and H2O2/CoCl2 degraded was different compared to the visually smooth surface 
morphology of the untreated and 3% H2O2 degraded Quadrathane B20, Bionate II, 
Quadrathane and Chronoflex C. All five biomaterials that were degraded with H2O2/CoCl2, for 
24 days, demonstrated various levels of surface pitting.  
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(A)  (B)  
(C)  (D)  
(E)  (F)  
Figure 4-20: Scanning electron micrographs of quadrathane with radiopacifiers (Quad 
B20) at (A, C, E) x1.2k and (B, D, F) x2.0k. (A & B) Untreated, (C & D) treated with 3% 
H2O2 at 37°C and (E & F) treated with 20% H2O2/0.1M CoCl2 at 37°C. 
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(A)  (B)  
(C)  (D)  
(E)  (F)  
Figure 4-21: Scanning electron micrographs of Bionate II 80A at (A, C, E) x1.2k and (B, D, 
F) x2.0k. (A & B) Untreated, (C & D) treated with 3% H2O2 at 37°C and (E & F) treated 
with 20% H2O2/0.1M CoCl2 at 37°C. 
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(A)  (B)  
(C)  (D)  
(E)  (F)  
Figure 4-22: Scanning electron micrographs of Quadrathane ARC 80A at (A, C, E) x1.2k 
and (B, D, F) x2.0k. (A & B) Untreated, (C & D) treated with 3% H2O2 at 37°C and (E & F) 
treated with 20% H2O2/0.1M CoCl2 at 37°C. 
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(A)  (B)  
(C)  (D)  
(E)  (F)  
Figure 4-23: Scanning electron micrographs of ChronoFlex C ARC 80A at (A, C, E) x1.2k 
and (B, D, F) x2.0k. (A & B) Untreated, (C & D) treated with 3% H2O2 at 37°C and (E & F) 
treated with 20% H2O2/0.1M CoCl2 at 37°C. 
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(A)  (B)  
(C)  (D)  
(E)  (F)  
Figure 4-24: Scanning electron micrographs of ChronoSil AL 80A 5% at (A, C, E) x1.2k and 
(B, D, F) x2.0k. (A & B) Untreated, (C & D) treated with 3% H2O2 at 37°C and (E & F) 
treated with 20% H2O2/0.1M CoCl2 at 37°C. 
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As the five biomaterials degraded with H2O2/CoCl2, for 24 days, demonstrated various levels of 
surface pitting, these surface pits were measured using ImageJ; an example of the measurement 
of the surface pits can be seen in Figure 4-25.  
(A)  (B)  
Figure 4-25: (A) SEM image, at x2.0k magnification, of Bionate II 80A treated with 20% 
H2O2/0.1M CoCl2 at 37°C; the same micrograph is used in Figure 4-21 (F). (B) ImageJ 
measurement of a surface pit and figure (B) is of the red highlighted section of (A). 
The dimension of pits, on the surface of the biomaterials, ranged between: 
 0.44 to 3.98 µm (Quadrathane B20) 
 0.44 to 5.88 µm (Bionate II) 
 0.48 to 3.99 µm (Quadrathane) 
 0.44 to 8.13 µm (Chronoflex C) 
 0.35 to 2.26 µm (Chronosil) 
  
 84 
 
4.3.2 Hydrolysis 
Figure 4-26 shows the discolouration between the (A) untreated biomaterials, (B) the 
biomaterials treated for 52 weeks with the ISO 10993-13 real-time degradation protocol [37 ± 
1°C] and (C) the accelerated degradation protocol [70 ± 2°C]: 
 
Figure 4-26: The five different biomaterials in three different groups; (A) Untreated 
(Control), (B) real-time degraded and (C) accelerated degraded groups. 
  
    (A)            (B)             (C)       
Quadrathane ARC B20 80A 
Bionate II 80A 
Quadrathane ARC 80A 
ChronoFlex C ARC 80A 
ChronoSil 80A 5% 
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4.3.2.1 HCI 
The ATR-FTIR spectrum of the untreated and hydrolytic degraded biomaterials is illustrated in 
Figure 4-27. In comparison to the H2O2/CoCl2 degraded specimens, no new absorbance peaks 
were observed at 930 cm-1 and 1174 cm-1 for the untreated, the real time degraded and the 
accelerated degraded specimens (Figure 4-27). Hyperspectral chemical images (HCIs) at 930 
cm-1 showed a lack of regionally variation and this can be further seen with the lack of change of 
the range of 930 cm-1 absorbance intensity (arbitrary unit [AU]) range between the untreated, 
real time and accelerated hydrolytically degraded Quadrathane B20, Bionate II and 
Quadrathane specimens (Figure 4-28). For ChronoFlex C, the absorbance range changed from 
1.45-1.65 AU (for the untreated) to 0.4-1.2 AU (for the accelerated hydrolytic degraded 
specimen (Figure 4-28). 
As there were no new absorbance peaks identified at 1174 cm-1, HCIs at 1174 cm-1 also 
showed a lack of regionally variation. Similar to the 930 cm-1 HCIs, lack of regional variation, 
and degradation specific variation, can be further seen with the lack of change of the range of 
1174 cm-1 absorbance intensity range (arbitrary unit [AU]) between the untreated, real time and 
accelerated hydrolytically degraded Quadrathane B20, Quadrathane and ChronoFlex C 
specimens (Figure 4-29). For Bionate II 80A, the approximate untreated absorbance range 
(1.46-1.62 AU) changed to 1.5-2.2 AU for the real-time hydrolytic degraded specimen (Figure 
4-29 (E)); however, no new absorbance peaks were identified at 1174 cm-1.   
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(A)  (B)  
(C)  (D)  
(E)  
Figure 4-27: Stacked ATR-FTIR spectra of untreated and in vitro hydrolytic degraded five 
biomaterials; (A) Quadrathane ARC 80A B20, (B) Bionate II 80A, (C) Quadrathane ARC 
80A, (D) ChronoFlex C 80A and (E) ChronoSil 80A 5%. Absorbance units are arbitrary 
units (AU). 
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(A)  (B)  
(C)  (D)  
(E)  (F)  
(G)  (H)  
(I)  (J)  
(K)  (L)  
(M)  (N)  
(O)  
Figure 4-28: Spatial variation of the absorbance intensites at 930 cm-1 for the five 
biomaterials; (A, D, G, J, M) untreated, (B, E, H, K, N) in vitro real time and (C, F, I, L, O) 
accelerated hydrolytic degraded specimens; (A-C) Quadrathane ARC 80A B20, (D-F) 
Bionate II 80A, (G-I) Quadrathane ARC 80A, (J-L) ChronoFlex C 80A and (M-O) ChronoSil 
80A 5%  
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(A)  (B)  
(C)  (D)  
(E)  (F)  
(G)  (H)  
(I)  (J)  
(K)  (L)  
(M)  (N)  
(O)  
Figure 4-29: Spatial variation of the absorbance intensites at 1174 cm-1 for the five 
biomaterials; (A, D, G, J, M) untreated, (B, E, H, K, N) in vitro real time and (C, F, I, L, O) 
accelerated hydrolytic degraded specimens; (A-C) Quadrathane ARC 80A B20, (D-F) 
Bionate II 80A, (G-I) Quadrathane ARC 80A, (J-L) ChronoFlex C 80A and (M-O) ChronoSil 
80A 5% 
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For Quadrathane 80A-B20 and Quadrathane 80A, HCIs at 1248 cm-1 showed a lack of 
regional variation and similar to 930 cm-1 and 1174 cm-1, this can be seen with the lack of 
change of the range of absorbance intensity range between the untreated, real time and 
accelerated hydrolytically degraded specimens (Figure 4-30). Comparing the absorbance peak 
intensity range of the Bionate II untreated (Figure 4-30 (D)) and accelerated hydrolytic 
degraded (Figure 4-30 (F)) specimens, the approximate range differed between the untreated 
(5.8-8 AU) and accelerated (3.8-6.8 AU) specimens. Similarly to Bionate II, ChronoFlex C 
untreated (Figure 4-30 (D)) and accelerated hydrolytic degraded (Figure 4-30 (F)) specimens 
approximate absorbance range changed from 8.2-10.1 AU to 6.8-8.1 AU. 
HCIs displayed isolated acquisitions of a new absorbance peak at 1650 cm-1 which was 
witnessed in 2 (out of 6) specimens for each of the groups; untreated, real time hydrolytic 
degraded and accelerated hydrolytic degraded groups. When compared to the untreated, the 
absorbance intensity peaks around 1635-1640 cm-1 of Quadrathane 80A-B20 and Quadrathane 
80A specimens increased in intensity for the real time degraded specimens (Figure 4-27). This 
led to an increase in the 1650 cm-1 absorbance intensity range (Figure 4-31 (B) and (H)). 
ChronoFlex C absorbance range at 1650 cm-1 for the untreated (0.9-1.3 AU) and real time (1-
1.5 AU) differed to the accelerated (1.8-3.6 AU). 
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 (A)  (B)  
(C)  (D)  
(E)  (F)  
(G)  (H)  
(I)  (J)  
(K)  (L)  
(M)  (N)  
(O)  
Figure 4-30: Spatial variation of the absorbance intensites at approximately 1248 cm-1 for 
the PCU biomaterials; (A, D, G, J, M) untreated, (B, E, H, K, N) in vitro real time hydrolytic 
degraded and (C, F, I, L, O) in vitro accelerated hydrolytic degraded specimens of the five 
biomaterials; (A-C) Quadrathane ARC 80A B20, (D-F) Bionate II 80A, (G-I) Quadrathane 
ARC 80A, (J-L) ChronoFlex C 80A and (M-O) ChronoSil 80A 5% 
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 (A)  (B)  
(C)  (D)  
(E)  (F)  
(G)  (H)  
(I)  (J)  
(K)  (L)  
(M)  (N)  
(O)  
Figure 4-31: Spatial variation of 1650 cm-1 for the PCU biomaterials; (A, D, G, J, M) 
untreated, (B, E, H, K, N) in vitro real time hydrolytic degraded and (C, F, I, L, O) in vitro 
accelerated hydrolytic degraded specimens of the five biomaterials; (A-C) Quadrathane 
ARC 80A B20, (D-F) Bionate II 80A, (G-I) Quadrathane ARC 80A, (J-L) ChronoFlex C 80A 
and (M-O) ChronoSil 80A 5% 
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4.3.2.2 µDMA 
Figure 4-32 and Figure 4-33 presents the storage stiffness and loss stiffness, respectively, of the 
five biomaterials, for normal and the in vitro hydrolytic degraded specimens.  
(A)  (B)  
(C)  (D)  
(E)  
Figure 4-32: Micro-level storage stiffness of the untreated, in vitro real-time (Real-time) 
and accelerated (Accelerated) hydrolytic degradation methods of the five biomaterials; 
(A) Quadrathane ARC 80A B20, (B) Bionate II 80A, (C) Quadrathane ARC 80A, (D) 
ChronoFlex C 80A and (E) ChronoSil 80A 5% (median ± 95% confidence intervals) 
 
 93 
 
(A)  (B)  
(C)  (D)  
(E)  
Figure 4-33: Comparison of the micro-level, surface loss stiffness of the untreated, in vitro 
ISO 10993-13 real-time (Real-time) and accelerated (Accelerated) hydrolytic degradation 
methods of the five biomaterials; (A) Quadrathane ARC 80A B20, (B) Bionate II 80A, (C) 
Quadrathane ARC 80A, (D) ChronoFlex C 80A and (E) ChronoSil 80A 5% (median ± 95% 
confidence intervals) 
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The median untreated and in vitro degraded storage stiffness (Figure 4-32) ranged, for the five 
biomaterials (Table 4-11). 
Table 4-11: Median range of storage stiffness (N/mm) values per biomaterial  
Biomaterial Group Range 
Quadrathane B20 
UNT 10.20 (0.1 Hz) to 12.74 (10 Hz)  
Real-time 16.01 (0.1 Hz) to 18.58 (10 Hz) 
Accelerated 12.22 (0.1 Hz) to 15.64 (10 Hz) 
Bionate II 
UNT 15.56 (0.1 Hz) to 18.49 (10 Hz) 
Real-time 30.17 (0.1 Hz) to 37.63 (10 Hz) 
Accelerated 24.71 (0.1 Hz) to 32.86 (10 Hz) 
Quadrathane 
UNT 11.86 (0.1 Hz) to 13.27 (3.16 Hz) 
Real-time 10.53 (0.1 Hz) to 12.66 (10 Hz) 
Accelerated 10.38 (0.1 Hz) to 13.91 (10 Hz) 
Chronoflex C 
UNT 18.05 (0.1 Hz) to 23.44 (10 Hz) 
Real-time 16.11 (0.1 Hz) to 20.29 (10 Hz) 
Accelerated 13.81 (0.1 Hz) to 17.96 (10 Hz) 
Chronosil 
UNT 8.93 (0.1 Hz) to 13.54 (10 Hz) 
Real-time 10.31 (0.1 Hz) to 16.09 (10 Hz) 
Accelerated 9.40 (0.1 Hz) to 14.05 (10 Hz) 
While, the median untreated and in vitro degraded loss stiffness (Figure 4-33) ranged, for the 
five biomaterials (Table 4-12). 
Table 4-12: Median range of loss stiffness (N/mm) values per biomaterial 
Biomaterial Group Range 
Quadrathane B20 
UNT 0.59 (0.1 Hz) to 2.73 (10 Hz)  
Real-time 1.11 (0.1 Hz) to 4.57 (10 Hz) 
Accelerated 1.06 (0.1 Hz) to 4.21 (10 Hz) 
Bionate II 
UNT 0.91 (0.1 Hz) to 4.85 (10 Hz) 
Real-time 2.39 (0.1 Hz) to 15.18 (10 Hz) 
Accelerated 2.33 (0.1 Hz) to 12.35 (10 Hz) 
Quadrathane 
UNT 0.74 (0.316 Hz) to 2.78 (10 Hz) 
Real-time 0.47 (0.1 Hz) to 2.27 (10 Hz) 
Accelerated 0.85 (0.1 Hz) to 3.23 (10 Hz) 
Chronoflex C 
UNT 1.33 (0.1 Hz) to 7.80 (10 Hz) 
Real-time 0.91 (0.1 Hz) to 6.15 (10 Hz) 
Accelerated 1.02 (0.1 Hz) to 5.29 (10 Hz) 
Chronosil 
UNT 1.15 (0.1 Hz) to 4.49 (10 Hz) 
Real-time 1.10 (0.1 Hz) to 5.93 (10 Hz) 
Accelerated 1.16 (0.1 Hz) to 4.71 (10 Hz) 
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The micro-level storage stiffness frequency dependent trends increased logarithmically in 
relation to frequency (p < 0.05) for all biomaterials (untreated and hydrolytic degraded) except 
for one position on the surface of Bionate II degraded with PBS at 37°C (Real-time); see 
equation 4.1, where A is a coefficient and B is a constant, and 8.5 Appendix E - Table 8-1 to 
Table 8-5. The micro-level loss stiffness of Chronoflex C and Chronosil were logarithmically 
frequency dependent in relation to frequency (p < 0.05) (equation 4.2, where C is a coefficient 
and D is a constant, and 8.5 Appendix E - Table 8-1 to Table 8-5). For the three other 
biomaterials (Quadrathane B20, Bionate II and Quadrathane), the frequency dependent trends 
of the loss stiffness behaved logarithmically (p < 0.05) at specific positions on the surface of the 
biomaterials (8.5 Appendix E - Table 8-1 to Table 8-5). 
The multiple comparison test results, that compared the untreated and in vitro hydrolytic 
degraded biomaterials, are shown in Table 4-13; the stated frequencies imply significant 
differences were detected (p < 0.05). Interestingly, the storage and loss stiffness of the Chronosil 
groups were not significantly different for all frequencies (p > 0.05); this result is similar to the 
Chronosil µDMA results for the oxidation study (see Table 4-6).  
Table 4-13: Multiple comparison test results for the micro-level, surface viscoelastic 
properties of the untreated and hydrolytic degraded long-term implantable polymers. The 
frequencies stated indicates that the comparison were significantly different (p < 0.05) 
between the in vitro ISO 10993-13 real-time (Real-time) and accelerated (Accelerated) 
hydrolytic degradation methods of the specific biomaterial. 
Biomaterial Multiple Comparison Test Storage Stiffness Loss Stiffness 
Quadrathane B20 
UNT – Real time 0.1 to 10 Hz 1 and 10 Hz 
UNT – Accelerated - 0.1 to 10 Hz 
Real time – Accelerated - - 
Bionate II 
UNT – Real time 0.1 to 10 Hz 0.1 to 10 Hz 
UNT – Accelerated - 0.1 Hz 
Real time – Accelerated - - 
Quadrathane 
UNT – Real time - - 
UNT – Accelerated - 0.316 and 3.16 Hz 
Real time – Accelerated - 0.1 to 0.316 Hz 
Chronoflex C 
UNT – Real time - 0.1 to 3.16 Hz 
UNT – Accelerated 0.1 to 10 Hz 1 to 10 Hz 
Real time – Accelerated - - 
Chronosil 
UNT – Real time - - 
UNT – Accelerated - - 
Real time – Accelerated - - 
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4.3.2.3 DMA 
The macro storage stiffness and loss stiffness of the five biomaterials, for normal and the in vitro 
hydrolytic degraded specimens, are presented in Figure 4-34 and Figure 4-35. 
(A) (B)  
(C)  (D)  
(E)  
Figure 4-34: Macro storage stiffness of the untreated, in vitro  real-time (Real-time) and 
accelerated (Accelerated) hydrolytic degradation methods of the five biomaterials; (A) 
Quadrathane ARC 80A B20, (B) Bionate II 80A, (C) Quadrathane ARC 80A, (D) ChronoFlex 
C 80A and (E) ChronoSil 80A 5% (median ± 95% confidence intervals) 
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(A) (B)  
(C)  (D)  
(E)  
Figure 4-35: Comparison of the macro loss stiffness of the untreated, in vitro ISO 10993-
13 real-time (Real-time) and accelerated (Accelerated) hydrolytic degradation methods of 
the five biomaterials; (A) Quadrathane ARC 80A B20, (B) Bionate II 80A, (C) Quadrathane 
ARC 80A, (D) ChronoFlex C 80A and (E) ChronoSil 80A 5% (median ± 95% confidence 
intervals) 
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The median untreated and in vitro degraded storage stiffness (Figure 4-34) ranged, for the five 
biomaterials (Table 4-14). 
Table 4-14: Median range of storage stiffness (N/mm) values per biomaterial  
Biomaterial Group Range 
Quadrathane B20 
UNT 9.51 (0.01 Hz) to 14.70 (49 Hz) 
Real-time 9.82 (0.01 Hz) to 15.24 (49 Hz) 
Accelerated 6.35 (0.01 Hz) to 11.60 (49 Hz) 
Bionate II 
UNT 13.99 (0.01 Hz) to 21.20 (49 Hz) 
Real-time 14.67 (0.01 Hz) to 23.45 (49 Hz) 
Accelerated 11.45 (0.01 Hz) to 19.08 (49 Hz) 
Quadrathane 
UNT 7.81 (0.01 Hz) to 11.29 (49 Hz) 
Real-time 8.16 (0.01 Hz) to 11.71 (49 Hz) 
Accelerated 5.43 (0.01 Hz) to 9.77 (49 Hz) 
Chronoflex C 
UNT 12.16 (0.01 Hz) to 19.10 (49 Hz) 
Real-time 13.14 (0.01 Hz) to 20.52 (49 Hz) 
Accelerated 9.44 (0.01 Hz) to 15.91 (49 Hz) 
Chronosil 
UNT 5.37 (0.01 Hz) to 12.53 (49 Hz) 
Real-time 5.65 (0.01 Hz) to 11.31 (49 Hz) 
Accelerated 5.08 (0.01 Hz) to 10.17 (49 Hz) 
While, the median untreated and in vitro degraded loss stiffness (Figure 4-35) ranged, for the 
five biomaterials (Table 4-15). 
Table 4-15: Median range of loss stiffness (N/mm) values per biomaterial 
Biomaterial Group Range 
Quadrathane B20 
UNT 0.53 (0.01 Hz) to 1.90 (49 Hz) 
Real-time 0.57 (0.01 Hz) to 1.93 (49 Hz) 
Accelerated 0.53 (0.01 Hz) to 1.77 (49 Hz) 
Bionate II 
UNT 0.65 (0.01 Hz) to 3.40 (49 Hz) 
Real-time 0.65 (0.01 Hz) to 4.38 (29 Hz) 
Accelerated 0.72 (0.01 Hz) to 3.62 (34 Hz) 
Quadrathane 
UNT 0.35 (0.01 Hz) to 1.36 (49 Hz) 
Real-time 0.36 (0.01 Hz) to 1.38 (49 Hz) 
Accelerated 0.39 (0.01 Hz) to 1.46 (49 Hz) 
Chronoflex C 
UNT 0.65 (0.01 Hz) to 2.98 (49 Hz) 
Real-time 0.65 (0.01 Hz) to 3.21 (49 Hz) 
Accelerated 0.64 (0.01 Hz) to 2.49 (49 Hz) 
Chronosil 
UNT 0.53 (0.01 Hz) to 3.26 (49 Hz) 
Real-time 0.40 (0.01 Hz) to 2.65 (49 Hz) 
Accelerated 0.39 (0.01 Hz) to 2.16 (49 Hz) 
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Similarly to the macro viscoelastic properties’ regression analyses in the oxidation study, all of 
the storage stiffness and loss stiffness trends increased logarithmically in relation to frequency (p 
< 0.05) for all biomaterials (equation 4.1, equation 4.2 and 8.6 Appendix F - Table 8-6 and 
Table 8-10).  
Table 4-16 shows the multiple comparison test results that compared the macro viscoelastic 
response of the untreated and in vitro hydrolytic degraded biomaterials; stated frequencies in 
Table 4-16 imply significant differences were detected (p < 0.05) between the groups. The 
storage stiffness of the four aromatic PCU biomaterials (Quadrathane B20, Bionate II, 
Quadrathane and Chronoflex C) was not significantly different (p > 0.05) for all frequencies. 
However, comparing the real-time and accelerated groups viscoelastic properties for these four 
aromatic PCUs, the viscoelastic properties were significantly different (p < 0.05) at specific 
frequencies. Chronosil untreated and real-time degraded groups were not significantly different 
(p > 0.05) for all tested frequencies, while the untreated and accelerated groups were 
significantly different at specific frequencies (p < 0.05). 
Table 4-16: Multiple comparison test results for the macro viscoelastic properties of the 
untreated and hydrolytic degraded long-term implantable polymers. The frequencies 
stated indicates that the comparison were significantly different (p < 0.05) between the 
in vitro ISO 10993-13 real-time (Real-time) and accelerated (Accelerated) hydrolytic 
degradation methods of the specific biomaterial. 
Biomaterial Multiple Comparison Test Storage Stiffness Loss Stiffness 
Quadrathane 
B20 
UNT – Real time - 0.02 and 0.03 Hz 
UNT – Accelerated - - 
Real time – Accelerated 0.01 to 15, 24, 34 to 49 Hz 24 and 39 Hz 
Bionate II 
UNT – Real time - - 
UNT – Accelerated - - 
Real time – Accelerated 0.01 to 24, 35 to 49 Hz 15, 20, 44 and 49 Hz 
Quadrathane 
UNT – Real time - - 
UNT – Accelerated - 0.01 to 15, 39 to 49 Hz 
Real time – Accelerated 0.01 to 24, 34 to 49 Hz 24 Hz 
Chronoflex C 
UNT – Real time - - 
UNT – Accelerated - - 
Real time – Accelerated 0.01 to 49 Hz 3 to 15, 29 to 49 Hz 
Chronosil 
UNT – Real time - - 
UNT – Accelerated 0.5 to 10, 20 to 49 Hz 0.01 to 49 Hz 
Real time – Accelerated 0.01 Hz - 
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4.3.2.4 SEM 
SEM images are presented of the surfaces of Quadrathane ARC 80A B20 (Figure 4-36), 
Bionate II 80A (Figure 4-37), Quadrathane ARC 80A (Figure 4-38), Chronoflex C 80A (Figure 
4-39) and Chronosil 80A 5% (Figure 4-40). Similar to the SEM images in the oxidation study 
(section 4.3.1.4), images (A), (C) and (E) are recorded at x1.2k magnification while images (B), 
(D) and (F) are at x2.0k magnification. SEM images (A) and (B) are Untreated biomaterial, (C) 
and (D) are biomaterials treated with PBS at 37°C (Real-time) and (E) and (F) are biomaterials 
treated with PBS at 70°C (Accelerated). 
There was no evidence of any other surface morphology changes, when comparing the 
untreated specimens to the in vitro hydrolytic degraded (Real-time and accelerated) specimens 
for the Quadrathane B20 biomaterial (Figure 4-36). There was no apparent visual surface 
morphological differences between Bionate II untreated and Real-time hydrolytic degraded 
specimens. However, compared to the untreated specimen, surface morphological changes of 
the Accelerated hydrolytic degraded specimen was witnessed (Figure 4-37). Small blistered 
areas on the surface of the Real-time and Accelerated degraded Quadrathane specimens was 
observed on the SEM images when compared to the untreated Quadrathane specimen (Figure 
4-38). Chronoflex C Accelerated hydrolytic degraded specimen observed larger blistered area 
on the surface of the specimen when compared to the untreated and Real-time degraded 
specimens (Figure 4-39). Further, the Chronosil real-time hydrolytic degraded surface displayed 
a difference in the surface morphology when compared to the visually smooth surface 
morphology of the untreated specimen; the Accelerated degraded specimen displayed a vast 
area of blistering (Figure 4-40). 
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(A)  (B)  
(C)  (D)  
(E)  (F)  
Figure 4-36: Scanning electron micrographs of Quadrathane with radiopacifiers 
(Quadrathane B20) at (A, C, E) x1.2k and (B, D, F) x2.0k. (A & B) Untreated, (C & D) 
treated with PBS at 37°C and (E & F) treated with PBS at 70°C. 
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(A)  (B)   
(C)  (D)  
(E)   (F)  
Figure 4-37: Scanning electron micrographs of Bionate II 80A at (A, C, E) x1.2k and (B, D, 
F) x2.0k. (A & B) Untreated, (C & D) treated with PBS at 37°C and (E & F) treated with PBS 
at 70°C. 
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(A)  (B)   
(C)  (D)  
(E)  (F)  
Figure 4-38: Scanning electron micrographs of Quadrathane ARC 80A at (A, C, E) x1.2k 
and (B, D, F) x2.0k. (A & B) Untreated, (C & D) treated with PBS at 37°C and (E & F) 
treated with PBS at 70°C. 
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(A)  (B)  
(C)  (D)  
(E)  (F)  
Figure 4-39: Scanning electron micrographs of Chronoflex C ARC 80A at (A, C, E) x1.2k 
and (B, D, F) x2.0k. (A & B) Untreated, (C & D) treated with PBS at 37°C and (E & F) 
treated with PBS at 70°C. 
 105 
 
(A)  (B)  
(C)  (D)  
 (E)  (F)  
Figure 4-40: Scanning electron micrographs of Chronosil AL 80A 5% at (A, C, E) x1.2k and 
(B, D, F) x2.0k. (A & B) Untreated, (C & D) treated with PBS at 37°C and (E & F) treated 
with PBS at 70°C. 
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4.4 Discussion 
Firstly, this chapter has quantified the frequency dependent viscoelastic behaviour of five long-
term implantable biomaterials: Quadrathane ARC 80A-B20, Bionate II 80A, Quadrathane 
ARC 80A, ChronoFlex C 80A and ChronoSil 80A 5%. The five biomaterials were viscoelastic 
throughout the frequency range tested. The macro-viscoelastic responses, of the five untreated 
biomaterials, were logarithmic with respect to frequency (p < 0.05; see 8.6 Appendix F) for all 
biomaterial specimens tested. Between the five biomaterials, the multiple comparison test 
results show significant differences between specific untreated groups for the macro (Table 4-7) 
and the micro (Table 4-3) viscoelastic properties. There were no significant differences (p > 
0.05), for the storage stiffness and the loss stiffness, between Quadrathane B20 – Quadrathane, 
Quadrathane B20 – Chronosil, and Bionate II – Chronoflex C, for all frequencies tested for the 
macro (Table 4-7) and the micro (Table 4-3) viscoelastic properties.  
Secondly, this chapter investigated the effect of in vitro oxidative degradation and in vitro 
hydrolytic degradation on the viscoelastic response of these five biomaterials. Similarly to the 
five untreated biomaterials, the macro-viscoelastic properties of the degraded biomaterials, by 
oxidative and hydrolytic protocols, were logarithmic with respect to frequency (p < 0.05; see 8.6 
Appendix F). The micro-viscoelastic properties of Chronosil were not significantly different 
when comparing the two oxidative degraded methods (3% H2O2 and H2O2/CoCl2) to the 
untreated biomaterials. Comparing the untreated to the H2O2/CoCl2 degradation methods, the 
storage stiffness and loss stiffness of Bionate II and Chronoflex C, for the micro and macro 
viscoelasticity, were not significantly different (p > 0.05) for any frequency tested. The in vitro 
H2O2/CoCl2 degradation protocol has been used in numerous studies (Christenson et al., 
2006b, 2004a; Hernandez et al., 2008) as it has been shown to have similar chemical structure 
and surface morphological changes when compared to in vivo degraded PCU biomaterials 
(Christenson et al., 2004a). The no significant differences of the untreated to the H2O2/CoCl2 
degradation Bionate II micro- and macro-viscoelastic properties at any frequency tested is an 
interesting finding. Therefore, future work is required to investigate the effect of in vivo 
degradation on the viscoelastic properties of these biomaterials and to investigate if the 
viscoelastic properties of the in vivo degraded biomaterials produces similar results to the in 
vitro H2O2/CoCl2 degraded biomaterials.  
The micro-viscoelastic properties of the untreated and the in vitro H2O2/CoCl2 degradation 
method for Quadrathane B20 and Quadrathane biomaterials, the storage stiffness and loss 
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stiffness were not significantly different (p > 0.05) for all frequencies except for the viscous 
property (loss stiffness) at 1 Hz for Quadrathane B20. Comparing surface micro-level 
viscoelastic response of these specific biomaterials, these results suggest that the in vitro 
H2O2/CoCl2 degradation method may not have an effect on the micro-level viscoelastic 
properties of Bionate II, Quadrathane, Chronoflex C and Chronosil; this finding is further 
discussed later in this discussion (section 4.4). 
The micro-viscoelastic properties of the untreated and the in vitro 3% H2O2 degradation 
method for Quadrathane B20 were not significantly different (p > 0.05) at any frequencies 
tested. For Quadrathane, the loss stiffness at 0.1 Hz was the only viscoelastic property 
significantly different (p < 0.05) comparing the untreated and in vitro 3% H2O2 degraded 
groups. Unlike the comparison between the untreated to the H2O2/CoCl2 degradation 
methods, the storage stiffness and loss stiffness of Bionate II and Chronoflex C, for the micro 
viscoelasticity between the untreated to the 3% H2O2 degradation, were significantly different (p 
< 0.05) at specific tested frequencies (Table 4-6). Bionate II 80A degraded with the in vitro 3% 
H2O2 degradation protocol has been shown to have a different chemical structure and surface 
morphological changes when compared to in vivo degraded PCU biomaterials (Dempsey et al., 
2014). These reasons led to Dempsey et al. (2014) to recommend the H2O2/CoCl2 degradation 
method when predicting segmented polyurethane (SPU) oxidative stability. However, a recent 
shape memory polyurethane study found that the 20% H2O2 /0.1 M  CoCl2 method resulted in 
rapid oxidation and complete mass loss in less than 30 days (Weems et al., 2017). Thus, the use 
of the H2O2/CoCl2 method may be too severe for certain scenarios. 
The macro viscoelastic properties of the five biomaterials, quantified by DMA, of these specific 
biomaterials, were significantly different (p < 0.05) at specific frequencies when comparing the 
untreated and 3% H2O2 degradation method. When comparing the untreated specimens and 
the in vitro H2O2/CoCl2 degraded specimens of Quadrathane B20 (0.3 Hz), Quadrathane (20 
Hz) and Chronosil (0.01 to 0.5 Hz), the macro loss stiffness were significantly different (p < 
0.05) at specific frequencies (stated in brackets and Table 4-10). Thus, the elastic property, 
which describes the ability of a structure to store energy, was not significantly different (p > 0.05) 
for any biomaterial, at any tested frequency, on the micro-scale or the macro-scale between the 
untreated and the in vitro H2O2/CoCl2 degraded groups. It has been recommended to use the 
H2O2/CoCl2 degradation method, when predicting segmented polyurethane (SPU) oxidative 
stability, due to the similarity between the chemical structure and surface morphological 
changes of the in vitro and in vivo degraded PCU biomaterials (Dempsey et al., 2014). 
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However, as the macro (by tensile DMA testing) and micro elastic property were not 
significantly different of all five biomaterials evaluated, it is concluded with caution that 
oxidation mechanisms, created by an in vitro mechanism that is comparative to the in vivo 
mechanism, may not affect the recoverable energy (also known as stored energy) of these five 
biomaterials. A caveat of this conclusion is that this does not apply to all forms of mechanical 
loading and potentially, all induced stress ranges.  
Other studies have examined the effect of in vitro oxidative degradation in relation to tensile 
strain (Christenson et al., 2004b; Dempsey et al., 2014) and Dynamic Mechanical Thermal 
Analysis (DMTA) (Hernandez et al., 2008), but not viscoelastic properties calculated by µDMA 
or DMA techniques. Schubert et al. (1997) discovered a 10% decrease in stress at high strains of 
treated PEUU specimens when compared to the untreated PEUU specimens. This result was 
similar to those of Christenson et al. (2004a) who found a minor decrease in stress at high 
strains when comparing the tensile stress-strain behaviour of in vitro oxidised PEU and PCU to 
untreated PEU and PCU. Apart from this decrease in stress, the Young’s modulus was 
unaffected (Christenson et al., 2004a). After 36 days of in vitro oxidation, Dempsey et al. (2014) 
stated that the ultimate tensile strength (UTS) of Bionate 80A, a PCU, was less when compared 
to the untreated specimens. However, the UTS of Bionate II 80A was greater for the specimens 
that were treated (Dempsey et al., 2014). The UTS of Bionate II 80A degraded with the 3% 
H2O2 degradation method was not significantly different from the untreated specimens 
(Dempsey et al., 2014). In contrast to Dempsey et al. (2014), for macro-viscoelasticity 
characterisation, Bionate II 80A storage and loss properties were not significant different, when 
comparing the untreated to the H2O2/CoCl2 degradation specimen, at any frequency. Further, 
when comparing the untreated to the 3% H2O2 degradation specimens, the storage property of 
the degraded specimens was significantly greater (p < 0.05) at specific frequencies while the loss 
property was not significantly different. The differences between the Dempsey et al. (2014) 
study and this chapter may be due to the response of PCU biomaterials at low and high strains.  
By using DMTA, Hernandez et al. (2008) discovered that the maximum loss factor (tan δ), of a 
PCU, reduced by approximately 0.05 while the storage modulus did not appreciably change 
after in vitro oxidation (H2O2/CoCl2 solution). From this, the author suggested that there was 
no significant changes in the hard-soft segment organisation in the bulk (Hernandez et al., 
2008). This present work discovered a similar result to Hernandez et al. (2008) with µDMA and 
DMA as the micro and macro storage property, of all five biomaterials, did not appreciably 
change after in vitro oxidation with the H2O2/CoCl2 method (Table 4-17).  
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Similarly to the comparison between the untreated and oxidative degraded specimens, the 
micro-viscoelastic properties of Chronosil were not significantly different when comparing the 
two hydrolytic degraded methods (real-time and accelerated) and the untreated biomaterials 
(Table 4-17). Comparing the untreated to real-time degraded specimens, the micro 
viscoelasticity of Bionate II was significantly different (p < 0.05) for every frequency tested. The 
micro-level viscoelastic properties of Quadrathane B20 and Chronoflex C were significantly 
different (p < 0.05) at specific frequency tested between the untreated to real-time degraded 
specimens. The micro-viscoelastic properties of the untreated and the real-time degradation 
method for Quadrathane were not significantly different (p > 0.05) for all frequencies. 
Comparing the untreated to accelerated degraded specimens, the micro-level loss property was 
significantly different (p < 0.05), for specific frequencies, for Quadrathane B20, Bionate II and 
Quadrathane; the storage property was not significantly different (p > 0.05) for all frequencies. 
This was different for the micro-scale viscoelastic properties of Chronoflex C as the storage and 
loss stiffness was significantly different, between the untreated and accelerated degraded 
specimens, at specific frequencies.  
Table 4-17: Summary table highlights the significant differences between the untreated 
and degraded groups [3% H2O2 (3%); H2O2/CoCl2; Real-time (Real) and Accelerated 
(Accel)] of the micro (µDMA) and macro (DMA) viscoelastic response, of the five 
biomaterials. The significant differences between the untreated and degraded specimens 
were at specific tested frequencies (S.F), all tested frequencies (A.F) or not significantly 
different (-)  
µDMA Storage Stiffness Loss Stiffness 
Biomaterial 3% H2O2/CoCl2 Real Accel 3% H2O2/CoCl2 Real Accel 
Quad B20 - - A.F - - S.F S.F A.F 
Bionate II S.F - A.F - S.F - A.F S.F 
Quadrathane - - - - S.F - - S.F 
Chronoflex C S.F - - A.F S.F - S.F S.F 
Chronosil - - - - - - - - 
DMA Storage Stiffness Loss Stiffness 
Biomaterial 3% H2O2/CoCl2 Real Accel 3% H2O2/CoCl2 Real Accel 
Quad B20 S.F - - - S.F S.F S.F - 
Bionate II S.F - - - - - - - 
Quadrathane S.F - - - S.F S.F - S.F 
Chronoflex C S.F - - - - - - - 
Chronosil S.F - - S.F - S.F - A.F 
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Comparing the untreated specimens against the real-time and accelerated degradation methods, 
the macro-storage stiffness of Quadrathane B20, Bionate II, Quadrathane and Chronoflex C 
was not significantly different (p > 0.05) for all frequencies. Further, the loss stiffness of Bionate 
II, and Chronoflex C were not significantly different when comparing the untreated specimens 
against the real-time and accelerated degradation methods; these macro-viscoelastic results 
highlight the hydrolytic stability of Bionate II 80A and Chronoflex C 80A. The loss stiffness of 
the untreated and real-time hydrolytic degraded Quadrathane specimens were not significantly 
different (p > 0.05) for all tested frequencies while the loss stiffness of the untreated and 
accelerated degraded Quadrathane specimens were significantly different (p < 0.05) at specific 
frequencies. The opposite result was found for Quadrathane with the radiopacifier additive; the 
loss stiffness of the untreated and real-time hydrolytic degraded Quadrathane B20 specimens 
were significantly different (p < 0.05) for all tested frequencies while the loss stiffness of the 
untreated and accelerated degraded Quadrathane B20 specimens were not significantly 
different (p > 0.05) at specific frequencies. The viscoelastic properties of Chronosil untreated 
and real-time specimens were not significantly different for all tested frequencies; this shows that 
the real-time hydrolytic degradation protocol did not have an effect on the elastic property, of 
these five biomaterials, for the frequencies and method tested. The storage stiffness of the 
Chronosil untreated and accelerated degraded specimens were significantly different (p < 0.05) 
at specific frequencies while the loss stiffness was significantly different for all frequencies tested. 
Similar to previous in vitro oxidation studies, studies have examined the effect of in vitro 
hydrolytic degradation in relation to tensile strain (Khan et al., 2005a; Serkis et al., 2015) of 
PCUs, but not viscoelastic properties calculated by µDMA or DMA techniques. Other studies 
have evaluated the effect of hydrolytic degradation of PEU (Chaffin et al., 2014, 2012; Mishra et 
al., 2015; Padsalgikar et al., 2015), PEU with silicone (Chaffin et al., 2014, 2013, 2012) and 
PDMS based polyurethane (Chaffin et al., 2014, 2013, 2012; Mishra et al., 2015; Padsalgikar et 
al., 2015); these materials were evaluated by quasi-static tensile tests (Chaffin et al., 2012; Mishra 
et al., 2015) and DMTA (Chaffin et al., 2012; Padsalgikar et al., 2015). The effect of hydrolytic 
degradation on the UTS (Khan et al., 2005a; Mishra et al., 2015), failure strain (Khan et al., 
2005a) and secant modulus (Khan et al., 2005a) of PCU biomaterials were previously 
investigated. Corethane 80A, now known as Bionate 80A (Dumbleton et al., 2009), showed the 
smallest drop, approximately 20%, in the UTS with the dry control specimens showing no 
significant changes in mechanical properties (Khan et al., 2005a). The failure strain of the 
biomaterial increased within the first 3-4 months of incubation (Khan et al., 2005a). However, 
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after 3-4 months, the failure strain decreased with incubation time (Khan et al., 2005a). At 100% 
strain, the secant modulus of Corethane 80A exhibited the smallest overall change of 
approximately 8% decrease while Chronoflex 80A showed the greatest increase, at the same 
strain, of approximately 15% (Khan et al., 2005a). With regards to hydrolytic stability, this 
present work discovered that the macro-viscoelastic storage stiffness and loss stiffness of Bionate 
II and Chronoflex C were not significantly different (p > 0.05) for all frequencies tested; this is 
for the comparison of the untreated specimens to the real-time and accelerated degraded 
specimens. As Khan et al. (2005a) stated that Corethane 80A showed the best overall stability 
while Chronoflex 80A showed some evidence of very minor hydrolysis, the author agrees with 
the hydrolytic stability assessment of Khan et al. (2005a) due to the lack of significant 
differences of the macro-viscoelastic response. However, the present study revealed that the 
micro-viscoelastic properties of Bionate II and Chronoflex C were significantly different (p < 
0.05) at specific frequencies tested. Thus, these results call into doubt the hydrolytic stability of 
these biomaterials and demonstrate the need to analyse material mechanical property changes 
on multiple scales.  
Mishra et al. (2015) investigated the in vitro hydrolytic stability of Bionate 55D, Chronoflex 80A 
and Quadrathane 80A. The authors found that the UTS, of all biomaterials evaluated in the 
study, decreases with increasing time (degradation time) and temperature with the highest rate 
of decrease observed at 80 °C (Mishra et al., 2015). The relative decrease in UTS, at 80 °C for 
52 weeks, was the highest for Chronoflex C, approximately 55-60%, while Quadrathane 80A 
was the lowest relative decrease of approximately 30%; other biomaterials, such as Bionate 55D, 
had a relative decrease of approximately 40% (Mishra et al., 2015). In the present work, only 
the macro-loss stiffness of the untreated Quadrathane specimens compared to the accelerated 
degraded specimens were significantly different at specific frequencies while, when comparing 
the untreated specimens to the accelerated degraded specimens, the macro-viscoelastic 
properties of Bionate II and Chronoflex C were not significantly different (p > 0.05) for all 
frequencies tested. The differences between Mishra et al. (2015) studies to this present work 
may be due to the differences in response of the degraded PCU biomaterials at low and high 
elongation strains. 
In this present work, the macro-viscoelastic properties of all biomaterial specimens, both 
untreated and degraded, exhibited frequency-dependent dynamic viscoelastic properties (p < 
0.001). Thus, it is suggested that when evaluating these biomaterials, the frequency dependent 
nature of these biomaterials is considered when designing experiments. A recent study 
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investigated the mechanisms of fatigue crack growth, of PCUs (Bionate 80A and Bionate 75D), 
with respect to time dependent effects and conditioning (Ford et al., 2018). Ford et al. (2018) 
discovered that specimens tested at 2, 5 and 10 Hz had a similar number of cycles to failure. 
However, the crack length at failure for 10 Hz was longer (p < 0.002) when compared to crack 
length of specimens tested at 2 and 5 Hz (Ford et al., 2018); this finding highlights the 
importance of evaluating the effect of frequency on these biomaterials. Interestingly, Ford et al. 
(2018) discovered that strain rate (10, 75 and 150 mm/min) did not have a statistically significant 
impact on the quasi-static tensile mechanical properties (Young’s modulus, ultimate strength 
and ultimate strain) of Bionate 80 A. However, at a high strain rate (500 mm/min) used in the 
dry time study, the elastic moduli were approximately twice as high than the slower 
displacement rates (10, 75, and 150 mm/min) (Ford et al., 2018). This further highlights the 
need to consider the frequency dependent nature of these biomaterials when designing 
experiments. 
With classical indenters, the force due to the water meniscus on the shaft of the indenter makes 
the analysis of indentation data more complicated (Chavan et al., 2012; Mattei et al., 2015). In 
order to perform AFM indentation in a liquid, the specimen needs to be mounted inside a 
specially designed fluid chamber which can limit the size of the specimen and increase the 
complexity of the equipment (Chavan et al., 2012). Further, the ferrule-top cantilever position is 
monitored by optical fibre interferometry rather than optical triangulation techniques used in 
AFM (Antonovaite et al., 2018). Thus, ferrule-top cantilevers offer advantages when testing 
specimens submerged in a liquid medium (Chavan et al., 2012; Mattei et al., 2015). Ferrule-top 
cantilever indenters have been used to develop high resolution images in air, vacuum, low 
temperatures and liquids (Chavan et al., 2012, 2011, 2010). Recently, ferrule-top indenters have 
been used to characterise the viscoelastic response of PDMS (Mattei et al., 2015) and hydrogels 
(Mattei et al., 2017, 2015) by the Nano-epsilon dot method, to measure the storage and loss 
properties of PDMS over a frequency range between 0.01-10 Hz (van Hoorn et al., 2016) and 
to gather viscoelastic maps, depth dependent and frequency dependent viscoelastic properties 
of mouse brain tissue (Antonovaite et al., 2018). Further, the ferrule-top technology has been 
designed and used to perform the integrated epidetection of Optical Coherence Tomography 
(OCT) depth-profiles and micron-scale indentation (Bartolini et al., 2017) and it has been 
inserted into an 18G needle to characterise the viscoelastic properties of soft tissues in situ 
(Beekmans et al., 2017). The µDMA work performed in this chapter, by a ferrule-top cantilever 
probe, adds to the recent work investigated with this technology and gives an understanding of 
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the effect of in vitro degradation on the micrometre-scale viscoelastic properties of PCU 
biomaterials. 
This chapter quantified the chemical structure changes due to in vitro degradation by using 
hyperspectral chemical imaging. Aromatic PCU biomaterials (Quadrathane ARC 80A-B20, 
Bionate II 80A, Quadrathane 80A and ChronoFlex C 80A) demonstrated evidence of PCU 
oxidative degradation as new absorbance peaks were observed at 930 cm-1 and 1174 cm-1; these 
new absorbance peaks have been associated with oxidative degradation (Cipriani et al., 2013; 
Faré et al., 1999). These new peaks were observed for all in vitro H2O2/CoCl2 degraded 
Quadrathane ARC 80A-B20 (with radiopacifier), Bionate II 80A and Quadrathane ARC 80A 
specimens; however, 5 out of 6 in vitro H2O2/CoCl2 degraded ChronoFlex C 80A specimens 
had new peaks at 930 cm-1 and 1174 cm-1. The one ChronoFlex C 80A HCI that did not 
demonstrate the new peaks at 930 cm-1 and 1174 cm-1 was a 6 × 6 acquisition HCI. A larger 
acquisition of ChronoFlex C 80A (30 × 10 acquisition), shown in Figure 4-9 (L) and Figure 4-10 
(L), highly the regional variation of the new peaks at 930 cm-1 and 1174 cm-1, respectively. With 
this wide variation, the result of the randomly selected 6 × 6 acquisition area of the ChronoFlex 
C 80A in vitro H2O2/CoCl2 degraded specimen, that did not have evidence of new peaks at 930 
cm-1 and 1174 cm-1, may be influenced by the small acquisition area (6 × 6). This further 
highlights the need of imaging a wide sample area to get a more in-depth understanding of the 
regional biomaterial degradation.  
The regional variation of degradation on some in vitro H2O2/CoCl2 degraded specimens was 
highly contrasting; see Figure 4-41 (A). New absorbance peaks at 930 cm-1 and 1174 cm-1 were 
witnessed to vary spatially across the biomaterial highlighting the heterogeneity of the 
biomaterial degradation. To highlight the contrasting heterogeneity nature of the degradation, 
one specific acquisition of the degraded ChronoFlex C specimen showed evidence of 
degradation with new absorbance peaks at 930 cm-1 and 1174 cm-1 present in the spectra while 
50 µm away, there was no evidence of degradation with no absorbance peaks at 930 cm-1 and 
1174 cm-1 present in the spectra. This contrasting spatial variation is shown in Figure 4-41; see 
Figure 4-41 (A) for the isolated, higher intensity (bright yellow) pixel in the HCI (pixel position 
26(x) and 4(y); highlighted with a red box) and (B) for the chemical ATR-FTIR spectra of this 
specific pixel and a more common spectrum from the untreated specimen (pixel position; 24(x) 
and 4(y); highlighted with a black box). This further emphasises the need of imaging a wide 
sample area to understand spatial variation of biomaterial degradation. 
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(A)  
(B)  
Figure 4-41: (A) H2O2/CoCl2 degraded ChronoFlex HCI at 1174 cm-1. On the HCI (A), at one 
specific point, a new 1174 cm-1 peak has been identified. (B) The chemical structure at 
this specific point (yellow pixel with a red box; pixel position 26(x) and 4(y)) is the 
different to another specific point (pixel with a black box around it; pixel position 24(x) 
and 4(y)) that did no show evidence of degradation (no absorbance peaks at 930 cm-1 and 
1174 cm-1 present). 
Christenson et al. (2004a) demonstrated that in vitro degradation of PEU and PCU, with the 
H2O2/CoCl2, at 37 °C for 24 days, led to ATR-FTIR spectra changes. Such changes were 
similar to explanted PCU rods from rabbits after 15 months and PCU specimens from rats after 
20 weeks (Christenson et al., 2004b) and after 1 year (Christenson et al., 2006a). From the 
ATR-FTIR spectrum and HCI, the new absorbance peak at 930 cm-1 provides evidence of O-H 
bending or bending of aliphatic CO2H while the 1174 cm-1 provides evidence of chain scission and 
crosslinking of the soft segment (Christenson et al., 2004a; Hernandez et al., 2008; Tanzi et al., 
2000; B. Ward et al., 2006; R. Ward et al., 2006); these new peaks are associated with oxidative 
degradation of PCU biomaterials (Christenson et al., 2004a; Cipriani et al., 2013; Faré et al., 
1999). A new absorbance peak at 1650 cm-1 (the potential degradation product of the aromatic 
amine (Christenson et al., 2004b)) provides evidence of hard segment chain scission 
(Christenson et al., 2007, 2006a, 2004a). This hard segment degradation has been shown to be 
inhibited by using an antioxidant inhibitor (Christenson et al., 2006a).  
y 
x 
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In this present work, the spectrum changes of Bionate II 80A (new peaks observed at 1174 cm-
1 and 1650 cm-1) are similar to previous work that examined Bionate 80A (Christenson et al., 
2006a, 2005, 2004a) and Bionate II 80A (Dempsey et al., 2014); Bionate 80A is the 
predecessor to Bionate II 80A. The in vitro H2O2/CoCl2 degraded Bionate II 80A ATR-FTIR 
spectrum absorbance peaks at 1174 cm-1 and 1650 cm-1 are also similar to Dempsey et al. 
(2014). Dempsey et al. (2014) degraded DSM Biomedical (DSM Biomedical, Berkeley, CA, 
USA) commercially available biomaterial specimens; Bionate 80A [PCU], Bionate 75D [PCU], 
Bionate II 80A [PCU], Bionate II 75D [PCU], CarboSil 20 80A (a thermoplastic silicone 
polycarbonate urethane [TSPCU]) and CarboSil 20 55D [TSPCU]. These biomaterials were 
degraded by two degradation methods; the in vitro H2O2/CoCl2 oxidation method for 36 days 
(instead of 24 days used in this thesis) and the in vitro 3 % H2O2 oxidation method for 1 year 
(Dempsey et al., 2014). Similar to this present work, Dempsey et al. (2014) discovered that 
Bionate II 80A degraded by the in vitro H2O2/CoCl2 oxidation method for 36 days exhibited 
evidence of surface crosslinking with the new peak appearing at 1174 cm-1 and exhibited 
evidence of hard segment degradation with the new peak at 1650 cm-1.  
For Bionate II 80A degraded by the in vitro 3% H2O2 degradation method, Dempsey et al. 
(2014) discovered that no peaks at 1174 cm-1 or 1650 cm-1 were detected. In this present work, 
no new peak at 1174 cm-1 was detected for specimens degraded by the in vitro 3% H2O2 
degradation method, however, new isolated peaks at 1650 cm-1 were detected in the HCI; this 
new peak at 1650 cm-1 on the surface of Bionate II 80A is a contradiction to Dempsey et al. 
(2014). Isolated acquisitions on 2 out of the 6 3% H2O2 oxidative degraded specimens, 2 out of 
6 real-time hydrolytic degraded specimens, 2 out of 6 accelerated hydrolytic degraded 
specimens demonstrated a new peak at 1650 cm-1 on the surface of Bionate II 80A. Similar 
conclusions may have been drawn in line with Dempsey et al. (2014) had point spectroscopy 
methods been utilised instead of HCI as these isolated peaks may have gone unnoticed 
(Dorrepaal et al., 2018). In addition to the new peak at 1650 cm-1 on the surface of the in vitro 
degraded Bionate II 80A, isolated acquisitions with a new peak at 1650 cm-1 was discovered on 
the surface of the untreated (control) Bionate II 80A specimens. These isolated hard segment 
degraded regions were unexpected and may have been caused by inconsistencies in the 
biomaterial mixing, formulation, manufacturing and/or sterilisation of the PCU biomaterials 
(Dorrepaal et al., 2018). 
 
 116 
 
In the present study, the lack of a new peak at 1174 cm-1 for specimens degraded by the in vitro 
3% H2O2 degradation method leads to agreement with Dempsey et al. (2014) that the 
accelerated in vitro H2O2/CoCl2 oxidation method should be the recommended choice for 
predicting oxidative stability of segmented polyurethanes. Dempsey et al. (2014) stated that the 
segmented polyurethanes tested were highly resistant to hydrolytic degradation as the in vitro 
3% H2O2 degradation method is 97% water and that no peaks at 1174 cm-1 or 1650 cm-1 were 
detected in their study. With regards to hydrolytic stability, no new absorbance peaks were 
observed at 930 cm-1 and 1174 cm-1 for the untreated, the real time degraded and the 
accelerated degraded specimens. For Quadrathane 80A-B20 and Quadrathane 80A, HCIs at 
1248 cm-1 (peak associated with O-C-O carbonate bonds) showed a lack of regionally variation 
and similar to 930 cm-1 and 1174 cm-1, this can be seen with the lack of change of the range of 
absorbance intensity range (arbitrary unit [AU]) between the untreated, real time and 
accelerated hydrolytically degraded specimens (Figure 4-30). Comparing the absorbance peak 
intensity range of the Bionate II untreated (Figure 4-30 (D)) and accelerated hydrolytic 
degraded (Figure 4-30 (F)) specimens, the approximate range differed between the untreated 
(5.8-8 AU) and accelerated (3.8-6.8 AU) specimens. Similarly to Bionate II, ChronoFlex C 
untreated (Figure 4-30 (J)) and accelerated hydrolytic degraded (Figure 4-30 (L)) specimens 
approximate absorbance range changed from 8.2-10.1 AU to 6.8-8.1 AU. These findings 
between the biomaterials are different to Khan et al. (2005a) who stated that Corethane 80A, 
now known as Bionate 80A (Dumbleton et al., 2009), showed the best overall stability while 
Chronoflex 80A showed some evidence of very minor hydrolysis by the decrease in soft and 
hard segments. 
Compared to the aromatic PCU biomaterials, Chronosil, an aliphatic PCU biomaterial 
synthesed with silicone, demonstrated no typical evidence of PCU degradation as no new 
absorbance peaks were observed at 930 cm-1 and 1174 cm-1 for specimens degraded by the 
four degradation methods. Further, there was no new peak at 1650 cm-1 and changes of the 
peak at approximately 1248 cm-1 were minimal. Minimal-to-no changes of other absorbance 
peaks were observed when comparing other peaks of the specimens degraded by the four 
degradation methods to the untreated Chronosil specimens. Similar to Quadrathane 80A-B20 
and Quadrathane 80A, minimal published work on Chronosil is available in the literature with 
only two scientific publications existing (Francolini and Piozzi, 2016; Vogels et al., 2017); 
neither of these studies investigated the chemical structure of Chronosil.  
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Normalisation with the internal reference peak has been previously used in numerous studies 
(Christenson et al., 2006a, 2006b, 2005; Dempsey et al., 2014; Khan et al., 2005b). With this 
normalisation technique, peaks are normalised to the C=C bond stretching of an aromatic ring 
of the hard segment; this peak is approximately 1591-1600 cm-1 (Christenson et al., 2006a, 
2006b, 2005, 2004a, 2004b; Dempsey et al., 2014; Khan et al., 2005b; Padsalgikar et al., 2015). 
This aromatic group and more specifically the 1591-1600 cm-1 peak, has been reported to 
remain unchanged with biodegradation (Wu et al., 1992). With this aromatic peak at 
approximately 1591-1600 cm-1, it has been recently stated that the use of this peak in this 
normalisation technique is not suitable as a neighbouring peak overlaps the C=C stretch peak 
and the consistency of its intensity between spectra cannot be assumed (Dorrepaal et al., 2018). 
To add to the unsuitability of this aromatic peak at approximately 1591-1600 cm-1, it can be 
seen in literature that this overlapping neighbouring peak is not present when specimens are 
degraded with the in vitro H2O2/CoCl2 degraded method. Thus, the four aromatic PCU 
biomaterials (Quadrathane B20, Bionate II, Quadrathane and ChronoFlex C) the spectra were 
normalised to a stable aromatic C-H out of plane bending peak at 819 cm-1 in this present work 
(Cipriani et al., 2013; Dorrepaal et al., 2018). As Chronosil is an aliphatic PCU with silicone 
biomaterial, and not aromatic, no normalisation of the 819 cm-1 was performed for this 
biomaterial. To understand the changes of the wavelengths of Chronosil and the other four 
aromatic PCU biomaterials, a secondary normalisation method, the Savitzky Golay technique, 
was also performed. 
Savitzky Golay is a method to pre-treat data (Savitzky and Golay, 1964). The method can be 
used to calculate the derivative at a particular wavelength by using a window of n data points and 
fitting a polynomial using the least squares method (Owen, 1995); in the present thesis a 
window size of 31 points (centre point ± 15 wave measurements) was used and the fit was a 
second order polynomial and a second order derivative. The in vitro H2O2/CoCl2 degraded 
SG second derivative spectra of the aromatic PCU biomaterials (8.7 Appendix G - Figure 8-14 
(A) to (D)) displayed an increase in gradient at 930 cm-1 and at 1174 cm-1. The in vitro 
H2O2/CoCl2 degraded SG second derivative spectra of Quadrathane with radiopacifier and 
Quadrathane displayed a decrease in gradient at 1635-1640 cm-1; these findings correlate to the 
shrinking of the Quadrathane 80A-B20 and Quadrathane 80A H2O2/CoCl2 degraded 
specimens peak around 1635-1640 cm-1 (Figure 4-8). By comparing the minimal changes in 
gradient of the in vitro degraded SG second derivative spectra (3% H2O2 [red] and 
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H2O2/CoCl2 [green}) to the untreated (black), ChronoSil appeared to be the most stable to 
oxidation (8.7 Appendix G - Figure 8-14). 
Savitzky Golay was also performed on the in vitro hydrolytic degraded biomaterials (8.7 
Appendix G - Figure 8-15). The in vitro accelerated hydrolytic degraded ChronoFlex C SG 
second derivative spectra peaks (Green) decreased in gradient for a number of wavelength 
positions (when compared to the untreated (black) or real-time degraded (red) SG second 
derivative spectra peaks); this is particularly apparent at 1247 cm-1 which is indicative of the O-
C-O carbonate bonds (8.7 Appendix G - Figure 8-15 (D)). The in vitro accelerated hydrolytic 
degraded Bionate II SG second derivative spectra (Green) peak gradient varied considerably 
(8.7 Appendix G - Figure 8-15 (B)); this variation of gradient was also witnessed for the in vitro 
accelerated hydrolytic degraded Chronosil SG second derivative spectra (Figure 8-15 (E)). 
Variation of peak gradient was witness for the real-time degraded SG second derivative spectra 
of Quadrathane with radiopacifier (Figure 8-15 (A)) and Quadrathane (Figure 8-15 (C)).  
This chapter also investigated surface morphological changes due to in vitro degradation. SEM 
images of the five biomaterials degraded with the in vitro H2O2/CoCl2 degradation method 
revealed various levels of pitting on the surface. The maximum dimension of the pits on the 
surface of the biomaterials varied; Quadrathane B20 0.44 to 3.98 µm, Bionate II 0.44 to 5.88 
µm, Quadrathane 0.48 to 3.99 µm, Chronoflex C 0.44 to 8.13 µm and Chronosil 0.35 to 2.26 
µm. Pitting on the surface of the PCU biomaterials has been previously documented for in vitro 
and in vivo oxidative degradation (Christenson et al., 2006a, 2004b; Dempsey et al., 2014). 
Christenson et al. (2004a) demonstrated that in vitro degradation of PEU and PCU, with the 
H2O2  / 0.1 M  CoCl2 solution at 37 °C for 24 days, led to surface pitting. PEU specimens had a 
large distribution of pit sizes ranging from 1 to 30 µm in diameter while PCU specimens pit 
sizes ranged from 1 to 10 µm (Christenson et al., 2004a); the pit size range of the present study 
is similar to Christenson et al. (2004a). Out of the five biomaterials investigated, Chronosil had 
the smallest pit sizes. This is not surprising as Chronosil is a PCU based silicone (PCU-S) 
elastomer. From an oxidation biostability perspective, PCU-S biomaterials have been ranked as 
the most superior when compared to PCU, PEU and PEU based silicone biomaterials; PEU < 
PEU-S ≤ PCU < PCU-S (Christenson et al., 2007, 2005).  
One pit was identified, by examining SEM images, on the surface of the 3% H2O2 degraded 
Quadrathane specimen while SEM images of Quadrathane B20, Bionate II and Chronoflex C 
biomaterials degraded with the in vitro 3% H2O2 degradation method revealed no evidence of 
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surface pitting when compared to the untreated specimens. This result was not a surprise as 
Dempsey et al. (2014) previously discovered that no significant evidence of erosion was found 
on the surface of PCU biomaterials after 12 months degradation with the in vitro 3% H2O2 
method. The lack of surface morphological differences with the 3% H2O2 method does not 
correlate with the surface pitting observed after 12 months in vivo exposure (Dempsey et al., 
2014). Dempsey et al. (2014) stated that as the 3% H2O2 method is immersed in 97% water 
medium, these PCU biomaterials are highly resistant to hydrolytic degradation. Comparing the 
untreated specimens to the in vitro real-time hydrolytic degraded specimens, there was no 
apparent visual surface morphological differences for Quadrathane B20 and Bionate II. Small 
localised blistered areas on the surface of the Real-time and Accelerated degraded Quadrathane 
specimens was observed when compared to the untreated Quadrathane specimens. While, a 
larger blistered area on the surface of the Chronoflex C accelerated hydrolytic degraded 
specimen was observed when compared to the untreated and real-time degraded specimens. 
Surface morphological changes of the accelerated hydrolytic degraded Bionate II specimens 
were witnessed when compared to the untreated specimen. With only small localised blistered 
areas on Quadrathane for the real-time degraded specimens, the author agrees with Dempsey et 
al. (2014) that the little-to-no surface morphological changes of the real-time degraded 
specimens, and the little-to-no surface pitting witnessed in the highly aqueous 3% H2O2 
method, suggests that these PCU biomaterials are highly resistant to surface morphological 
changes due to hydrolytic degradation. This finding further affirms the statement of Dempsey et 
al. (2014) on the hydrolytic stability of PCU. As discussed earlier in this discussion, the 
hydrolytic stability statement of PCU biomaterials is further supported by the findings that the 
macro-viscoelastic properties of Bionate II and Chronoflex C were not significantly different for 
all frequencies tested while, the loss property of Quadrathane B20 and Quadrathane were only 
significantly different at specific frequencies. However, as previously discussed above, the 
micro-level viscoelastic properties, calculated by µDMA, were significantly different, at specific 
frequencies, between the surfaces of the untreated and real-time hydrolytic degraded specimens 
for Quadrathane B20, Bionate II and Chronoflex C; these findings question the hydrolytic 
stability of these biomaterials. 
Chronosil is different to the other four PCU biomaterials in two different ways: (1) ChronoSil is 
an aliphatic biomaterial (not aromatic like the other biomaterials) and (2) ChronoSil has a 5% 
silicone additive. The difference between aliphatic and aromatic lies in the organisation of the 
hydrocarbons; aromatic compounds have hydrocarbons in one or more ring shape while 
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functional groups are aliphatic if there is no aromatic ring directly attached (Speight, 2017). The 
organisation of the functional group affects the chemical and physical properties of molecules 
(Speight, 2017). Secondly, the use of silicone as an additive to PCU has been shown to improve 
the biostability of the biomaterial; PEU < PEU-S ≤ PCU < PCU-S (Christenson et al., 2007, 
2005). Interestingly, when comparing the untreated specimens to the specimens degraded by 
the in vitro oxidative and in vitro hydrolytic methods, the micro-viscoelastic properties of 
Chronosil were not significantly different for all frequencies (p > 0.05); this result highlights the 
in vitro oxidation and hydrolytic stability of Chronosil. Factors such as specimen surface 
roughness and surface contaminations have been stated as potential influences on the calculated 
specimen moduli (Chavan et al., 2012). All five biomaterials degraded with the H2O2/CoCl2 
oxidation method displayed pitting on the surface of the biomaterials. The pit size range 
differed depending on the biomaterial and Chronosil had the smallest range of pit sizes; this 
result, alongside the minimal changes in gradient of the in vitro oxidative degraded SG second 
derivative spectra of Chronosil, highlights the oxidative stability of Chronosil over the other 
PCU biomaterials evaluated. However, in the comparison of the untreated specimens to the 
H2O2/CoCl2 specimens, the micro-scale viscoelastic properties were found to be not 
significantly different (p > 0.05) for all frequencies except for the viscous property (loss stiffness) 
at 1 Hz for Quadrathane B20. This highlights that the increase in surface roughness, due to 
pitting of the surface from oxidation, may not have a major influence on the micro-
viscoelasticity of these biomaterials (apart from Quadrathane B20). 
Earlier in this discussion, a comparison of the micro viscoelastic properties between the 
untreated to the H2O2/CoCl2 degraded biomaterials, for the five separate biomaterials, was 
discussed. From the analysis of the multiple comparison test (Table 4-6), the storage stiffness 
and loss stiffness were not significantly different (p > 0.05) for all frequencies except for the 
viscous property (loss stiffness) at 1 Hz for Quadrathane B20. It was suggested that the in vitro 
H2O2/CoCl2 degradation method may not have an effect on the micro-level viscoelastic 
properties of four of the biomaterials evaluated (Bionate II, Quadrathane, Chronoflex C and 
Chronosil) Further, the viscous property of Quadrathane B20 at 1 Hz was the only significant 
difference (p < 0.05) recorded and the in vitro H2O2/CoCl2 degradation method did not have 
an effect on the micro-level elastic response of Quadrathane B20 at any tested frequency. These 
suggestions should be interpreted with caution.  
Firstly, it is currently unknown what effect implantation and in vivo degradation has on the 
micro-level viscoelastic response of the surface of these biomaterials; future work of quantifying 
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changes of the viscoelastic properties due to in vivo degradation, by µDMA, is required. 
Therefore, the conclusions in comparing the surface of these biomaterials to the widely used in 
vitro H2O2/CoCl2 degradation method may or may not represent what happens to the 
biomaterials in the in vivo environment. In vitro biostability studies are useful to provide 
directional guidance for in vivo studies (Wilkoff et al., 2015). Once components/devices are 
implanted, the body attempts to breakdown biomaterials by numerous degradative reactions 
which includes oxidative, hydrolytic and enzymatic. No in vitro method can fully replicate and 
predict the in vivo performance of a biomaterial (Padsalgikar et al., 2015) and fully replicates 
the biochemical and biomechanical stresses experienced in the body (Wilkoff et al., 2015). 
Therefore, the in vitro H2O2/CoCl2 degradation method may not replicate changes that occur 
with the micro-viscoelasticity due to in vivo degradation even though the method has been 
shown to replicate chemical structure and surface morphological changes; this may be a 
potential limitation of the in vitro H2O2/CoCl2 degradation method. 
It has been stated that this chemical degradation and surface morphological changes are only on 
the surface of the polymers (Christenson et al., 2006a; Trommsdorff et al., 2004a, 2004b; 
Trommsdorff and Koettig, 2005) and 100 µm below the surface, the chemical composition 
remained unchanged when compared to the control (Trommsdorff and Koettig, 2005). Cipriani 
et al. (2013) stated that most of the observed surface changes, due to in vivo degradation, 
occurred less than 10 µm. Therefore, an indentation of 5 µm with amplitude of 100 nm was 
used to characterise the viscoelastic response. Complex viscoelastic responses are produced 
when micro and nano-indentations are produced upon the surfaces of polymers (Briscoe et al., 
1998). The viscoelastic response of these materials provide mechanical properties which are 
often a function of the geometry of the contact, the penetration depth (strain), the loading (or 
strain) rate and the ambient temperature (Briscoe et al., 1998). Therefore, the viscoelastic 
properties quantified by µDMA may be dependent on one or more of these factors.  
As stated in the statistical analysis section in the material and methods of this chapter (section 
4.2.6), it must be noted that findings and conclusions made from the micro-level viscoelastic 
properties, calculated with the µDMA method, is limited by statistical pseudo-replication, i.e. 
multiple observations on the same unit. Thus, findings and conclusions are specific to the 
surface of the specific biomaterials evaluated so, it may not give a fair representation of a wider 
comparison of all biomaterials. However, the author is unaware of a study that has quantified 
the micro-level frequency dependent viscoelastic properties of untreated and in vitro 
degradation PCU biomaterials; this work gives an insight into the viscoelastic response. Further, 
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van Hoorn et al. (2016) demonstrated that this ferrule-top indentation method can provide 
spatially-resolved map of large variations in the mechanical properties. These variations can be 
orders of magnitude across the surface of a soft specimen thanks to high sensitivity over larger 
cantilever deflections (> µm) (van Hoorn et al., 2016). Future work is required to: (1) quantify 
the micro-level viscoelastic properties, by µDMA, with independent measurements, (2) map 
local viscoelastic properties across the surface of specific specimens (in X and Y directions) to 
variations in regional viscoelastic response and (3) correlate the regional viscoelastic response 
map to the HCI of the biomaterials and investigate if localised chemical structure changes has 
an effect on the localised viscoelastic response.   
Previous work have evaluated the hydrolytic stability of biomaterials have been evaluated by 
accelerated degradation methods (Chaffin et al., 2014, 2013, 2012; Khan et al., 2005a; 
Mahomed et al., 2010; Mishra et al., 2015). These accelerated hydrolytic degradation methods 
used evaluated temperatures above 37 °C. To correlate mechanical differences of a biomaterial 
degraded at an elevated temperature to mechanical differences at 37 °C, the principle of the 
time-temperature superposition (TTS) can be applied. An assumption of TTS is that the 
material’s behaviours responds equally in the temperature range being tested i.e., the material’s 
response is independent of temperature (Padsalgikar et al., 2015). This is stated in a Note in 
ISO 10993-13 where, “consideration of the thermal properties of the additives in the polymeric 
material is recommended” (ISO, 2010). To investigate a material’s temperature independence, 
a DMTA temperature sweep can be utilised and the log-log plotting of the storage and loss 
moduli can identify the temperature independence; if this plot is linear, TTS assumption has 
been fulfilled (Padsalgikar et al., 2015). Padsalgikar et al. (2015) showed that studies which used 
accelerated hydrolytic degradation methods to degrade inhomogeneous (multiphase) systems 
may potentially not have met TTS; this previous study showed this non-linearity of Elast-Eon 
(AorTech, Weybridge, Surrey, UK). Future work is required to investigate the temperature 
independence of the biomaterials used in this thesis and used in previous studies. Thus, 
findings of accelerated hydrolytic degradation biomaterials used in this thesis and in previous 
studies should be interpreted with caution as these findings, by accelerated hydrolysis, may not 
correlate to the actual findings in an in vitro real-time degradation study with a longer time 
period or to the actual findings an in vivo degradation study. The lack of correlation between 
the in vitro accelerated hydrolytic degraded specimens and in vivo degraded specimens was 
shown by Padsalgikar et al. (2015). The authors found that the in vitro accelerated hydrolytic 
degraded specimens’ molecular weight and tensile properties were not correlated to the in vivo 
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degraded specimens (Padsalgikar et al., 2015). This finding further highlights the need for 
caution when interpreting the results and findings of the accelerated hydrolytic degradation 
biomaterials. No in vitro degradation method fully replicates the biochemical and 
biomechanical stresses experienced in the body (Wilkoff et al., 2015). Thus, it is important to 
examine explanted implants, by a retrieval analysis, to assess the implant’s performances and 
investigate whether the implant, and its material components, has been affected from the 
biological environment (Kurtz et al., 2009).  
DMA is commonly known as a forced, non-resonance technique (Placet and Foltête, 2010). As 
the materials are tested with a frequency scan, occasionally, conditions can be found where the 
material-instrument system begins to resonate at certain frequencies (Menard, 2008). These 
resonant frequencies obscure the desired information about the material at the specific, 
resonant frequencies (Menard, 2008). To overcome these resonant frequencies, changes of the 
specimen shape, which in turn changes the mass of the specimen, or change of the applied 
sinusoidal loading are required (Menard, 2008). Influential factors that have an effect on the 
experiments include the type of load, frequency evaluated, clamps used, temperature program 
and specimen geometry (Ehrenstein et al., 2004). By using a BOSE Electroforce 3200 
apparatus, Placet and Foltête (2010) reported a resonance effect due to the dynamic behaviour 
of the whole setup. The authors noted that this resonant frequency slightly moved depending 
on the specimen type and geometry (Placet and Foltête, 2010). Further, this resonance 
disturbed the measurements of the viscoelastic properties of the specimen at this specific 
frequency (Placet and Foltête, 2010). Even though DMA is considered a non-resonance 
technique, on a frequency sweep, some resonance phenomena is inevitable to appear whatever 
the apparatus and specimen geometry used (Placet and Foltête, 2010). In this present work, 
these resonance phenomena occurred at specific tested frequencies (f ≥ 20 Hz). The 
appearance of this resonance was specific to a biomaterial and/or a group (untreated or 
degraded) and may have only appeared for one (or more) specimens in the sample; the 
appearance of this resonance can be seen by the large 95% confidence interval error bars in 
Figure 4-18, Figure 4-19, Figure 4-34 and Figure 4-35.  
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4.5 Chapter Summary 
 The five biomaterials (Quadrathane ARC 80A-B20, Bionate II 80A, Quadrathane ARC 
80A, ChronoFlex C 80A and ChronoSil 80A 5%) were viscoelastic throughout the 
frequency range tested; this highlights the need to evaluate biomaterials utilising 
frequency dependent mechanical testing techniques.  
 Chronosil was the most biostable biomaterial as no new absorbance peaks were 
observed at 930 cm-1 and 1174 cm-1 for all specimens degraded by the four degradation 
methods. The micro-viscoelastic properties of Chronosil were not significantly different 
when comparing the four degraded methods to the untreated biomaterials. 
 Aromatic PCU biomaterials degraded by the in vitro H2O2/CoCl2 method 
demonstrated evidence of PCU oxidative degradation as new absorbance peaks were 
observed at 930 cm-1 and 1174 cm-1. Regional variation of degradation on some in vitro 
H2O2/CoCl2 degraded specimens was highly contrasting; this emphasises the need of 
imaging a wide sample area to understand spatial variation of biomaterial degradation. 
No new peaks at 930 cm-1 and 1174 cm-1 were detected for specimens degraded by the 
3% H2O2 degradation method, the real time hydrolytic degradation method and the 
accelerated hydrolytic degradation method. 
 Comparing the untreated to the H2O2/CoCl2 degradation methods, the storage stiffness 
and loss stiffness of Bionate II and Chronoflex C, for the micro and macro 
viscoelasticity, were not significantly different (p > 0.05) for any frequency tested. The 
macro-viscoelastic properties of the five biomaterials were significantly different (p < 
0.05) at specific frequencies when comparing the untreated and 3% H2O2 degradation 
method. 
 Comparing the untreated specimens against the hydrolytic degradation methods, the 
macro-storage stiffness of Quadrathane B20, Bionate II, Quadrathane and Chronoflex 
C was not significantly different (p > 0.05) for all frequencies.  
 SEM images of the five biomaterials degraded with the in vitro H2O2/CoCl2 
degradation method revealed various levels of pitting on the surface; Chronosil had the 
smallest pit sizes. One pit was identified on the surface of the 3% H2O2 degraded 
Quadrathane specimen while SEM images of Quadrathane B20, Bionate II and 
Chronoflex C revealed no evidence of surface pitting.  
The next chapter investigates the biostability of the PCU and silicone components of the BDyn 
posterior dynamic stabilisation device.   
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5 Biostability of the BDyn Posterior Dynamic Stabilisation device 
This chapter is based on two peer-reviewed articles published in the Journal of Mechanical 
Behaviour of Biomedical Materials (Lawless et al., 2016) and the Journal of Biomedical 
Materials Research Part B: Applied Biomaterials (Lawless et al., 2018). 
5.1 Introduction 
Low back pain has been associated with factors such as age, whole body vibration, lifting, 
twisting, psychosocial factors, and low educational status (Hoogendoorn et al., 2000; Hoy et al., 
2010). Alongside heavy and frequent lifting, long term vibration exposure was stated as a high 
risk factor of low back pain (Magnusson et al., 1996). Numerous studies have evaluated the 
effect of vibration and quantified the viscoelastic properties of the spinal structures in vitro 
(Gadd and Shepherd, 2011; Holmes and Hukins, 1996; Kasra et al., 1992; Zhou et al., 2014) 
and in vivo (Panjabi et al., 1986; Wilder et al., 1982).  
In the seated position, the human lumbar spine has been reported to be resonant between 4–5 
Hz (Panjabi et al., 1986; Wilder et al., 1982). Thus, it is important to assess the frequency 
dependant behaviour of these viscoelastic spinal implants, its components, and assess how these 
implants behave at spinal resonant frequencies. Some studies have investigated the dynamic 
stiffness of spinal implants (Benzel et al., 2011; Dahl et al., 2011; LeHuec et al., 2003), while 
Gloria et al. (2011) quantified the dynamic viscoelastic properties of a disc prosthesis. However, 
a detailed assessment of the BDyn posterior dynamic stabilisation device is absent.  
Once implanted, the body attempts to breakdown biomaterials by numerous degradative 
reactions which includes oxidative, hydrolytic and enzymatic. It is important that the materials 
of an implant can withstand the environment in the human body and not become degraded to a 
point where the implant cannot perform its intended function (Gurappa, 2002). In vitro 
biostability studies are useful to provide directional guidance for in vivo studies (Wilkoff et al., 
2015). To understand how the degradation affects the mechanical behaviour of a material, 
many studies focus on the in vitro degradation of films (Christenson et al., 2005, 2004a; 
Dempsey et al., 2014; Hernandez et al., 2008; Schubert et al., 1997) or standard tensile 
specimen shapes (Dempsey et al., 2014) and not how degradation affects the components of 
orthopaedic implants and the implant itself.    
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In vitro degradation methods are useful as a biomaterial screening method or to analyse the 
degradation behaviour of a material and/or component in body contact; however, they do not 
fully reproduce degradation that happens in vivo (ISO, 2010; Wilkoff et al., 2015).  No in vitro 
degradation method fully replicates the biochemical and biomechanical stresses experienced in 
the body (Wilkoff et al., 2015). Thus, it is important to examine explanted implants, by a 
retrieval analysis, to assess the implant’s performances and investigate whether the implant, and 
its material components, have been affected by the biological environment (Kurtz et al., 2009).  
The aim of this chapter is to provide a detailed investigation of the effect of biodegradation on 
the BDyn posterior dynamic stabilisation device and compare the viscoelastic response of the 
untreated (control), in vitro degraded and in vivo degraded elastomeric components of the 
BDyn device. Between the untreated (control), in vitro degraded and in vivo degraded 
elastomeric components, this study will: 
 Quantify and compare the frequency dependent viscoelasticity of the untreated BDyn 
devices and its components; this comparison is to assess if a particular elastomeric 
component had an influence, or had a dominant effect, on the viscoelastic properties of 
the device. 
 Quantify and compare the frequency dependent viscoelasticity of the control, in vitro 
and in vivo degraded BDyn device components; these are also compared to the 
assembled BDyn device with degraded components.  
 Compare the chemical structure changes of the control, in vitro and in vivo degraded 
BDyn device components. 
 Compare the macro morphological and surface morphological changes of the control, 
in vitro and in vivo degraded BDyn device components. 
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5.2 Materials and Methods 
5.2.1 BDyn devices and components 
Six BDyn 1 level, six BDyn 2 level PDS devices, six silicone and six polycarbonate urethane 
(PCU) components (Figure 5-1) were obtained from S14 Implants (Pessac, France). All devices 
and elastomeric components were sterilised using ethylene oxide (EtO) (Steriservices, Bernay, 
France) (see section 3.2). 
 
Figure 5-1: From left to right; BDyn 1 level (BDyn 1), BDyn 2 level (BDyn 2), 
polycarbonate urethane (PCU) component and silicone component. BDyn can be used to 
bridge one segment level (vertebra-disc-vertebra) or multiple segment levels; see section 
2.4.2 for more information on the BDyn implant. 
After publication of the study which compared the viscoelastic properties of the BDyn devices 
and its components (Lawless et al., 2016), the PCU rings and silicone cushions were degraded 
using a 20% hydrogen peroxide (H2O2) and 0.1 M cobalt (II) chloride hexahydrate 
(CoCl2.6H2O) oxidative solution method (see section 3.3). 
Six BDyn 1 level explanted devices from three patients, which contained six silicone and six 
PCU components were sent to S14 Implants (Pessac, France) after complications with the 
devices (see Table 5-1). The titanium alloy housing was carefully cut along the laser weld to 
expose the PCU and silicone components and the components were sterilised. Patient details 
were unobtainable, however, estimated implantation time (based on distribution of implants to 
retrieval surgery date) were approximated (see Table 5-1).  
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Table 5-1: Clinical information for the six explants from three individual patients.  
 
5.2.2 Spectroscopy – ATR-FTIR and HCM 
5.2.2.1 ATR-FTIR 
Attenuated total reflectance Fourier transform infra-red (ATR-FTIR) point spectroscopy was 
performed on the untreated and in vitro degraded BDyn components (PCU ring and silicone 
cushion). Twenty spectra, with a spectral resolution of 2 cm-1 between 600 and 4000 cm-1, were 
acquired and mean averaged to obtain each spectrum (Simmons et al., 2004). The PCU spectra 
were cut between 750 and 2000 cm-1 and normalised to the internal reference 819 cm-1 peak, 
the stable aromatic C–H out of plane bending peak (Dorrepaal et al., 2018). Linear baseline 
correction was performed subsequent to the internal reference normalisation and followed by a 
baseline shift of one arbitrary unit (Dorrepaal et al., 2018). 
5.2.2.2 HCM  
Attenuated total reflectance Fourier transform infra-red hyperspectral chemical mapping 
(HCM) was performed on the untreated and the explanted BDyn components (PCU ring and 
silicone cushion). The light aperture size of 150 µm (in the x and y dimension) was selected 
which implies that the single point detector was 37.5 µm. For the HCM of the explant 
specimens, a grid of data points was selected and the distance between each pixel was 100 µm; 
this creates a spatially resolved, non-contiguous map. This HCM method has been shown to be 
advantageous in the assessment of larger specimen regions and time-sensitive studies (Dorrepaal 
et al., 2018). For each map, a minimum of 100-pixel spectra were recorded; the maximum was 
300-pixel spectra for Explant 5 HCMs.  
Twenty spectra with a spectral resolution of 2 cm-1
 
between 675 and 4000 cm-1 were acquired 
and mean averaged to obtain each spectrum (Simmons et al., 2004). Similar to the ATR-FTIR 
spectra (see section 5.2.2.1), the PCU spectra were cut between 750 and 2000 cm-1, normalised 
to the internal reference 819 cm-1 peak and linear baseline correction was performed 
subsequent to the internal reference normalisation and followed by a baseline shift of one 
arbitrary unit (Dorrepaal et al., 2018). 
Patient ID BDyn ID Approx. Implant Time (months) Reason for Revision 
PAT1 Explant 1 Explant 2 17 "Failure of Device" 
PAT2 Explant 3 Explant 4 21 Screw Breakage 
PAT3 Explant 5 Explant 6 6 Unknown 
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A secondary normalisation method, the Savitzky Golay (SG) technique (Savitzky and Golay, 
1964), was also performed to understand the changes of the wavelengths of the PCU and 
silicone explanted components. The SG window size was 31 wave measurements (a buffer size 
of 15 on either side of the centre point), the fit was a second order polynomial and a second 
order derivative.  
Spectral assignments and wavenumbers (cm-1) for the PCU ring and Silicone cushion are listed 
in Table 5-2 and Table 5-3, respectively. 
Table 5-2: Spectral assignment and wavenumber for the BDyn PCU component 
(Christenson et al., 2004a, 2004b; Cipriani et al., 2013; Dorrepaal et al., 2018; Hernandez 
et al., 2008; Shen et al., 2011; Smith, 1998; B. Ward et al., 2006; R. Ward et al., 2006) 
Spectral assignment Wavenumber (cm-1) 
C=O stretching vibration of free carbonate 1740-1737 
C=O stretching vibration of hydrogen-bonded carbonate 1720 
C=O stretching vibration of hydrogen-bonded urethane 1705-1701 
NH2 free aromatic amine 1650 
Aromatic C=C stretching vibration  1598-1596 
CH2 bending vibration 1466 
O-C-O stretching vibration of carbonate  1254-1246 
N–H bending and C–N stretching vibration of urethane 1223-1220 
C-C crosslinking (branched ether) 1174 
C-O 1110 
C-O-C of urethane 
C-H bending in plane aromatic ring 
O-H bending or bending of aliphatic CO2H 
1079 
1018 
930-931 
C-H bending out of plane aromatic ring 816-819 
  
Table 5-3: Spectral assignment and wavenumber for the BDyn silicone component 
(Ghanbari-Siahkali et al., 2005; Mahomed et al., 2015; Simmons et al., 2006, 2004) 
Spectral assignment Wavenumber (cm-1) 
O=H stretch 3318 
C-H stretch in CH3 bend 2958 
C=O stretch 1704 
N-H bend and C-N stretch 1529 
Si-CH3 stretch  1257 
Si-O-Si stretch 1065 
Si-O-Si stretch  1016 
(Si-CH3)2 stretch 792 
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5.2.3 Dynamic Mechanical Analysis (DMA) 
To facilitate the comparison of viscoelastic properties, the testing protocol for viscoelastic 
properties of control, in vitro and in vivo degraded BDyn devices, and its components, were 
kept consistent. The experimental factors such as applied sinusoidal load, investigated 
frequencies, machine fixtures used, etc. discussed henceforth were kept consistent for control, 
in vitro and in vivo degraded BDyn devices, and its components unless stated otherwise.  
The storage and loss stiffness were calculated for 21 different frequencies between 0.01 Hz to 
30 Hz; see section 2.2.3.2 for more information on how the storage and loss stiffness was 
calculated. This frequency range is greater than the ASTM F2346 stated physiological 
frequency range of 0.1 Hz to 8 Hz (ASTM, 2011); the maximum tested frequency (30 Hz) is 
the same as the maximum recommended frequency for cyclical loading of components used in 
spinal surgical fixation (ASTM, 2014; Kurtz and Edidin, 2006). 
All devices and components were tested in air at 37°C ± 1°C and the temperature was 
monitored throughout the test (see section 3.7, Figure 3-7 and 8.4 Appendix D). Custom-
designed grips were used to clamp the titanium alloy rods and/or titanium alloy elastomer 
housing of the BDyn device and the devices were secured by twelve horizontal screws (Figure 
5-2).  
   
Figure 5-2: Testing of (A) BDyn 1 level, (B) BDyn 2 level and (C) one of the elastomeric 
components 
For testing of the BDyn 1 level and BDyn 2 level devices, the titanium alloy mobile and fixed 
rods were gripped (Figure 5-2 (A) and (B)). The BDyn device is designed to work in both 
(A)
 
 
      
(C)
 
 
      
(B)
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tension and compression, therefore, a sinusoidally varying load of between +20 N (tension) and 
-20 N (compression) was applied to the devices.  
The silicone and PCU components were tested inside the titanium alloy housing, with the 
mobile titanium rod and the titanium housing gripped for testing (Figure 5-2 (C)). The silicone 
and PCU components are only loaded in compression, therefore, a sinusoidally varying load of 
between -1 N and -20 N (compression) was applied to the elastomeric components. Testing the 
elastomeric components to this load range and inside the titanium alloy housing gave a direct 
comparison between the BDyn devices and the silicone and PCU components.  
The in vitro degraded individual components were tested first, then the degraded PCU and 
silicone components were randomly paired, assembled in the BDyn titanium housing and 
tested (Table 5-4). Similarly to the in vitro testing, the in vivo degraded individual components 
were tested then the PCU and silicone components were paired, assembled and tested in the 
BDyn titanium housing. The pairing of the explanted PCU and silicone components were the 
same as the explanted BDyn devices. Testing the device assembled with degraded components 
gave a direct comparison between the untreated (control) BDyn devices to the BDyn device 
with degraded components. 
Table 5-4: Number of specimens used in the control (untreated) (Lawless et al., 2016), in 
vitro degraded (Lawless et al., 2018) and in vivo degraded studies. The PCU ring and 
silicone cushion, used in the control study, were in vitro degraded (†). The in vitro 
degraded PCU rings (†) and silicone cushions (†) were randomly assembled in the BDyn 
device (‡) and tested; the explanted, in vivo degraded PCU rings (ᶿ) and silicone cushions 
(ᶿ)  were assembled in the BDyn device (ᶲ) and tested.  
Study BDyn 1 level BDyn 2 level PCU ring Silicone cushion 
Control Six Six Six Six 
in vitro Six‡ - Six†  Six† 
in vivo Sixᶲ - Sixᶿ Sixᶿ 
 
The order of device and component testing was randomised by using the Excel Random 
Function (Redmond, Washington, USA). A custom MATLAB (MathWorks, Natick, MA, 
USA) script was created (and validated against the calculated viscoelastic properties from the 
DMA software) to further analyse the mechanical response of the BDyn components and 
devices (8.8 Appendix H). 
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5.2.4 Scanning Electron Microscopy (SEM) 
Untreated and in vitro specimens were sputter coated with ~30 nm layer of gold by using an 
Agar B7340 sputter coater (Agar Scientific, Stansted, Essex, UK). In vivo specimens were 
sputter coated with ~25 nm layer of gold by using an Emscope SC500 sputter coater (Emscope 
Laboratories, Kent, UK). ImageJ 1.48v (National Institutes of Health, Bethesda, MD, USA) 
was used to measure surface pits. The scale bar on a specific SEM image was used to calibrate 
the image. As the pits were irregular in shape, the major diameters of numerous pits were 
recorded and a range of pit sizes (µm) was reported.   
5.2.5 Statistical analysis 
The 95% confidence intervals were calculated (n = 6) for the storage and loss stiffness of the 
untreated (control) and in vitro degraded specimens. Due to the variability of the explanted 
components, no 95% confidence intervals were calculated and the explanted components (PCU 
rings and silicone cushions) and BDyn device, with the explanted components, were plotted 
individually. To evaluate the differences among the untreated BDyn devices and untreated 
components (i.e. to assess if a particular elastomeric component had a dominant effect on the 
viscoelastic properties of the device), Kruskal-Wallis one-way analysis of variance (ANOVA) on 
ranks was performed. If the Kruskal-Wallis ANOVA showed significant differences (p < 0.05), 
the multiple comparison Tukey test was used to evaluate significant differences (p < 0.05). 
Wilcoxon signed rank tests were performed to compare the differences of the elastomeric 
components before and after in vitro degradation. Whereas a Wilcoxon rank sum test 
compared the normal BDyn viscoelastic properties to the BDyn device assembled with the 
degraded components. Due to the variability of the explanted components, no sample 
comparison tests were performed. Instead, whether the individual explanted component’s 
viscoelastic properties lie within the 95% confidence interval error bounds of the control and in 
vitro oxidation specimens was recorded. Regression analyses were performed to evaluate the 
frequency dependent nature of the storage (k’) and loss (k’’) property and the significance of the 
fit (equation 5.1 and 5.2): 
𝒌′ = 𝑨 𝐥𝐧(𝒇) + 𝑩 for  𝟎. 𝟎𝟏 ≤ 𝒇 ≤ 𝟑𝟎  Equation 5.1 
𝒌′′ = 𝑪 𝐥𝐧(𝒇) + 𝑫 for  𝟎. 𝟎𝟏 ≤ 𝒇 ≤ 𝟑𝟎  Equation 5.2 
where f is frequency (independent variable), A and C are coefficients and B and D are the 
constants of the logarithmic regression. All results with p < 0.05 were considered significant.  
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5.3 Results 
5.3.1 Comparison of viscoelasticity of BDyn devices and its components 
The frequency dependent trends of the storage and loss stiffness of the BDyn 1 level device, 
BDyn 2 level device, the silicone component and the PCU component are shown in Figure 5-3. 
The BDyn devices and its components were viscoelastic throughout the frequency range tested. 
Also, the storage stiffness was larger than the loss stiffness for all frequencies tested.    
(A)  (B)  
Figure 5-3: (A) Storage stiffness (k’) and (B) loss stiffness (k’’) against ln(frequency) for 
the 1 level BDyn device (BDyn 1), 2 level BDyn device (BDyn 2), silicone component 
(Silicone) and polycarbonate urethane (PCU) component (median ± 95% confidence 
intervals). Graph legend is consistent for both plots and can be seen in the k’ plot. 
The storage stiffness and loss stiffness of the BDyn 1 level device, BDyn 2 level device, silicone 
component and PCU component were defined by logarithmic fits (Equation 5.1 and 5.2). The 
mean storage stiffness and loss stiffness logarithmic trends of the devices and components were 
all found to be significant (p < 0.05). The coefficients (A and C) and constants (B and D) which 
define the storage and loss stiffness logarithmic trends for individual specimens are provided in 
Table 5-5.  
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Table 5-5: Storage stiffness (equation 5.1) and loss stiffness (equation 5.2) regression 
analyses of the BDyn devices and its components. Cofficients for the individual specimens’ 
storage and loss trends are provided. 
  k’  k’’ 
Specimen ID 
 
A B R² P Value 
 
C D R² P Value 
BDyn 1 - 1  2.86 104.7 0.98 0.0001 
 
1.51 16.69 0.96 0.0001 
BDyn 1 - 2  3.03 112.0 
125.1 
0.99 0.0001 
 
1.57 16.60 0.95 0.0001 
BDyn 1 - 3  4.11 0.97 0.0001 
 
1.59 18.16 0.97 0.0001 
BDyn 1 - 4  2.56 96.94 0.98 0.0001 
 
1.37 15.65 0.94 0.0001 
BDyn 1 - 5  3.85 119.9 0.97 0.0001 
 
1.82 18.69 0.96 0.0001 
BDyn 1 - 6  1.68 90.40 0.93 0.0001 
 
1.28 11.68 0.85 0.0001 
BDyn 1 - Mean  3.02 108.2 0.98 0.0001  1.52 16.25 0.95 0.0001 
PCU - 1   8.70 158.0 0.96 0.0001 
 
3.76 20.66 0.90 0.0001 
PCU - 2  7.70 146.6 0.96 0.0001 
 
3.38 18.86 0.89 0.0001 
PCU - 3  5.30 110.9 0.96 0.0001 
 
2.43 13.83 0.88 0.0001 
PCU - 4  6.44 129.3 0.95 0.0001 
 
2.93 16.86 0.90 0.0001 
PCU - 5  5.53 115.1 0.93 0.0001 
 
2.73 15.89 0.90 0.0001 
PCU - 6  4.81 106.6 0.95 0.0001 
 
2.40 13.66 0.90 0.0001 
PCU - Mean  6.41 127.8 0.95 0.0001  2.94 16.63 0.89 0.0001 
Silicone - 1   2.02 84.11 0.97 0.0001 
 
0.84 10.76 0.95 0.0001 
Silicone - 2  1.76 78.13 0.97 0.0001 
 
0.83 10.51 0.95 0.0001 
Silicone - 3  1.37 62.44 0.96 0.0001 
 
0.72 7.90 0.95 0.0001 
Silicone - 4  1.53 64.36 0.96 0.0001 
 
0.75 8.87 0.96 0.0001 
Silicone - 5  1.28 58.89 0.96 0.0001 
 
0.70 7.56 0.95 0.0001 
Silicone - 6  1.72 73.81 0.96 0.0001 
 
0.81 9.65 0.96 0.0001 
Silicone - Mean  1.61 70.29 0.97 0.0001  0.78 9.21 0.95 0.0001 
BDyn 2 - 1   0.12 36.40 0.11 0.1405 
 
0.43 4.88 0.82 0.0001 
BDyn 2 - 2  0.34 39.79 0.60 0.0001 
 
0.48 4.95 0.83 0.0001 
BDyn 2 - 3  0.10 43.32 0.02 0.4991 
 
0.65 6.00 0.71 0.0001 
BDyn 2 - 4  0.40 44.92 0.34 0.0055 
 
0.86 9.73 0.77 0.0001 
BDyn 2 - 5  0.16 37.61 0.19 0.0454 
 
0.53 4.69 0.70 0.0001 
BDyn 2 - 6  0.49 46.11 0.73 0.0001 
 
0.55 6.84 0.90 0.0001 
BDyn 2 - Mean  0.27 41.36 0.45 0.0010  0.58 6.18 0.82 0.0001 
 
The storage stiffness of the individual BDyn 1 level device, silicone component and PCU 
component specimens also all followed a logarithmic trend which was found to be significant (p 
< 0.05; Table 5-5). Two out of the six BDyn 2 level devices did not follow a significant 
logarithmic trend. The range of the BDyn 2 level device mean storage stiffness was between 
39.41 N/mm to 42.82 N/mm for the 0.01 Hz – 29 Hz frequency range (Figure 5-3); this 
differed to the BDyn 1 level device storage stiffness range (95.56 N/mm to 119.29 N/mm). Due 
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to this 8% change in the BDyn 2 level storage stiffness range, the mean and standard deviation 
was analysed individually for all six BDyn 2 level devices (see Table 5-6).  
The loss stiffness of the BDyn 1 level device ranged from 10.72 N/mm to 23.42 N/mm while 
the BDyn 2 level device ranged from 4.26 N/mm to 9.57 N/mm. Unlike the storage stiffness of 
individual specimens, the loss stiffness of all the individual devices and components followed a 
significant logarithmic trend (p < 0.05, see Table 5-5).  
Table 5-6: Mean and standard deviation of the storage stiffness (N/mm) for the BDyn 2 
level device. 
Specimen ID Mean Standard Deviation 
BDyn 2 - 1 36.36 0.89 
BDyn 2 - 2 39.69 1.10 
BDyn 2 - 3 43.30 1.57 
BDyn 2 - 4 45.97 1.72 
BDyn 2 - 5 37.57 0.91 
BDyn 2 - 6 45.97 1.44 
 
The Kruskal-Wallis ANOVA on ranks detected significant differences (p ≤ 0.001) for the 
storage and loss stiffness, for all tested frequencies. The multiple comparison test results are 
shown in Table 5-7. The frequencies stated in this table indicate that the difference between the 
components and devices were significantly different (p < 0.05).  
Table 5-7: Multiple comparison test results for the 1 level BDyn device (BDyn 1), 2 level 
BDyn device (BDyn 2), silicone component (Sil) and polycarbonate urethane (PCU) 
component. The frequencies stated indicates that the comparison were significantly 
different (p < 0.05).  
Multiple Comparison Test Storage Stiffness Loss Stiffness 
BDyn 2 – BDyn 1 0.01 Hz to 29 Hz 0.01 Hz to 29 Hz 
PCU – BDyn 1 - - 
Sil – BDyn 1  - 0.01 Hz to 0.2 Hz, 0.4 Hz, 0.75 Hz, 1 Hz 
PCU – BDyn 2 0.01 Hz to 29 Hz 0.1 Hz to 29 Hz 
Sil – BDyn 2 - - 
Sil – PCU  1 Hz to 29 Hz 10 Hz to 29 Hz 
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5.3.2 Macro-morphological (control, in vitro and in vivo degraded specimens) 
In vitro degradation of the BDyn elastomeric components led to a change in transparency of 
the PCU ring (Figure 5-4 (A) and (B)) and the silicone cushion (Figure 5-4 (C) and (D)). 
 
Figure 5-4: PCU components (A) before and (B) after in vitro degradation. Silicone 
components (C) before and (D) after in vitro degradation.  
When compared to the explanted in vivo degraded elastomeric components, none of the 
explanted components became more transparent; increased transparency was seen with the in 
vitro oxidative degraded components (see Figure 5-5 and Figure 5-6).  
 
Figure 5-5: PCU rings (A-C) and Silicone cushions (D-F). Normal (A & D), in vitro 
degraded components (B & E) and explanted, in vivo degraded components (C & E). 
Component (C) and (E) are Explant 4 from patient 2. 
  
(A) (B) (C) (D) 
(A)       (B)   (C)  
  (D)         (E)      (F)  
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All six PCU rings and all six silicone cushions, from the explanted BDyn devices, displayed 
some form of morphological changes (Figure 5-6). The silicone cushion of Explant 1 (see 
Figure 5-6(A)) and Explant 2 (see Figure 5-6 (B)) displayed plastic deformation with the silicone 
cushion of Explant 2 being more severe than Explant 1. The PCU ring of Explant 3 (see Figure 
5-6(C)) and Explant 4 (see Figure 5-6 (D)) displayed plastic deformation associated with 
extensive flexion of the BDyn implants. The silicone cushion explanted component of Explant 
5 (see Figure 5-6 (E)) has an imprint of the mobile rod and is more severe than the silicone 
cushion of Explant 6 (see Figure 5-6 (F)). Both PCU rings from Explant 5 (Figure 5-6 (E)) and 
Explant 6 (Figure 5-6 (F)) have extensive plastic deformation with the PCU ring from Explant 6 
being compressed at an angle due to contact with the titanium housing. 
 
   
 
   
 
   
Figure 5-6: Explanted PCU rings and silicone cushion components from PAT1 (A) Explant 
1, (B) Explant 2; PAT2 (C) Explant 3, (D) Explant 4; PAT3 (E) Explant 5 and (F) Explant 6. 
The approximate implantation time was 17 months for PAT1, 21 months for PAT2 and 6 
months for PAT3. 
  
(A)      (B) 
(C)      (D) 
(E)      (F) 
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5.3.3 Viscoelasticity (control, in vitro and in vivo degraded specimens) 
Figure 5-7 presents the storage stiffness and loss stiffness of the BDyn implant, the PCU 
component and the silicone component, for normal and the in vitro degraded components.  
The mean in vitro degraded PCU and silicone components storage stiffness ranged between 
87.5 N/mm to 135.3 N/mm and 51.6 N/mm to 60.7 N/mm, respectively. The BDyn implant 
storage stiffness ranged between 84.46 N/mm to 99.36 N/mm. The storage stiffness 
logarithmically increased in relation to frequency (p < 0.05) (equation 5.1, where A is a 
coefficient and B is a constant, and Table 5-8). For the PCU component, silicone component 
and BDyn implant assembled with the degraded components, the storage stiffness was larger 
than the loss stiffness for all frequencies tested.  
The in vitro degraded PCU and silicone components loss stiffness ranged between 6.03 N/mm 
to 24.45 N/mm and 4.59 N/mm to 10.83 N/mm, respectively. The BDyn implant loss stiffness 
ranged between 8.13 N/mm to 21.99 N/mm. Similarly to the storage stiffness, the loss stiffness 
logarithmically increased in relation to frequency (p < 0.05) (equation 5.2, where C is a 
coefficient and D is a constant, and Table 5-8). 
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Figure 5-7: Storage stiffness (k’) against ln(f) for normal and degraded (A) BDyn device 
(BDyn), (C) PCU component (PCU), and (E) silicone component (Sil). Loss stiffness (k’’) 
against ln(f) for normal and degraded  (B) BDyn device (BDyn), (D) PCU component 
(PCU), and (F) silicone component (Sil). All plots are median ± 95% confidence intervals. 
 
(A)      (B) 
(C)      (D) 
(E)      (F) 
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Table 5-8: Storage stiffness (equation 5.1) and loss stiffness (equation 5.2) regression 
analyses of the BDyn devices and its components. Cofficients (A, B, C and D) for the 
individual specimens’ storage and loss stiffness (N/mm) trends are provided. 
  k’  k’’ 
Specimen ID 
 
A B R² P Value 
 
C D R² P Value 
BDyn 1 – 1  2.70 105.1 0.93 <0.001 
 
1.71 16.44 0.90 <0.001 
BDyn 1 – 2  1.30 86.97 0.81 <0.001 1.21 11.13 0.80 <0.001 
BDyn 1 – 3  1.18 89.60 0.96 <0.001  1.43 14.64 0.81 <0.001 
BDyn 1 – 4  0.78 85.13 0.64 <0.001  1.21 11.03 0.82 <0.001 
BDyn 1 – 5  3.10 99.41 0.87 <0.001  1.77 15.20 0.80 <0.001 
BDyn 1 – 6  1.25 80.33 0.97 <0.001  1.11 8.88 0.77 <0.001 
BDyn 1 - Mean  1.72 91.10 0.97 <0.001  1.41 12.89 0.82 <0.001 
PCU – 1   6.31 102.7 0.94 <0.001 
 
2.73 14.25 0.90 <0.001 
PCU – 2  6.75 123.0 0.96 <0.001 
 
2.45 14.59 0.89 <0.001 
PCU – 3  6.32 118.8 0.96 <0.001 
 
2.25 13.71 0.89 <0.001 
PCU – 4  5.19 101.2 0.96 <0.001 
 
1.93 11.31 0.88 <0.001 
PCU – 5  5.82 107.5 0.95 <0.001 
 
2.07 12.94 0.89 <0.001 
PCU – 6 5.13 101.5 0.96 <0.001 
 
1.87 11.43 0.89 <0.001 
PCU – Mean  5.92 109.1 0.95 <0.001  2.22 13.02 0.89 <0.001 
Silicone – 1   1.07 52.47 0.96 <0.001 
 
0.64 6.22 0.93 <0.001 
Silicone – 2  1.50 63.66 0.97 <0.001 
 
0.86 9.54 0.96 <0.001 
Silicone – 3  0.66 45.32 0.90 <0.001 
 
0.61 5.96 0.90 <0.001 
Silicone – 4  1.40 62.22 0.97 <0.001 
 
0.72 7.63 0.95 <0.001 
Silicone – 5  1.09 53.44 0.96 <0.001 
 
0.66 6.49 0.93 <0.001 
Silicone – 6 1.23 59.42 0.96 <0.001 
 
0.71 7.78 0.95 <0.001 
Silicone - Mean  1.16 56.09 0.97 <0.001  0.70 7.27 0.94 <0.001 
 
Table 5-9 provides the frequencies at which the PCU and silicone components were 
significantly different before and after in vitro degradation. The storage and loss stiffness of the 
silicone component, before and after in vitro degradation, were significantly different for the 
frequency range tested while the PCU component loss stiffness was only significantly different 
for certain frequencies namely 0.5 Hz, 4 Hz to 29 Hz. Also, the storage stiffness of the BDyn 
device, assembled with in vitro degraded components, was significantly different from 0.2 Hz to 
20 Hz while, the loss stiffness was significantly different from 0.01 Hz to 0.3 Hz and 0.5 Hz to 
15 Hz. 
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Table 5-9: Wilcoxon Signed Rank test results for the PCU and Silcone components and 
Wilcoxon Rank Sum test for the BDyn Device. The frequencies stated indicates a 
significantly different (p < 0.05) between the untreated and degraded specimens. 
Component Storage Stiffness Loss Stiffness 
PCU - 0.5 Hz, 4 Hz to 29 Hz 
Silicone 0.01 Hz to 29 Hz 0.01 Hz to 29 Hz 
BDyn Device 0.2 Hz to 20 Hz 0.01 Hz to 0.3 Hz, 0.5 Hz to 15 Hz 
 
Figure 5-8 presents the storage stiffness of the BDyn device assembled with the explanted 
components, the explanted PCU components and the explanted silicone components. The loss 
stiffness of the BDyn device assembled with the explanted components, the explanted PCU 
components and the explanted silicone components are also presented in Figure 5-8. The 
normal and in vitro degraded viscoelastic properties of the BDyn implant, PCU component and 
silicone component, presented in Figure 5-7, are illustrated in Figure 5-8 to show differences 
between the viscoelasticity of the normal, the in vitro degraded and in vivo degraded scenarios.  
A wide variability of the explanted PCU and silicone components storage and loss stiffness 
exist. However, the frequency dependent behaviour of the PCU ring storage stiffness seemed to 
be in “pairs” and these “pairs” match the set of explants from a specific patient (see Figure 5-8 
(C) and (D) and Table 5-1). The storage and loss stiffness of the explanted PCU and silicone 
components were logarithmically frequency-dependent (p < 0.001; see Table 5-10). The storage 
stiffness of three BDyn devices were logarithmically frequency dependent, namely Explant 1, 
Explant 2 and Explant 6. The loss stiffness of the BDyn devices, assembled with the explanted 
components, were logarithmically frequency-dependent (p < 0.001; see Table 5-10). 
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Figure 5-8: Storage stiffness (A, C, E) and loss stiffness (B, D, F) against ln(freq) for 
normal, in vitro andin vivo degraded (A & B) BDyn devices, (C & D) PCU ring components 
and (E & F) Silicone cushion components.  Normal and in vitro data are median ± 95% 
confidence intervals. Graph legend (B) is consistent for all plots (A – F).   
 
(A)      (B) 
(C)      (D) 
(E)      (F) 
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Table 5-10: Storage stiffness (k') and loss stiffness (k'') regression analyses of the 
explanted BDyn components (Explant PCU and Explant Silicone). These components were 
reassembled into the Ti Alloy housing of the BDyn device (Explant BDyn 1). A and C 
represent the coefficients of the logarithmic regression of k’ and k’’, respectively. B and D 
are the constants of k’ and k’’, respectively. 
 
k' = Aln(f) + B 
 
k'' = Cln(f) + D 
Specimen ID A B R² p Value 
 
C D R² p Value 
Explant BDyn 1 – 1  0.45 49.26 0.331 0.006 
 
0.95 5.15 0.690 <0.001 
Explant BDyn 1 – 2 -7.19 17.94 0.450 <0.001 
 
3.32 12.20 0.528 <0.001 
Explant BDyn 1 – 3 -0.32 47.22 0.083 0.207 
 
0.83 4.29 0.652 <0.001 
Explant BDyn 1 – 4 -2.71 50.43 0.104 0.155 
 
1.52 8.40 0.570 <0.001 
Explant BDyn 1 – 5 -0.58 59.52 0.095 0.173 
 
1.01 5.76 0.696 <0.001 
Explant BDyn 1 – 6 2.87 111.95 0.943 <0.001 
 
2.04 15.57 0.847 <0.001 
BDyn 1 – Control 3.02 108.17 0.98 <0.001  1.52 16.25 0.95 <0.001 
BDyn 1 – in vitro  1.72 91.10 0.97 <0.001  1.41 12.89 0.82 <0.001 
Explant PCU – 1 5.43 115.35 0.901 <0.001 
 
3.11 20.99 0.928 <0.001 
Explant PCU – 2 6.08 121.81 0.914 <0.001 
 
3.33 20.17 0.898 <0.001 
Explant PCU – 3 2.47 61.08 0.906 <0.001 
 
1.47 11.86 0.915 <0.001 
Explant PCU – 4 2.32 57.22 0.858 <0.001 
 
1.14 11.10 0.892 <0.001 
Explant PCU – 5 4.87 115.85 0.946 <0.001 
 
2.23 14.51 0.905 <0.001 
Explant PCU – 6 4.12 105.38 0.971 <0.001 
 
1.91 16.00 0.935 <0.001 
PCU – Control  6.41 127.77 0.95 <0.001  2.94 16.63 0.89 <0.001 
PCU – in vitro 5.92 109.1 0.95 <0.001  2.22 13.02 0.89 <0.001 
Explant Silicone – 1 1.72 55.76 0.971 <0.001 
 
0.67 7.152 0.978 <0.001 
Explant Silicone – 2 1.10 69.78 0.597 <0.001 
 
1.15 11.06 0.943 <0.001 
Explant Silicone – 3 0.64 55.22 0.506 <0.001 
 
0.67 7.72 0.924 <0.001 
Explant Silicone – 4 1.04 72.08 0.875 <0.001 
 
0.90 9.71 0.935 <0.001 
Explant Silicone – 5 1.78 63.62 0.946 <0.001 
 
0.76 10.57 0.968 <0.001 
Explant Silicone – 6 1.14 51.90 0.978 <0.001 
 
0.83 8.54 0.930 <0.001 
Silicone – Control 1.61 70.29 0.97 <0.001  0.78 9.21 0.95 <0.001 
Silicone – in vitro 1.16 56.09 0.97 <0.001  0.70 7.27 0.94 <0.001 
          
BDyn 1 level specimen 2 (‘Explant BDyn 1 – 2’ in Table 5-10), which was one of the three 
BDyn devices whose storage stiffness was logarithmically frequency dependent (p < 0.05; Table 
5-10), had a negative coefficient (A) of -7.19. Between 3 Hz to 4 Hz, the storage stiffness of the 
BDyn Explant 2 decreased from 36.54 N/mm to 7.84 N/mm. At 29 Hz, the storage stiffness of 
the BDyn Explant 2 was -62.35 N/mm. The loss stiffness of Explant BDyn 1 – 2 had a sharp 
increase from 3 Hz to 4 Hz with the loss stiffness increasing from 7.70 N/mm to 35.75 N/mm. 
Highlighting this sharp increase in the loss stiffness is important as it is believed that this BDyn 
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device, with explanted components, is resonant around this frequency; between 3 and 5 Hz. 
Further discussion of this finding can be found in section 5.4.   
Explant BDyn device 6 was the only device to have its storage stiffness within the 95% 
confidence interval error bars for every frequency tested (Figure 5-8 (A) and Table 5-10). 
Further, the storage and loss stiffness, of the explanted PCU rings, explanted silicone cushions 
and the BDyn device with explanted components, were within the normal and in vitro 95% 
confidence intervals at specific frequencies (Table 5-11).  
Table 5-11: Stated frequencies indicate that the viscoelastic properties lies between the 
untreated (normal) or the in vitro degraded (in vitro) 95% confidence interval bounds. 
normal Ex 1 Ex 2 Ex 3 Ex 4 Ex 5 Ex 6 
k’       
BDyn - - - - - 0.01-29 
PCU 0.01-29  0.01-29 - - 0.01-29 0.01-10 
Sil  - 0.01-29 - 0.01-29 0.01-29 - 
k’’       
BDyn - 15-20 - 29 - 0.01-20 
PCU 15-29  10-24 0.01-0.2, 0.4 0.01-0.1 0.01-24 0.2-15 
Sil - 0.01-0.4  0.02, 0.05-0.3, 0.5-3, 29  0.01-29 5-29 0.01-29 
in vitro Ex 1 Ex 2 Ex 3 Ex 4 Ex 5 Ex 6 
k’       
BDyn - - - - - - 
PCU 0.04-29  - - - 0.2-29  0.01-20  
Sil 0.01-29 29 0.01-29  - 0.01-0.5, 24-29 0.01-29  
k’’       
BDyn - 20, 29 - 29 - 0.01-5 
PCU - - 0.1-4 0.2-2 4-29 15-29 
Sil 0.01-29 - 0.01-29 - - 0.01-15 
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5.3.4 Chemical structure (control, in vitro and in vivo degraded specimens) 
The ATR-FTIR spectrum of the PCU and silicone components is illustrated in Figure 5-9 and 
Figure 5-10, respectively. 
 
Figure 5-9: Stacked ATR-FTIR spectra of PCU control (Normal), in vitro oxidative 
degraded and six explanted components. Absorbance units are arbitrary units (AU). 
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Figure 5-10: Stacked ATR-FTIR spectra of silicone control (Normal), in vitro oxidative 
degraded and six explanted components. Absorbance units are arbitrary units (AU). 
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Evidence of crosslinking of the PCU has been established as a new absorbance peak was 
observed at 1174 cm-1 [range: 1183 cm-1 to 1160 cm-1] for the in vitro and in vivo degraded 
explants except for one explanted PCU component (Explant 6), as seen in Figure 5-9. The 
PCU in vitro and in vivo degraded PCU specimens also showed hard segment degradation with 
the presence of a new aromatic amine group at 1650 cm-1 [range: 1662 cm-1 to 1630 cm-1] this 
hard segment degradation was more prominent for the in vivo degraded, explanted PCU 
components (Figure 5-11 (A)).  
(A)  (B)  
Figure 5-11: Stacked ATR-FTIR cut spectra of (A) PCU control (Normal), in vitro oxidative 
degradation and the six explanted components; cut wavelength range of 1350 cm-1 to 
1950 cm-1 and (B) silicone control (Normal), in vitro oxidative degradation and the six 
explanted components; cut wavelength range of 675 cm-1 to 1400 cm-1. 
There was no evidence of changes to the chemical structure of the in vitro degraded silicone 
specimens (Figure 5-10). However, when compared to the untreated and in vitro degraded 
specimens, changes to the chemical structure of the explanted components with the reduction 
in the peak at 1065 cm-1; this bond is associated with the Si-O-Si stretch of the silicone (Figure 
5-11 (B)). Further, the explanted silicone components displayed a slight increase in peak height 
at 1257 cm-1 which is associated with the Si-CH3 stretch of the silicone components. 
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Hyperspectral chemical maps demonstrated a new peak at 1650 cm-1 was observed regionally at 
one or multiple locations, on all explanted silicone components (see Figure 5-12).  
(A)  (B)  
(C) (D)  
(E)  (F)  
(G)  
Figure 5-12: Spatial variation of the new peak witnessed at approximately 1650 cm-1 for 
the silcione components; (A) untreated, (B) Explant 1, (C) Explant 2, (D) Explant 3, (E) 
Explant 4, (F) Explant 5 and (G) Explant 6. The height of the 1650 cm-1 peak varied across 
the surface of the component; for the range of the peak height across the specimens; see 
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the scale bar at each HCM. The variation (approximate range) of the (A) untreated 
specimen is low (0.012-0.019 AU) compared to the explanted components with regionally 
high peak heights (range of (E) is approximately 0.01-0.12 AU). These are HCMs (not a 
continuous images) and the distance between acquisitions is 100 µm. 
HCM demonstrated that the chemical structure changes at 1065 cm-1 (associated with the Si-O-
Si stretch; see Figure 5-13) and 1257 cm-1 (associated with the Si-CH3 stretch; see Figure 5-14) 
varied regionally across the explanted silicone components.  
(A)  (B)   
(C) (D)   
(E)  (F)  
Figure 5-13: Spatial variation of 1065 cm-1 for the silcione components; (A) Explant 1, (B) 
Explant 2, (C) Explant 3, (D) Explant 4, (E) Explant 5 and (F) Explant 6. These are HCMs 
(not a continuous images) and the distance between acquisitions is 100 µm. 
 
 151 
 
(A)  (B)  
(C)  (D)  
(E)  (F)  
Figure 5-14: Spatial variation of 1257 cm-1 for the silicone components; (A) Explant 1, (B) 
Explant 2, (C) Explant 3, (D) Explant 4, (E) Explant 5 and (F) Explant 6. These are HCMs 
(not a continuous images) and the distance between acquisitions is 100 µm. 
From the HCM of the in vivo degraded, explanted PCU rings, a decrease and a spatial variation 
in absorbance peak intensity at 1248 cm-1 [range: 1235 cm-1 to 1260 cm-1] was observed (Figure 
5-15). Further, a new absorbance peak at 1174 cm-1, which provides evidence of chain scission 
and crosslinking of the soft segment, was detected and varied across all explanted PCU 
components except for Explant 6 (Figure 5-16); for Explant 6, no new peak was detected for 
any of the individually acquired spectra.  
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(A)   (B)  (C)  
(D) (E)  (F)  
Figure 5-15: Spatial variation of 1248 cm-1 for the PCU components; (A) Explant 1, (B) 
Explant 2, (C) Explant 3, (D) Explant 4, (E) Explant 5 and (F) Explant 6. These are HCMs 
(not a continuous images) and the distance between acquisitions is 100 µm. 
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(A)  (B)  (C)  
(D)  (E)  (F)  
Figure 5-16: Spatial variation of 1174 cm-1 for the PCU components; (A) Explant 1, (B) 
Explant 2, (C) Explant 3, (D) Explant 4, (E) Explant 5 and (F) Explant 6. These are HCMs 
(not a continuous images) and the distance between acquisitions is 100 µm. 
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A new absorbance peak at 1650 cm-1, which provides evidence of hard segment chain scission, 
was witnessed in all six explanted component HCMs (Figure 5-17). 
(A)   (B)  (C)  
(D)  (E)  (F)  
Figure 5-17: Spatial variation of 1650 cm-1 for the PCU components; (A) Explant 1, (B) 
Explant 2, (C) Explant 3, (D) Explant 4, (E) Explant 5 and (F) Explant 6. These are HCMs 
(not a continuous images) and the distance between acquisitions is 100 µm. 
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A new absorbance peak at 1650 cm-1 was witnessed in one specific acquisition of the untreated 
PCU component HCM; see Figure 5-18 (A) for the isolated, higher intensity (bright yellow) 
pixel in the HCM (pixel position 2(x) and 2(y); highlighted with a red box) and (B) for the 
chemical ATR-FTIR spectra of this specific pixel and a more common spectrum from the 
untreated specimen (pixel position; 7(x) and 10(y); highlighted with a black box). 
(A)   (B)  
Figure 5-18: (A) Untreated (control) PCU specimen HCM at 1650 cm-1. On the HCM (A), at 
one specific point, a new 1650 cm-1 peak has been identified. This specific point (yellow 
pixel with a red box around it; pixel position 2(x) and 2(y)). (B) is the chemical structure 
spectra of the one specific point (pixel position 2(x) and 2(y)) and another, more 
common, spectra (pixel with a black box around it; pixel position 7(x) and 10(y)) 
witnessed on the surface of the untreated PCU specimen. The PCU specimen is a HCM (not 
a continuous images) and the distance between acquisitions is 100 µm. 
  
y 
x 
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5.3.5 Surface morphological (control, in vitro and in vivo degraded specimens) 
Representative SEM images of the surface morphology of the PCU and silicone components 
are shown in Figure 5-19 and Figure 5-20, respectively. The PCU specimens degraded for 24 
days, with the 20% H2O2/0.1 M CoCl2 method, demonstrated surface pitting. The major 
diameter of these surface pits ranged from 0.65 µm to 4.58 µm. For the in vitro degraded 
silicone specimens, there was no evidence of surface pitting, or any other surface morphology 
changes, with when compared to the untreated silicone specimens (Figure 5-20). 
(A)  (B)  
(C)  (D)  
Figure 5-19: Scanning electron micrographs of Bionate II 80A PCU rings at (A & C) x1.2k 
and (B & D) x2.0k. (A & B) Untreated and (C & D) treated with 20% H2O2/0.1M CoCl2 at 
37°C. 
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(A)  (B)  
(C)  (D)  
Figure 5-20: Scanning electron micrographs of MED 4770 silicone cushion at (A & C) x1.2k 
and (B & D) x2.0k. (A & B) Untreated and (C & D) treated with 20% H2O2/0.1M CoCl2 at 
37°C. 
Figure 5-21 and Figure 5-22 show the surface morphology of the explanted PCU rings and 
silicone cushions, respectively. All explanted PCU rings and silicone components demonstrated 
micro-level surface morphological changes. The PCU rings explanted from Patient 1 (Explant 
BDyn 1 and Explant BDyn 2) both had partial tears close to the inner radius of the annulus 
(Figure 5-21 (B)). Environmental stress cracks (ESC) were witnessed on the surface of all six 
PCU rings, with the PCU ring from Explant 5 having the least, and pockets of surface pits were 
witnessed on specific areas of all six PCU rings; pits measured ranged between 0.26 µm to 8.34 
µm. The surface morphological changes on the PCU varied per specimen which is 
demonstrated with Figure 5-21 (H) and Figure 5-21 (I); both images are from the same 
specimen (PCU 5) but the pitting and ESC is in a localised area and not across the whole 
surface.   
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Figure 5-21: (A) Environment Stress Cracking (ESC) of PCU 1; (B) Circumferential partial 
tear near the inner radius of the PCU annulus [PCU 1]; (C) De-laminated (gouged) area of 
PCU 2; (D) Environment Stress Cracking (ESC) of PCU 2 (E) Abrasion (gouging) track 
[PCU 3]; (F) Pitting on exposed area of PCU 3; (G) Delamination (flaking) and plastic 
deformation [PCU 4]; (H) Isolated pitting and ESC [PCU 5]; (I) minimal-to-little surface 
deformation [PCU 5].  
 
(A)    (B)      (C) 
(D)    (E)      (F) 
(G)    (H)      (I) 
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Similarly to the PCU rings, the silicone cushions illustrated a wide variety of surface 
morphological changes from abrasive wear track (Figure 5-22 (A)), gouged areas (Figure 5-22 
(B)) to minimal surface morphological changes (Figure 5-22 (E)). Various levels of ESC were 
witnessed on the surface of all six specimens while adhesive surface morphological changes, 
similar to (D) and (I), was witnessed in 2 out of 6 explants. 
    
 
   
 
    
 
Figure 5-22: (A) Abrasive edge shearing and gouged area of Sil 1; (B) Gouged area of Sil 1; 
(C) Creep depression of Sil 2; (D) Adhesive surface damage [Sil 3]; (E) little-to-no surface 
morphological changes [Sil 3]; (F) ESC [Sil 4]; (G) Creep depression [Sil 5] (H) ESC on the 
base of Sil 5; (I) Adhesive surface damage [Sil 6] 
 
(A)    (B)      (C) 
(D)    (E)      (F) 
(G)    (H)      (I) 
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5.4 Discussion 
Firstly, this chapter has quantified the frequency dependent viscoelastic properties of a posterior 
dynamic stabilisation (PDS) spinal implant. The BDyn devices and its components were 
viscoelastic throughout the frequency range tested. As shown in Figure 5-3, the BDyn 1 level 
device storage stiffness (95.56 N/mm to 119.29 N/mm) and the loss stiffness (10.72 N/mm to 
23.42 N/mm). Within the physiological frequency range tested, the elastic property of the 
BDyn device is influenced by the PCU ring and the silicone cushion for every frequency. 
However, the viscous response of the BDyn device is influenced by the PCU ring for every 
frequency and only at a specific frequency by the silicone cushion; the silicone cushion was 
significantly different at 0.01 to 0.2, 0.4, 0.75 and 1 Hz (p < 0.05).  
Secondly, this chapter has quantified the frequency-dependent viscoelastic properties of a 
posterior dynamic stabilisation device with in vitro oxidative degraded components. Similarly to 
the untreated components and BDyn device, the degraded components and BDyn device, 
assembled with degraded components, were viscoelastic throughout the frequency range tested. 
The degraded BDyn 1 level device storage stiffness (84.46 N/mm to 99.36 N/mm) and loss 
stiffness (8.13 N/mm to 21.99 N/mm) were less than the storage stiffness (95.56 N/mm to 
119.29 N/mm) and loss stiffness (10.72 N/mm to 23.42 N/mm) for the normal BDyn 1 level 
device. However, the reductions in viscoelastic properties of the PCU ring (Bionate II 80A) and 
silicone cushion components, due to the in vitro degradation process, are significantly different 
for specific frequencies (p < 0.05; Table 5-9). The same PCU biomaterial (Bionate II 80A) was 
evaluated by the same in vitro degradation process (H2O2/CoCl2) for ASTM D1708 specimens 
in Chapter 4 (Table 4-17). The micro (µDMA with an indenter) and macro (tension) 
viscoelastic properties of Bionate II 80A were not significantly different for any frequency when 
comparing the untreated to the H2O2/CoCl2 degradation method. This demonstrates the 
importance of understanding the viscoelastic properties of specimens and implantable 
components in relation to frequency. 
As in vitro testing can only give a certain amount of insight into the degradation of an 
orthopaedic device or its components, there was a need to assess the viscoelastic, chemical 
composition and surface morphological changes, of the BDyn device, from implantation in the 
body environment. Thirdly, a retrieval analysis of six BDyn posterior dynamic stabilisation 
devices (from three patients) was presented in this chapter. The range of the approximate 
implantation was 6-21 months (an average time of 14.67 ± 7.77 months). A wide variability of 
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the explanted PCU and silicone components storage and loss stiffness existed. At specific 
frequencies, the storage and loss stiffness, of the explanted PCU rings, explanted silicone 
cushions and the BDyn device with explanted components, were within the normal and in vitro 
95% confidence intervals (Table 5-11). This finding further demonstrated the importance of 
analysing the changes of viscoelasticity of specimens over a frequency sweep. 
The viscoelastic properties of intervertebral disc replacement devices have been quantified with 
frequency sweeps (Dahl et al., 2011; Gloria et al., 2011; van den Broek et al., 2012a). As shown 
in Figure 5-3, the BDyn 1 level device storage stiffness (95.56 N/mm to 119.29 N/mm) and the 
loss stiffness (10.72 N/mm to 23.42 N/mm) were less than the storage stiffness (541.7 N/mm to 
957 N/mm) and loss stiffness (approximately 62 N/mm to 200 N/mm) of a multi-structural 
intervertebral disc (IVD) replacement device (Gloria et al., 2011). Depending on the 
degenerated state of the IVD, the transfer of load through the posterior elements can range 
from 8% to 40% (Pollintine et al., 2004). With less than 10% of the net compressive load 
transferred through the posterior elements of a healthy IVD (Kurtz and Edidin, 2006; Pollintine 
et al., 2004), the differences between the BDyn PDS implant and IVD replacement storage 
stiffness and loss stiffness ranges were expected. Furthermore, Gloria et al. (2011) applied 40 N 
± 10 N sinusoidal load through a frequency range of 0.01 Hz to 30 Hz.  
The BDyn 1 level dynamic stiffness ranged from 96.16 N/mm (0.01 Hz) to 120.02 N/mm (29 
Hz) while the BDyn 2 level device ranged from 39.66 N/mm (0.01 Hz) to 42.44 N/mm (29 
Hz). These values are comparable to the dynamic stiffness of a polyurethane nucleus device 
(216.24 N/mm–285.47 N/mm; 0.25 Hz–20 Hz), but an order of magnitude less stiff than 
polyethylene and titanium-alloy cervical disc replacements (Dahl et al., 2011). The dynamic 
stiffness for the AxioMed Freedom Lumbar device, tested between 1200 N to 2000 N at 3 Hz 
by Benzel et al. (2011), varied between 1.55 – 3.48 kN/mm. Rischke et al. (2011) stated that a 
previous study of the AxioMed Freedom device showed that the response of the polymer core 
did not change between 1 Hz and 3 Hz, but at 4 Hz, or higher, the core temperature increased 
and the polymer response decreased. Van der Broek et al. (2012a) demonstrated that the 
Biomimetic Artificial Intervertebral Disc axial dynamic stiffness, for 0.01 Hz to 10 Hz range, 
was between 3.0 kN/mm to 4.7 kN/mm; this range was within the standard deviation range of 
the natural intervertebral disc tested by Smeathers and Joanes (1988). Alongside the variation in 
material properties, the differences between the dynamic stiffness of the intervertebral disc 
replacement studies (Benzel et al., 2011; Dahl et al., 2011; van den Broek et al., 2012a) and the 
present study are also a result of testing differences.  
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Another issue with comparison of dynamic stiffness stated from different studies is that various 
authors calculate the dynamic stiffness by using different techniques. Dahl et al. (2011) 
determined the dynamic stiffness by calculating the best-fit slope of the force-displacement 
curve while, Benzel et al. (2011) calculated the force/displacement for the first 1,000 cycles, at 3 
Hz. This present study calculated the viscoelastic properties by following ISO 6721 (ISO, 
2011). As the dynamic stiffness can be affected by load (Kasra et al., 1992), any comparison 
between different methods and studies must be made with caution. To characterise the dynamic 
viscoelastic properties (storage and loss stiffness) of a structure, one must acquire the dynamic 
stiffness (k*) and the phase angle (δ) between the force and displacement sinusoidal cycle. If δ 
is not reported with k*, then the dynamic viscoelastic behaviour of a structure cannot be 
ascertained. Some studies (Dahl et al., 2011; LeHuec et al., 2003) have examined the damping 
effect of disc replacement spinal implants. Both Dahl et al. (2011) and LeHuec et al. (2003) 
calculated the transmissibility damping ratio (ζ), but not the loss factor (η), to determine the 
viscous dissipation of disc replacement implants. As the BDyn devices possess multiple degrees 
of freedom and are non-linear in behaviour, an approximate comparison to ζ was not 
performed as the damping ratio is defined on the grounds of the linear single degree of 
freedom viscous model (Carfagni et al., 1998). Even though an approximate η can be 
determined from ζ, to fully characterise the viscoelastic properties of a structure or a material, 
both the storage and loss stiffness (or modulus for a material) should be quantified. 
The retrieval analysis section of this chapter analysed six explanted BDyn posterior dynamic 
stabilisation devices from three patients. Failure of an implant may involve a variety of factors 
which includes patient, surgeon and implant related (Kurtz et al., 2009). Natural variability in 
the human environment, biomechanical loading differences, physicians’ implantation and 
explantation may cause damage to an explanted device (Wilkoff et al., 2015). Thus, it is difficult 
to definitively state what has affected the explanted BDyn devices. However, hereafter, the 
author makes hypotheses on the failure of the devices. 
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As the average implantation time is 14.67 months, it is believed that the reasons for the 
explanation were not due to infectious reasons. This average implantation time is close to the 
implantation mean average (19.91 months) for non-infection complications with the Dynesys 
device (Lutz et al., 2012); the mean average implantation time for infection complications was 
43.25 months (Lutz et al., 2012). However, one patient had an infectious complication, 
requiring material removal, 2 months post-operation while another patient had a wound 
infection after 1 month (Lutz et al., 2012).  
For Patient 1 (Explant 1 and Explant 2), the surgical construction used was asymmetrical with 
three pedicle screws on one side (Explant 1) of the spinous process and four pedicle screws on 
the other side (Explant 2). The authors do not know what the purpose of this construct was but 
from this construct, it seems that there may have been an applied bending moment or an 
asymmetrical distribution of load through the bilateral system. This may have led to high level 
of load being applied to the silicone cushion of Explant 2 and this creep may have plastically 
deformed the silicone cushion (see Figure 5-6 (B) and Figure 5-23). To investigate this 
hypothesis further, an investigation of this asymmetrical pedicle screw construct, using ISO 
12189 or ASTM F1717, is required. 
  
Figure 5-23: (Left) Silcone cushion untreated and (Right) Explant 2 silicone cushion from 
Patient 1. The Explant 2 silicone cushion image (Right) was taken after SEM hence, the 
gold coating on the silicone cushion. 
The plastic deformation of Explant 3 and 4 PCU ring suggests that the device was under tension 
within the patient and the deformation, of the PCU rings, were potentially caused by creep. The 
abnormal application of the load due to the tension of the system may have further led to the 
screw breakage complication; this is further evident as the caudal-most screw fractured. On the 
top side of Explant 3 (see Figure 5-6 (C) and Figure 5-24 (A)) and Explant 4 (see Figure 5-6 
(D)), the inner section, close to the inner radius of the PCU annuli, have extruded through the 
gap at the top of the titanium housing. Further evidence of this tension of the mobile rod is 
apparent on the underside of the PCU ring as an imprint is visible (Figure 5-24). 
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(A)   (B)  
Figure 5-24: (A) Explant 3 top side and (B) Explant 3 underside. Evidence of the creep 
tension of the BDyn device (compression of the PCU ring) by the extrusion of the PCU ring 
with (A)  the imprint of the titanium housing on the topside of the PCU ring and (B) the 
imprint of the mobile rod on the underside of the PCU ring.  
Unlike Explants 3 and 4, where the deformation seems consistent with each other, the plastic 
deformation of Explant 5 and Explant 6 (from Patient 3) components varied. The inner 
annulus PCU ring of Explant 5 has warped to an elliptical shape which was potentially due to an 
angulation of the titanium alloy mobile rod (Figure 5-6 (E)). Further evidence of this is 
witnessed in the plastic deformation of the silicone cushion of Explant 5. This angulation of the 
bilateral system may also be the reason why the PCU ring of Explant 6 has been compressed on 
one side of the PCU annulus (see Figure 5-6 (E) and Figure 5-6 (F)). Unfortunately, no 
information of the cause of the removal, of the BDyn devices from Patient 3, is available.  
All six PCU rings and six silicone cushions displayed some form of macroscopic (Figure 5-6) or 
microscopic (Figure 5-19 and Figure 5-20) surface morphological changes. Plastic deformation 
(Cipriani et al., 2013; Ianuzzi et al., 2010; Neukamp et al., 2015) and microscopic surface 
damage (Neukamp et al., 2015; Trommsdorff et al., 2004b) of explanted devices are not 
uncommon. Explanted Dynesys PCU spacers have demonstrated imprints from the articulating 
pedicle screw and polyethylene-terephthalate (PET) cord (Cipriani et al., 2013; Ianuzzi et al., 
2010; Neukamp et al., 2015; Shen et al., 2011). Interestingly, the two PCU rings from Patient 1 
had deep circumferential partial cracks near the inner radius of the PCU annulus; these were 
discovered with scanning electron microscopy. A previous study of explanted Dynesys PCU 
spacers revealed that two of the PCU spacers had cracks, one of which extended from the 
centre of the PCU spacer to the outer surface (Ianuzzi et al., 2010). Further, a recent study 
discovered that higher loading frequencies of PCU biomaterials in tension resulted in the 
formation of multiple crack tips, variable crack growth rate and out of plane crack growth (Ford 
et al., 2018). This further demonstrates the importance of understanding these viscoelastic 
biomaterials in relation to frequency. 
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It has been previously noted that explanted Dynesys PCU spacers had mild scratches (Cipriani 
et al., 2013; Neukamp et al., 2015; Shen et al., 2011), potentially from the removal procedures 
(Cipriani et al., 2013; Shen et al., 2011), and also, abrasive wear zones likely from impingement 
with surrounding bony structures (Cipriani et al., 2013; Ianuzzi et al., 2010; Neukamp et al., 
2015). In this present work, none of the deformation of the PCU rings or silicone cushions is 
attributed to bony structure interaction as the PCU ring and silicone cushion are encased in a 
titanium alloy housing (Figure 2-15). However, the deformation of the PCU rings and silicone 
cushions has been attributed to interactions with the BDyn titanium housing and/or the mobile 
rod. Neukamp et al. (2015) discovered that the Dynesys PCU spacers with abrasive wear zones 
had tissue with either isolated or extensive inflammation and wear debris. It would be beneficial 
for future BDyn retrieval studies to examine periprosthetic tissue samples for wear debris and 
inflammation; this would give an understanding of the benefits of the BDyn titanium housing as 
a protection barrier between the tissue and the elastomeric components. 
The mean storage stiffness trends of the normal and in vitro degraded BDyn components and 
the BDyn devices, assembled with normal or in vitro degraded components, all followed a 
logarithmic increasing trend with frequency (p < 0.05; Table 5-8). Further, the storage stiffness 
of the explanted BDyn device components (PCU ring and silicone cushion were logarithmically 
frequency-dependent (p < 0.001; Table 5-10). This is deemed a positive result for the BDyn 
device and its components as the elastic (storage) property of various spinal structures has been 
widely documented to increase as the frequency increases (Gadd and Shepherd, 2011; Holmes 
and Hukins, 1996; Izambert et al., 2003; Zhou et al., 2014). Discrete Fourier Transforms of 
load-relaxation curves demonstrated that the storage modulus of the human lumbar spine 
increased with frequency (Holmes and Hukins, 1996). Between 0.01 Hz to 10 Hz, Smeathers 
and Joanes (1988) reported that the stiffness of the intervertebral disc increased as the loading 
rate increased; Izambert et al. (2003) also reported that the axial dynamic stiffness, of the 
intervertebral disc, increased between 10 Hz – 30 Hz. By performing DMA on intact and 
denucleated intervertebral discs, Gadd and Shepherd (2011) reported an increasing logarithmic 
trend for the storage stiffness for intact and denucleated IVD, while Zhou et al. (2014) stated a 
significantly increasing storage moduli of intact, denucleated and hydrogel injected porcine 
intervertebral discs.  
The low range of standard deviation (Table 5-6), the minimal logarithmic slope coefficients 
(coefficient A; Table 5-5) and the varied R2 values (Table 5-5) raise questions regarding the 
BDyn 2 level device storage stiffness logarithmic trends. This minimal increase in storage 
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stiffness with frequency was unexpected as the elastomer components of the device exhibit a 
logarithmically increasing trend. It is speculated that the minimal storage stiffness increase of the 
BDyn 2 level device is due to the testing configuration. With the BDyn 2 level device, a mobile 
rod is located between four elastomeric components. The BDyn 1 level and 2 level DMA 
testing configuration stated here is not similar to the in vivo scenario. By securing the BDyn 
device to the vertebra, an applied load to the device may not displace the two polymer systems 
equally; hence, the difference in displacement will affect the dynamic stiffness (k*) and in turn, 
the storage (k’) and loss (k’’) stiffness. However, viscoelastic data described in this thesis could 
be used to validate a BDyn finite element model and by incorporating a BDyn FE model with 
the Lumbar Model Generator (Lavecchia et al., 2018), the effect of BDyn on the lumbar spine 
could be assessed.  
The loss stiffness trends of the normal, in vitro and in vivo degraded BDyn components and 
BDyn devices, assembled with the respected components, all followed a logarithmically 
increasing trend as the frequency increased (p < 0.05; Table 5-5, Table 5-8 and Table 5-10). 
These results are different to the studies of Holmes and Hukins (1996) and Gadd and 
Shepherd (2011). Holmes and Hukins (1996) reported that the loss modulus decreased as the 
frequency increased. However, similar to the storage stiffness trends, the in vitro degradation 
did not affect the frequency-dependant behaviour when compared to the untreated components 
or BDyn 1 level device. However, the logarithmic equation coefficients (A and C) and constants 
(B and D) of the in vitro degraded specimens were lower than the normal specimens. In 
relation to the explanted (in vivo degraded) components, the in vivo degradation did not affect 
the significance of the logarithmic frequency-dependant behaviour when compared to the 
untreated components. However, the logarithmic trends coefficients (A or C) and constants (B 
or D), of the components and BDyn 1 level device, assembled with the in vivo degraded 
components, varied for the storage and loss stiffness. Interestingly, some of the storage and loss 
stiffness coefficients (A and C) and constants (B and D) are similar in specific pairings and these 
pairs are patient specific, e.g. the coefficient (A) of Patient 2, the PCU Explant 3 is 2.47 N/mm 
while PCU Explant 4 is 2.32 N/mm (see Table 5-10 for coefficients and constants value and 
Figure 5-8 for plots). These pairings highlight that the changes in the viscoelastic response of the 
elastomeric components may be due to the specific environmental conditions that the bilateral 
system is exposed to.   
 167 
 
No resonant frequencies were identified for the normal (untreated) and in vitro degraded BDyn 
1 level devices and components. Holmes and Hukins (1996) have shown that the lumbar 
specimens did not exhibit shock absorbing properties in pure compression. If shock absorbing 
properties existed, there would be a sharp peak detected in the loss modulus in the frequency 
range (Holmes and Hukins, 1996). This result is similar to Gadd and Shepherd (2011) and 
Zhou et al. (2014) as they also did not find a peak in the loss modulus for a nucleated or de-
nucleated ovine and porcine IVD, respectively. Other studies, which examined in vitro human 
intervertebral disc specimens without the posterior elements, have recorded resonant 
frequencies between 8 Hz – 10.4 Hz (Izambert et al., 2003), 22.2 Hz – 40.9 Hz (Marini et al., 
2015) and 23.5 Hz – 33 Hz (Kasra et al., 1992). The response differences between these studies 
could be due to the different applied preloads and the amplitude of the oscillation (Marini et 
al., 2015) and the method of testing.  
Unlike the normal (untreated) and in vitro degraded BDyn 1 level devices, a sharp peak in the 
loss property (k’’) was detected for the BDyn device Explant BDyn 1 level – 2 (see Explant 2 
plot in Figure 5-8 (B), Figure 5-25 (B) and Figure 5-25 (C)). The BDyn device was assembled 
with Explant 2 PCU ring and silicone cushion (Figure 5-6 (B)). In the frequency sweep test of 
BDyn Explant 2, the sharp increase of the loss stiffness occurred at 4 Hz (see Figure 5-25 (C)). 
Alongside the sharp increase in the loss stiffness, the storage stiffness (k’) decreased sharply and 
tan delta sharply increased after the increase in k’’ (Figure 5-25 (C); this is similar to the ideal 
DMA curves (see Figure 5-25 (A)).  
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 (A)    
(B) (C)  
Figure 5-25: (A) Typical, ideal DMA curves for an amorphous polymer [adapted from the 
book Thermal Analysis of Plastics by Ehrenstein et al. (2004)], (B) BDyn Explant 2 DMA 
curves [complex (k*), storage (k’), loss (k’’) stiffness and tan delta] versus ln(freq) for the 
full frequency range, (C)  BDyn Explant 2 DMA curves [complex (k*), storage (k’), loss (k’’) 
stiffness and tan delta] versus frequency (1 to 15 Hz). The curves for (C) are zoomed in to 
the frequency range 1 to 15 Hz to show the resonant frequency at 4 Hz.  
As previously discussed in section 4.4, to overcome these resonant frequencies, changes of the 
specimen shape or change of the applied sinusoidal loading method are required (Menard, 
2008). Unlike the discussion of resonance in section 4.4, it is believed that the resonant 
frequency, which occurred at 4 Hz, is due to the severely plastically deformed silicone cushion 
(see Figure 5-6 (B) and Figure 5-23 (Right)) and interaction of the BDyn implant between its 
PCU ring and plastically deformed silicone cushion. Further, no other BDyn device assembled 
with explanted components experienced a resonant frequency at 4 Hz, therefore, the plastic 
deformation of the silicone cushion, i.e. specimen shape change, and the interaction with this 
plastically deformed component is believed to be the cause.  
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The identified resonant frequency of 4 Hz, indicated by the sharp increase in the viscous 
property (Holmes and Hukins, 1996) is not a beneficial finding. Any resonance of the device at 
any frequency is a limitation of the device as the resonance may damage the device and in a 
worst-case scenario, the device may fail. To highlight the severity of this resonant issue, Panjabi 
et al. (1986) recorded the average in vivo lumbar vertebrae resonant frequency at 4.4 Hz for the 
axial direction with the person in the seated position. This resonant frequency, for the seated 
position, is similar to the frequencies at which Wilder et al. (1982) recorded the greatest 
transmissibility in the male and female lumbar spine of 4.9 Hz and 4.75 Hz, respectively. 
Wilder et al. (1982) also recorded two further resonant frequencies at 9.5 Hz and 12.7 Hz for 
both genders.  
From the ATR-FTIR spectra of the in vitro oxidative degraded PCU rings, new absorbance 
peak at 1174 cm-1 and 1650 cm-1 were observed. These new absorbance peaks provided 
evidence of chain scission and crosslinking of the soft segment (Christenson et al., 2004a; 
Hernandez et al., 2008; Tanzi et al., 2000) and evidence of hard segment chain scission  
(Christenson et al., 2007, 2006a, 2004a), respectively. These spectrum changes are similar to 
previous work (Christenson et al., 2006a, 2004a); however, the new peaks observed at 1174 cm-
1 and 1650 cm-1 are not as prominent as previous studies (Christenson et al., 2005, 2004a). The 
in vitro degraded PCU ATR-FTIR spectrum absorbance peaks at 1174 cm-1 and 1650 cm-1, are 
similar to another study (Dempsey et al., 2014) that degraded PCU specimens with an 
accelerated oxidation method for 36 days. The PCU spectra in previous work were normalised 
to the internal reference peak which is the C=C bond stretch of the aromatic ring of the hard 
segment (range: 1591 cm-1 to 1600 cm-1 peak) (Christenson et al., 2006a, 2004a, 2004b; 
Padsalgikar et al., 2015), which has been stated to remain unchanged in degradation (Wu et al., 
1992). However, such an approach is not suitable as a neighbouring peak overlaps the C=C 
bond stretch and consistency of its intensity cannot be assumed (Dorrepaal et al., 2018). Thus, 
the stable aromatic C–H out of plane bending peak was used as the internal reference peak 
(Dorrepaal et al., 2018).  
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Silicone has demonstrated excellent biostability with no identifiable in vivo degradation 
(Wilkoff et al., 2015) and due to this excellent biostability, silicone has been used to modify 
PEU and PCU to increase the biostability with the intention to inhibit degradation. The 
oxidation method, used in this study, has been previously used to analyse how degradation 
affects PCU/PEU (Christenson et al., 2005, 2004a; Dempsey et al., 2014; Hernandez et al., 
2008; Schubert et al., 1997) and PCU/PEU modified with silicone (Christenson et al., 2005). In 
comparison to unmodified PEU and PCU, the percent loss of silicone-modified PEU and PCU 
soft-segment was less than the unmodified PEU and PCU; this may be an indication of slower 
rates of crosslinking due to the addition on silicone (Christenson et al., 2005). The H2O2/CoCl2 
in vitro method has been shown to reproduce chemical and physical degradation similar to in 
vivo oxidative degradation of PEU and PCU (Christenson et al., 2006a), but not for silicone. It 
was expected that there would be no significant change in the viscoelastic properties of the 
silicone cushion, by using this H2O2/CoCl2 degradation method. However, the storage and loss 
stiffness of the treated silicone component was significantly different, for every frequency tested, 
when compared to viscoelastic properties before degradation (Table 5-9). That said, there were 
no changes evident in the ATR-FTIR spectra of the in vitro degraded silicone component 
(Figure 5-10) and unlike the PCU ring, no pitting or surface morphology changes were observed 
for the silicone cushions (Figure 5-20).  
For in vitro degradation, the components were completely exposed to the H2O2/CoCl2 solution 
without taking into account the effect of the titanium alloy housing, as titanium and hydrogen 
peroxide are incompatible. As the BDyn elastomeric components are surrounded by a titanium 
alloy housing, previously, it was hypothesised that the titanium housing will have an effect on the 
degradation of the polymer components (Lawless et al., 2018). By using hyperspectral chemical 
mapping, this present chapter shows degradation occurred, in some form, for all six PCU rings; 
these results demonstrate that the titanium housing does not have a role in stopping degradation 
of the PCU rings. Five out of six explanted PCU rings HCMs had new absorbance peaks at 
1174 cm-1 and all six explanted PCU rings had new absorbance peaks at 1650 cm-1; these 
findings were further confirmed by the SG second derivative spectra of the explanted PCU 
components (8.9 Appendix I - Figure 8-16) displayed an increase in prominence at 1650 cm-1 
for all explants and at 1174 cm-1 for PCU Explants 1 to 5 (Figure 8-16 (A) to (E)).  
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It must be stated that new absorbance peaks at 1650 cm-1 were discovered by hyperspectral 
chemical mapping on a specific acquisition of the untreated PCU ring. This demonstrates that 
the hard segment degradation was localised for this particular ring and oxidation and 
implantation play no part in this degradation. This observation of a localised, hard segment 
degraded region on the untreated PCU component was not unexpected as hard segment 
degradation of separate, untreated PCU components has been recently discovered in a recent 
publication in which I am co-first author (Dorrepaal et al., 2018). This hard segment 
degradation may have been caused by one or more factors including, potential inconsistencies 
in the biomaterial mixing/formulation/manufacture process and/or in the sterilisation of the 
PCU components; at this time the hard segment changes cannot be attributed to a single factor 
(Dorrepaal et al., 2018). However, this finding highlights the importance of the objective nature 
of hyperspectral mapping as this localised hard segment degradation, of the untreated PCU 
ring, may have been unnoticed or could be over-represented (Dorrepaal et al., 2018). 
Explanted orthopaedic implants, which contain PCU components, have demonstrated new 
absorbance peaks at 1650 cm-1 and/or 1174 cm-1 to demonstrate biological oxidative 
degradation (Cipriani et al., 2013; Ianuzzi et al., 2010; Neukamp et al., 2015). However, 
another explant study did not find new absorbance peaks linked to biological oxidative 
degradation (Shen et al., 2011). Ianuzzi et al. (2010) discovered that 10 PCU spacers, from six 
patients, had evidence of PCU biodegradation and experienced this degradation on the surface 
where the spacer would make contact with tissue. Examination of retrieved Dynesys PCU 
spacers revealed that chemical changes were negligible 100 µm below the surface (Cipriani et 
al., 2013; Shen et al., 2011; Trommsdorff et al., 2004a) and that significant chemical changes 
are confined to the surface (Cipriani et al., 2013). It was suggested that with only 10 µm of the 
surface alteration would suggest no influence on the bulk mechanical properties of the entire 
device (Cipriani et al., 2013). The in vitro degradation, of the BDyn PCU and silicone 
components, section of this chapter demonstrated that the viscoelastic properties of the BDyn 
spinal PDS device, and its individual components, were significantly different, at certain 
frequencies, due to in vitro oxidation (see Table 5-9). Further, explanted components, and the 
explanted components assembled in the BDyn titanium alloy housing, section of this chapter 
demonstrated that the viscoelastic properties of the BDyn spinal PDS device, and its individual 
components, outside the 95% confidence interval error bars, at certain frequencies, due to in 
vivo degradation (see Table 5-11). These findings demonstrate the importance of performing 
mechanical tests and quantifying viscoelastic properties of the frequency dependent viscoelastic 
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medical devices and not to suggest that due to a small layer of the surface being affected by 
oxidation, that it will not affect the mechanical properties of the device.   
Even though Wilkoff et al. (2015) stated that explanted silicone components had demonstrated 
excellent biostability with no identifiable in vivo degradation, in the authors’ study, 3 out of 22 
specimens after 2–3 years implantation and 1 out of 24 specimens after 4–5 years implantation 
demonstrated new peaks near 1650 cm-1 (Wilkoff et al., 2015). As stated earlier in this 
discussion, in vitro oxidative degraded silicone BDyn component demonstrated good 
biostability with no change to the ATR-FTIR spectra and no surface morphology changes. 
However, HCMs demonstrated that a new peak at 1650 cm-1 was observed regionally at one or 
multiple locations, on all explanted silicone components (Figure 5-12). Further, chemical 
structure changes at 1065 cm-1 (associated with the Si-O-Si stretch) and 1257 cm-1 (associated 
with the Si-CH3 stretch) were witnessed and these changes varied regionally across the 
explanted silicone components (Figure 5-13 and Figure 5-14). The findings of a new peak at 
1650 cm-1, chemical structure changes at 1065 cm-1 and at 1257 cm-1 were further confirmed 
with Savitzky Golay as a new sharp increase at 1650 cm-1, a decrease in gradient at 1065 cm-1 
and an increase in gradient at 1257 cm-1, respectively (8.9 Appendix I - Figure 8-17). Similar to 
the observation of a localised, hard segment degraded region on the untreated PCU 
component, the regionalised nature of new peak at 1650 cm-1 on the silicone components may 
have gone unnoticed or could be over-represented if HCMs were not utilised (Dorrepaal et al., 
2018). 
SEM images of the in vitro and in vivo degraded PCU components revealed pitting on the 
surface of the PCU components which has been previously documented for in vitro and in vivo 
oxidation of PCU (Christenson et al., 2004b; Dempsey et al., 2014). The pit shapes and sizes 
varied between the in vitro degraded and explanted, in vivo degraded PCU rings with the 
measured pit diameters of the in vitro degraded PCU ring ranging between 0.65 µm and 4.58 
µm while the in vivo degraded PCU pit diameters ranged between 0.26 µm – 8.34 µm. These 
ranges, for the in vitro and in vivo degraded PCU rings pit diameters, are similar to the in vitro 
degraded Bionate II 80A (0.44 µm – 5.88 µm) and, from a previous study, in vitro degraded 
Bionate 80A (1 µm – 10 µm) (Christenson et al., 2004a).  
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SEM images (Figure 5-21 (A), (C), (D) and (G)) displayed environmental stress cracking (ESC) 
of the explanted PCU surfaces; ESC was witnessed on the surface of some silicone components 
(Figure 5-22 (F) and (H)). It has been stated that ESC, of explanted Dynesys PCU spacers, is 
one of the most evident factors in the detection of oxidative degradation as these degraded areas 
were abraded and cracked potentially from mechanical loading (Cipriani et al., 2013); however, 
oxidative degradation was apparent in homogenous zones i.e. no abrasion or surface cracked 
zones (Cipriani et al., 2013). It has been shown that ion implantation increases the scratch 
resistance and increases the hardness of a surface layer of polymers (Calcagno et al., 1992; 
Kondyurin and Bilek, 2014). The silicone cushion viscoelastic properties were shown to be 
significantly affected, for each tested frequency, by the level of ion treatment (p < 0.05) while the 
PCU ring viscoelastic properties remain unchanged due to the level of ion treatment, for every 
frequency tested (p > 0.05); see 8.10 Appendix J – section 8.10.3.1. Due to ion treatment, the 
polymer surface layer becomes carbonised and the hardness of the surface layer is higher than 
the hardness of the underlying polymer (Kondyurin and Bilek, 2014). This increase of hardness 
of the surface layer may make the surface layer more brittle. Thus, ESC and delamination may 
be more likely to occur. Further research is required to investigate the advantages (increase 
scratch resistance, altering the coefficient of friction, etc.) over the disadvantages (surface layer 
becoming more brittle) of polymers to be used in orthopaedic devices. Also, further research is 
required to investigate the influence of ESC on the viscoelastic response of these biomaterials. 
The in vitro replication of ESC could be performed by utilising two methods decribed by Zhao 
et al. (1995, 1993). The Zhao-type, or modified Zhao-type, uses human plasma or glass wool 
soaked with a H2O2 and CoCl2 to replicate ESC. These ESC replication methods are widely 
used in literature (Gallagher et al., 2017; Khan et al., 2005a; Martin et al., 2001; Taylor et al., 
2005). However, the precise mechanism of action remains unknown (Gallagher et al., 2017). 
Due to the complex, multi-material structure of the BDyn device and the desired test 
configuration, difficulties in the Proportional-Integral-Derivative-Offset (PIDO) tuning of the 
BOSE 3200 testing machine load control transpired. For consistent, comparable data of the 
devices and its individual components, a maximum load of ± 20 N was applied. Load has been 
shown to affect the mechanical properties of an elastomeric total disc replacement (Mahomed 
et al., 2012) while an increase of preload has been shown to significantly increase the dynamic 
stiffness of the intervertebral disc (Kasra et al., 1992). As the dynamic stiffness can be affected 
by load (Kasra et al., 1992), any comparison between different methods and studies must be 
made with caution. For consistency reasons, the methods between testing the untreated, in vitro 
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degraded and in vivo degraded explanted components all remained unchanged; this was 
important to understand how the degradation processes affects the frequency dependent 
viscoelastic properties.  
Regardless, no in vitro degradation method fully replicates the biochemical and biomechanical 
stresses experienced in the body (Wilkoff et al., 2015) thus, the in vivo degraded scenario was 
also investigated. However, the DMA test configuration is not similar to the in vivo scenario 
where the mobile and fixed rods are secured to the pedicles (Figure 2-15). By securing the 
mobile rod to the vertebra, an applied load to the device may not displace the two, bilateral 
polymer systems equally; hence, the difference in displacement will affect the dynamic stiffness 
(k*) and in turn, the storage (k’) and loss (k’’) stiffness. The BDyn device is designed to allow 
partial movement along the anatomical planes. This chapter quantified the viscoelastic 
properties of the normal, in vitro and in vivo degraded BDyn components, and BDyn 1 level 
device with the assembled components in the device, uniaxially. Rotation of the moveable rod, 
around an anatomical plane, may affect the response of the out-of-phase displacement to an 
applied force and hence, affect the viscoelastic properties. However, these limitations do not 
alter the conclusions of this chapter because the sinusoidally applied loads ensured a direct 
comparison between the normal and degraded components/devices.   
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5.5 Chapter Summary 
 The viscoelastic properties of the posterior stabilisation BDyn device and its 
components are frequency dependent. As the frequency increased, the storage stiffness 
and the loss stiffness increased for the untreated components and BDyn devices; this 
highlights the need to evaluate biomaterials and devices utilising frequency dependent 
mechanical testing techniques. 
 In vitro oxidation degradation affected the viscoelasticity of the specific components and 
the BDyn device, assembled with the degraded components, at specific frequencies; this 
highlights the importance of analysing changes of viscoelastic properties, of degraded 
biomaterials, in terms of frequency and medical devices into which they are 
incorporated, using a frequency sweep. 
 In vitro oxidation degradation displayed changes to the chemical structure and exhibited 
surface morphology changes of the PCU components. There were no changes evident 
in the ATR-FTIR spectra and no surface morphology changes of the in vitro degraded 
silicone component.  
 All six explanted PCU rings displayed changes to the chemical structure associated to 
hard segment degradation while 5 (out of 6) explanted PCU rings evidence of soft 
segment degradation on hyperspectral chemical maps (HCMs). HCMs of the silicone 
components demonstrated that a new peak at 1650 cm-1 was observed regionally at one 
or multiple locations, on all explanted silicone components.  
 All six explanted PCU rings and explanted six silicone cushions displayed some form of 
macroscopic or microscopic surface morphological changes. 
 No resonant frequencies were reported for the untreated and in vitro degraded 
components and devices. Resonance was detected in the frequency sweep test of BDyn 
Explant 2 with the sharp increase of the loss stiffness occurred at 4 Hz; this is not a 
beneficial finding for the device and further adds to the importance of evaluating 
orthopaedic devices with frequency dependent mechanical testing techniques. 
The next chapter provides an overall discussion, future research necessary to further develop 
our understanding of the biostability of elastomeric orthopaedic devices and biomaterials and 
general conclusions of this thesis. 
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6 Overall discussion, future work and conclusions 
This thesis investigated the in vitro and in vivo biostability of the BDyn posterior dynamic 
stabilisation (PDS) orthopaedic (spinal) device elastomeric biomaterials and the in vitro 
biostability of five long-term implantable polycarbonate urethane biomaterials. To reduce 
exposure to potentially harmful frequencies of the spine, understanding the resonance or 
natural frequencies, of the spine, is important (Panjabi et al., 1986). In addition, assessing the 
behaviour of such spinal implant devices, especially at spinal resonant frequencies, is important. 
Any resonance of a spinal device, at any frequency, is a limitation of the device as the resonance 
may damage the device and in a worst-case scenario, the device may fail. This thesis adds to the 
minimal work that has been previously undertaken in understanding the frequency dependent 
response of implantable devices and the frequency dependent behaviour of the biomaterials 
used in such implants.  
The viscoelasticity (calculated by DMA) of the untreated, in vitro and in vivo degraded BDyn 
components and the BDyn device assembled with degraded components were compared. The 
viscoelastic properties of the BDyn device and its components are frequency dependent. As the 
frequency increased, the storage stiffness and the loss stiffness increased for the untreated 
components and BDyn devices; this highlights the need to evaluate biomaterials and devices 
utilising frequency dependent mechanical testing techniques. In vitro oxidation degradation 
affected the viscoelasticity of the specific components and the BDyn device, assembled with the 
degraded components, at specific frequencies; this highlights the importance of analysing 
changes of viscoelastic properties, of degraded biomaterials, in terms of frequency and medical 
devices into which they are incorporated, using a frequency sweep. 
The BDyn components chemical structure (HCI and ATR-FTIR), macro-morphological plastic 
deformation and surface morphology (SEM) were compared. In vitro oxidation degradation 
displayed changes to the chemical structure and exhibited surface morphology changes of the 
PCU components while the in vitro degraded silicone components displayed no changes in the 
ATR-FTIR spectra and surface morphology. All six explanted, in vivo degraded PCU rings and 
silicone cushions displayed some forms of macroscopic or microscopic surface morphological 
changes. All six explanted PCU rings displayed changes to the chemical structure associated to 
hard segment degradation while 5 (out of 6) explanted PCU rings had evidence of soft segment 
degradation on hyperspectral chemical maps (HCMs). HCMs of the silicone components 
demonstrated that a new peak at 1650 cm-1 was observed regionally at one or multiple 
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locations, on all explanted silicone components. Further, chemical structure changes associated 
with the Si-O-Si stretch (1065 cm-1) and the Si-CH3 stretch (1257 cm-1) were witnessed.  
Unlike the untreated and in vitro degraded components and devices, resonance was detected in 
the frequency sweep test of the BDyn Explant 2 with the sharp increase of the loss stiffness 
which occurred at 4 Hz; this resonant frequency is similar to the frequencies recorded by 
Panjabi et al. (1986) and Wilder et al. (1982). Further, this resonant frequency is not a 
beneficial finding for the device and further adds to the importance of evaluating orthopaedic 
devices with frequency dependent mechanical testing techniques.  
The in vitro biostability of five commercially available, long-term implantable polycarbonate 
urethane (PCU) biomaterials with regards to viscoelasticity (µDMA and DMA), chemical 
structure (HCI) and surface morphology (SEM) were investigated. This was performed by 
degrading the biomaterials by four separate in vitro degradation protocols. The five biomaterials 
(Quadrathane ARC 80A-B20, Bionate II 80A, Quadrathane ARC 80A, ChronoFlex C 80A 
and ChronoSil 80A 5%) were viscoelastic throughout the frequency range tested. Further, the 
macro-viscoelastic properties of the five untreated and degraded biomaterials were logarithmic 
with respect to frequency for all biomaterial specimens tested. Similar to the BDyn device and 
its components, this highlights the need to evaluate biomaterials utilising frequency dependent 
mechanical testing techniques and the frequency dependent nature of these materials must be 
considered by researchers. 
The in vitro H2O2/CoCl2 degradation method, used to degrade PCU, has been shown to 
produce similar chemical structure and surface morphological changes to PCU biomaterials 
degraded in vivo. Interestingly, the micro- and macro-viscoelastic properties of Bionate II and 
Chronoflex C H2O2/CoCl2 degraded specimens were not significantly different (p > 0.05) for 
any frequency tested when compared to the untreated; this highlights the oxidative stability, with 
regards to their viscoelastic properties, of these biomaterials. Further, the macro-viscoelastic 
properties of Bionate II and Chronoflex C real-time and accelerated hydrolytic degraded 
specimens were not significantly different (p > 0.05) for any frequency tested when compared to 
the untreated; this highlights the hydrolytic stability, with regards to their macro-viscoelastic 
properties, of these biomaterials. However, the micro-viscoelastic properties of Bionate II and 
Chronoflex C were significantly different (p < 0.05) at specific frequencies tested; thus, this calls 
into doubt the hydrolytic stability of these biomaterials and highlights the importance of the 
need to assess material mechanical response property changes on different scales. 
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The surface micro-level viscoelastic response of the Quadrathane H2O2/CoCl2 degraded 
specimens were not significantly different when compared to the untreated. The micro-scale 
and the macro-scale elastic property (storage stiffness) was not significantly different (p > 0.05) 
for any biomaterial, at any tested frequency, between the untreated and the in vitro 
H2O2/CoCl2 degraded groups. Therefore, it is concluded with caution that oxidation 
mechanisms, created by an in vitro mechanism that is comparative to the in vivo mechanism, 
may not affect the recoverable energy of these five biomaterials; a caveat of this conclusion is 
that this does not apply to all forms of mechanical loading and potentially, all induced stress 
ranges. To add to this conclusion, the macro-elastic property of the real-time and accelerated 
hydrolytic degraded Quadrathane B20, Bionate II, Quadrathane and Chronoflex C specimens 
was not significantly different (p > 0.05), to the untreated specimens, for all tested frequencies; 
this finding demonstrates the hydrolytic stability of these biomaterials. However, with regards to 
viscoelastic properties, the oxidative and hydrolytic stability of these biomaterials is called into 
doubt as the macro-viscoelastic properties, of the five biomaterials, were significantly different (p 
< 0.05) at specific frequencies when comparing the untreated and 3% H2O2 degradation 
method; the hydrolytic stability is called into doubt as the 3% H2O2 method is 97% water.  
For all Chronosil specimens degraded by the four degradation methods, the micro-viscoelastic 
properties Chronosil was not significantly different for all tested frequencies and no new 
absorbance peaks were observed at 930 cm-1 and 1174 cm-1 on all HCIs; this highlights the 
biostability of this polycarbonate urethane based silicone biomaterial. Further, SEM images of 
the five biomaterials degraded with the in vitro H2O2/CoCl2 degradation method revealed 
various levels of pitting on the surface and Chronosil had the smallest range of pit sizes. This 
finding, alongside the minimal changes in gradient of the in vitro oxidative degraded SG second 
derivative spectra of Chronosil, further highlights the biostability of Chronosil over the other 
PCU biomaterials evaluated. HCIs of the aromatic PCU biomaterials degraded by the in vitro 
H2O2/CoCl2 method demonstrated evidence of PCU oxidative degradation as new absorbance 
peaks were observed at 930 cm-1 and 1174 cm-1. Regional variation of degradation on some in 
vitro H2O2/CoCl2 degraded specimens was highly contrasting; this emphasises the need of 
imaging a wide sample area to understand spatial variation of biomaterial degradation. No new 
peaks at 930 cm-1 and 1174 cm-1 were detected for specimens degraded by the 3% H2O2 
degradation method, the real time or the accelerated hydrolytic degradation methods.  
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As these motion preserving implants are novel and clinical precedence is slowly emerging with 
retrieval analysis studies, it is challenging for engineers to develop in vitro tests to accurately 
predict in vivo performance (Kurtz et al., 2009). At the cell membrane-biomaterial surface 
interface, the macrophages and FBGCs release degradative agents such as reactive oxygen 
intermediates (oxygen free radicals), enzymes and acid (Anderson et al., 2008; Christenson et 
al., 2007; Heiple et al., 1990; Sheikh et al., 2015; Wright and Silverstein, 1983). From the 
explanted BDyn components, micro-scale (ESC and surface pitting) and macro-scale 
morphological changes were witnessed. To further develop our understanding of the biostability 
of implantable devices and biomaterials, I believe future in vitro studies should be in performed 
with multiple in vitro tests, on implantable devices, to more accurately predict in vivo 
performance and these in vitro tests should include: 
 Cholesterol Esterase (CE) or another enzyme (to replicate enzymatic degradation) 
 Human plasma or glass wool (to replicate ESC) 
 H2O2/CoCl2 (to replicate pitting) 
 Mechanical fatigue testing (to replicate plastic deformation) 
The order of these experiments would have to be decided following preliminary testing. By 
encapsulating different characteristics caused by implantation (in vivo degradation), this could 
help biomedical engineers to more accurately predict in vivo performances by in vitro methods.  
It would be beneficial, of future BDyn retrieval studies, to examine periprosthetic tissue 
samples for wear debris and inflammation; this would give an understanding of the benefits of 
the BDyn titanium housing as a protection barrier between the tissue and the elastomeric 
components. As the explant that had a resonant frequency had an asymmetrical pedicle screw 
construct, it would be beneficial to investigate the load transfer through an asymmetrical pedicle 
screw construct by using, as a general and not strict guidance, the ISO 12189 or ASTM F1717 
standard. Further, future work should involve fatigue test of BDyn under ISO 12189 and the 
investigation of the effect of this fatigue loading to the viscoelastic properties of the device and 
components.  
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Future work should focus on assessing the effect of component manufacturing factors 
(sterilisation, ion treatment, etc.) on the viscoelastic properties of these biomaterials. To give a 
better understanding of the effect of regionalised degradation on mechanical response, it is 
purposed that future work combines HCI and micro-DMA to correlate if a change in the 
mechanical response, of the biomaterials, can be detected by a change in the chemical structure. 
If a correlation exists and can be quantified, this would be further advantage of the use of HCI. 
Further, it is proposed that new, developing technology, such as optical coherence elastography 
(OCE) (Bartolini et al., 2017), is utilised in future studies to investigate potential spatial 
variations and depth penetration of degraded biomaterials.  
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The overall conclusions from this thesis are: 
 The five biomaterials (Quadrathane ARC 80A-B20, Bionate II 80A, Quadrathane ARC 
80A, ChronoFlex C 80A and ChronoSil 80A 5%), the posterior stabilisation BDyn 
device and the BDyn components were viscoelastic throughout the frequency ranges 
tested;  
 Except for Chronosil, the micro- and macro-viscoelastic properties of all biomaterials 
were affected by one (or more) in vitro degradation method(s); only the macro-
viscoelastic properties of Chronosil was affected by in vitro degradation methods; 
 Aromatic PCU biomaterials degraded by the in vitro H2O2/CoCl2 method 
demonstrated evidence of PCU oxidative degradation; this degradation regionally varied 
across the surface some specimens; 
 Chronosil was the most biostable biomaterial degraded by the four degradation 
methods. The micro-viscoelastic properties of Chronosil were not significantly different 
when comparing the four degraded methods to the untreated biomaterials; 
 In vitro oxidation degradation affected the viscoelasticity of the specific components and 
the BDyn device, assembled with the degraded components, at specific frequencies. No 
resonant frequencies were reported for the untreated and in vitro degraded components 
and devices. Resonance was detected in the frequency sweep test of a BDyn device, 
assembled with explanted components, at 4 Hz; 
 SEM images of the six explanted PCU rings and explanted six silicone cushions 
displayed microscopic surface morphological changes. SEM images of the five 
biomaterials degraded with the in vitro H2O2/CoCl2 degradation method, the in vitro 
and in vivo degraded BDyn PCU components revealed pitting on the surface. The 
range of the measured pit diameters of the in vitro degraded five biomaterials, in vitro 
and in vivo degraded PCU rings varied; Chronosil had the smallest pit sizes.  
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8 Appendices 
8.1 Appendix A – dimensions of the ASTM D1708 specimens 
 
Figure 8-1: Dimensions of the ASTM D1708 specimens 
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8.2 Appendix B – dimensions of the BDyn device and components 
 
Figure 8-2: Section view of the BDyn device 
 202 
 
 
Figure 8-3: Dimensions of the titanium alloy mobile rod of the BDyn device 
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Figure 8-4: Dimensions of the titanium alloy housing of the BDyn device 
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Figure 8-5: Dimensions of the titanium alloy fixed rod of the BDyn device 
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Figure 8-6: Dimensions of the PCU ring of the BDyn device 
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Figure 8-7: Dimensions of the silicone cushion of the BDyn device 
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8.3 Appendix C – dimensions of the μDMA probe 
 
Figure 8-8: Dimensions of the micro-DMA probe 
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8.4 Appendix D – dimensions of the DMA water bath chamber 
 
Figure 8-9: Water bath used in DMA testing 
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Figure 8-10: Exploded view of the water bath 
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Figure 8-11: Dimensions of the outer pipe of the water bath 
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Figure 8-12: Dimensions of the inner pipe of the water bath 
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Figure 8-13: Dimensions of the base plate of the water bath 
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8.5 Appendix E – Regression (µDMA) 
Table 8-1: Storage stiffness (equation 4.1) and loss stiffness (equation 4.2) regression 
analyses of Quadrathane ARC 80A B20.  
  k’  k’’ 
Specimen ID 
 
A B R² P Value 
 
C D R² P Value 
UNT – M1  0.692 12.02 0.972 0.002 
 
0.527 1.485 0.776 0.048 
UNT – M2  1.111 12.98 0.989 0.001 
 
0.487 1.462 0.868 0.021 
UNT – M3  0.790 12.31 0.957 0.004  0.476 1.304 0.835 0.03 
UNT – M4  0.408 10.42 0.982 0.001 
 
0.406 1.133 0.776 0.049 
UNT – M5  0.349 11.29 0.975 0.002 
 
0.379 1.218 0.752 0.057 
UNT – M6  0.279 9.67 0.834 0.03 
 
0.309 1.031 0.851 0.026 
Real time – M1  0.818 18.14 0.978 0.001 
 
0.648 2.348 0.760 0.054 
Real time – M2  0.766 14.50 0.946 0.005 
 
0.580 1.627 0.854 0.025 
Real time – M3  0.869 19.23 0.992 0.001 
 
0.814 2.430 0.829 0.032 
Real time – M4  0.568 18.26 0.989 0.001  0.792 2.535 0.749 0.058 
Real time – M5  0.509 16.15 0.795 0.042 
 
0.667 2.059 0.749 0.058 
Real time – M6  0.266 8.97 0.946 0.005 
 
0.227 0.850 0.894 0.015 
Accelerated – M1  0.771 13.82 0.991 0.001 
 
0.689 2.255 0.804 0.039 
Accelerated – M2  0.811 13.69 0.920 0.01 
 
0.607 2.115 0.871 0.02 
Accelerated – M3  0.736 13.87 0.980 0.001 
 
0.675 2.215 0.844 0.028 
Accelerated – M4  0.819 14.18 0.995 0.001 
 
0.828 2.326 0.819 0.035 
Accelerated – M5  0.512 12.37 0.895 0.015  0.529 1.794 0.834 0.03 
Accelerated – M6  0.606 12.54 0.981 0.001  0.548 1.755 0.769 0.051 
UNT – M1  0.666 14.73 0.998 0.001  0.709 1.960 0.846 0.027 
UNT – M2  0.834 15.27 0.986 0.001  0.589 1.960 0.750 0.058 
UNT – M3  0.720 14.70 0.984 0.001  0.600 1.896 0.826 0.033 
UNT – M4  0.865 14.66 0.986 0.001  0.501 1.628 0.850 0.026 
UNT – M5  0.818 12.65 0.998 0.001  0.592 1.594 0.788 0.045 
UNT – M6  0.660 13.51 0.992 0.001 
 
0.533 1.566 0.848 0.026 
3% H2O2 – M1  0.527 16.44 0.946 0.005  0.610 1.955 0.868 0.021 
3% H2O2 – M2  0.714 17.02 0.987 0.001  0.805 2.170 0.828 0.032 
3% H2O2 – M3  0.432 16.16 0.881 0.018  0.678 1.903 0.846 0.027 
3% H2O2 – M4  0.892 17.02 0.881 0.018  0.676 1.906 0.810 0.037 
3% H2O2 – M5  0.512 16.87 0.973 0.002  0.592 1.834 0.823 0.033 
3% H2O2 – M6  0.501 16.18 0.939 0.006  0.778 2.151 0.699 0.078 
H2O2/CoCl2 – M1  0.502 12.78 0.965 0.003 
 
0.407 1.358 0.885 0.017 
H2O2/CoCl2 – M2  0.517 12.83 0.975 0.002 
 
0.382 1.389 0.737 0.063 
H2O2/CoCl2 – M3  0.690 12.27 0.919 0.01 
 
0.527 1.491 0.764 0.053 
H2O2/CoCl2 – M4  0.582 12.57 0.996 0.001 
 
0.405 1.455 0.810 0.038 
H2O2/CoCl2 – M5  0.588 12.62 0.974 0.002 
 
0.462 1.449 0.805 0.039 
H2O2/CoCl2 – M6  0.570 12.51 0.983 0.001  0.535 1.591 0.750 0.058 
 
 
 214 
 
Table 8-2: Storage stiffness (equation 4.1) and loss stiffness (equation 4.2) regression 
analyses of Bionate II 80A.  
  k’  k’’ 
Specimen ID 
 
A B R² P Value 
 
C D R² P Value 
UNT – M1  0.973 18.84 0.990 0.001 0.994 2.666 0.797 0.041 
UNT – M2  0.609 17.06 0.974 0.002  0.751 2.150 0.869 0.021 
UNT – M3  0.652 17.23 0.932 0.008  0.851 2.293 0.872 0.02 
UNT – M4  0.676 16.94 0.946 0.005  0.920 2.279 0.803 0.04 
UNT – M5  0.823 17.04 0.985 0.001  0.845 2.237 0.888 0.017 
UNT – M6  0.463 16.61 0.815 0.036  0.727 2.047 0.819 0.035 
Real time – M1  1.543 34.05 0.937 0.007  3.170 7.020 0.693 0.08 
Real time – M2  1.196 32.91 0.676 0.087  2.428 6.141 0.799 0.041 
Real time – M3  1.487 31.95 0.908 0.012  2.503 6.106 0.760 0.054 
Real time – M4  1.524 34.12 0.985 0.001  2.517 6.391 0.765 0.052 
Real time – M5  2.197 36.40 0.982 0.001  3.293 7.762 0.758 0.055 
Real time – M6  2.285 31.54 0.979 0.001  2.381 5.799 0.768 0.051 
Accelerated – M1  0.720 15.78 0.922 0.009  0.675 2.012 0.812 0.037 
Accelerated – M2  2.107 29.95 0.941 0.006  2.051 5.653 0.858 0.024 
Accelerated – M3  1.828 29.77 0.995 0.001  1.983 5.818 0.818 0.035 
Accelerated – M4  1.645 28.20 0.997 0.001  2.100 5.366 0.807 0.038 
Accelerated – M5  2.030 29.59 0.972 0.002  2.364 6.165 0.779 0.047 
Accelerated – M6  1.106 22.81 0.949 0.005  1.107 3.834 0.717 0.07 
UNT – M1  0.737 24.53 0.548 0.153  1.468 4.197 0.740 0.061 
UNT – M2  0.622 25.41 0.676 0.088  1.748 4.541 0.805 0.039 
UNT – M3  1.182 26.08 0.977 0.001  1.842 4.656 0.803 0.039 
UNT – M4  1.470 25.80 0.991 0.001  1.623 4.418 0.852 0.025 
UNT – M5  0.393 25.73 0.184 0.472  1.202 3.913 0.946 0.005 
UNT – M6  1.665 24.46 0.969 0.002  1.802 4.292 0.811 0.037 
3% H2O2 – M1  0.152 22.11 0.080 0.644  0.605 2.831 0.704 0.076 
3% H2O2 – M2  0.098 21.31 0.026 0.795  0.901 2.993 0.665 0.092 
3% H2O2 – M3  -0.168 22.24 0.058 0.697  0.791 3.072 0.725 0.067 
3% H2O2 – M4  -0.181 21.38 0.067 0.674  0.800 2.926 0.742 0.061 
3% H2O2 – M5  0.425 20.84 0.432 0.228  0.640 2.545 0.769 0.051 
3% H2O2 – M6  0.198 21.61 0.104 0.596  0.688 2.767 0.896 0.015 
H2O2/CoCl2 – M1  1.345 23.49 0.896 0.015  1.340 3.694 0.847 0.027 
H2O2/CoCl2 – M2  1.578 22.92 0.980 0.001  1.417 3.569 0.844 0.028 
H2O2/CoCl2 – M3  1.383 25.56 0.939 0.006  1.619 4.388 0.754 0.056 
H2O2/CoCl2 – M4  1.624 25.78 0.999 0.001  1.698 4.448 0.817 0.035 
H2O2/CoCl2 – M5  1.466 23.56 0.970 0.002  1.422 3.719 0.777 0.048 
H2O2/CoCl2 – M6  1.060 23.07 0.991 0.001  1.275 3.693 0.828 0.032 
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Table 8-3: Storage stiffness (equation 4.1) and loss stiffness (equation 4.2) regression 
analyses of Quadrathane ARC 80A.  
  k’  k’’ 
Specimen ID 
 
A B R² P Value 
 
C D R² P Value 
UNT – M1  0.449 10.80 0.888 0.016 0.436 1.215 0.760 0.054 
UNT – M2  0.157 11.88 0.821 0.034  0.343 1.164 0.902 0.013 
UNT – M3  0.523 13.04 0.944 0.006  0.511 1.519 0.788 0.044 
UNT – M4  0.256 12.55 0.916 0.011  0.418 1.378 0.766 0.052 
UNT – M5  0.297 12.81 0.827 0.032  0.346 1.231 0.781 0.047 
UNT – M6  0.528 13.56 0.981 0.001  0.407 1.425 0.808 0.038 
Real time – M1  0.551 15.56 0.966 0.003  0.717 1.817 0.784 0.046 
Real time – M2  0.563 15.92 0.887 0.017  0.664 1.792 0.839 0.029 
Real time – M3  0.505 10.89 0.983 0.001  0.297 0.986 0.892 0.016 
Real time – M4  0.332 8.22 0.973 0.002  0.347 0.853 0.763 0.053 
Real time – M5  0.477 12.55 0.918 0.01  0.418 1.214 0.939 0.006 
Real time – M6  0.465 10.23 0.988 0.001  0.364 1.037 0.896 0.015 
Accelerated – M1  0.789 12.10 0.993 0.001  0.427 1.657 0.874 0.02 
Accelerated – M2  0.927 11.12 0.997 0.001  0.433 1.485 0.864 0.022 
Accelerated – M3  0.901 11.12 0.994 0.001  0.460 1.511 0.807 0.038 
Accelerated – M4  0.759 12.05 0.969 0.002  0.548 1.731 0.814 0.036 
Accelerated – M5  0.696 12.38 0.976 0.002  0.533 1.650 0.841 0.028 
Accelerated – M6  1.015 13.48 0.990 0.001  0.588 1.969 0.899 0.014 
UNT – M1  0.331 10.26 0.432 0.228  0.582 1.524 0.876 0.019 
UNT – M2  0.667 12.06 0.985 0.001  0.595 1.565 0.902 0.013 
UNT – M3  0.435 14.13 0.444 0.22  0.736 1.942 0.855 0.025 
UNT – M4  0.968 15.95 0.937 0.007  0.844 2.309 0.942 0.006 
UNT – M5  0.973 16.17 0.960 0.003  1.145 2.651 0.806 0.039 
UNT – M6  0.704 15.42 0.931 0.008  0.998 2.396 0.837 0.029 
3% H2O2 – M1  0.560 12.63 0.963 0.003  0.613 1.611 0.876 0.019 
3% H2O2 – M2  0.414 12.02 0.911 0.012  0.585 1.395 0.929 0.008 
3% H2O2 – M3  0.575 13.20 0.932 0.008  0.642 1.520 0.828 0.012 
3% H2O2 – M4  0.503 11.94 0.863 0.023  0.468 1.298 0.903 0.013 
3% H2O2 – M5  0.615 12.95 0.958 0.004  0.666 1.666 0.836 0.03 
3% H2O2 – M6  0.656 13.12 0.931 0.008  0.740 1.863 0.889 0.016 
H2O2/CoCl2 – M1  0.519 11.12 0.938 0.007  0.452 1.348 0.860 0.023 
H2O2/CoCl2 – M2  0.881 16.25 0.981 0.001  0.816 2.144 0.944 0.006 
H2O2/CoCl2 – M3  0.474 11.70 0.929 0.008  0.514 1.374 0.848 0.027 
H2O2/CoCl2 – M4  0.548 13.79 0.976 0.002  0.795 2.004 0.816 0.036 
H2O2/CoCl2 – M5  0.616 13.43 0.987 0.001  0.609 1.804 0.853 0.025 
H2O2/CoCl2 – M6  0.623 14.63 0.959 0.004  0.848 2.149 0.895 0.015 
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Table 8-4: Storage stiffness (equation 4.1) and loss stiffness (equation 4.2) regression 
analyses of ChronoFlex C 80A.  
  k’  k’’ 
Specimen ID 
 
A B R² P Value 
 
C D R² P Value 
UNT – M1  1.017 20.03 0.983 0.001 1.320 3.434 0.880 0.018 
UNT – M2  1.162 20.39 0.940 0.006  1.255 3.418 0.841 0.028 
UNT – M3  1.361 20.36 0.962 0.003  1.621 3.892 0.840 0.029 
UNT – M4  1.048 20.92 0.989 0.001  1.362 3.503 0.866 0.022 
UNT – M5  1.119 20.29 0.936 0.007  1.367 3.546 0.848 0.026 
UNT – M6  1.166 20.07 0.936 0.007  1.369 3.390 0.843 0.028 
Real time – M1  0.975 18.93 0.957 0.004  1.102 2.894 0.885 0.017 
Real time – M2  0.741 17.91 0.952 0.004  1.036 2.735 0.872 0.02 
Real time – M3  0.954 18.20 0.972 0.002  0.998 2.673 0.909 0.012 
Real time – M4  0.947 18.07 0.958 0.004  1.081 2.801 0.860 0.023 
Real time – M5  0.814 17.72 0.988 0.001  1.226 2.807 0.823 0.034 
Real time – M6  0.965 18.08 0.999 0.001  1.061 2.593 0.854 0.025 
Accelerated – M1  0.959 15.45 0.977 0.002  0.953 2.461 0.881 0.018 
Accelerated – M2  1.002 15.99 0.992 0.001  0.854 2.518 0.902 0.013 
Accelerated – M3  0.909 15.62 0.988 0.001  0.866 2.474 0.885 0.017 
Accelerated – M4  0.875 15.61 0.997 0.001  0.848 2.477 0.892 0.016 
Accelerated – M5  1.378 17.54 0.994 0.001  1.100 3.040 0.870 0.021 
Accelerated – M6  0.855 15.91 0.985 0.001  0.969 2.713 0.845 0.027 
UNT – M1  1.279 22.82 0.996 0.001  1.704 4.088 0.828 0.032 
UNT – M2  0.887 19.80 0.902 0.014  1.305 3.232 0.771 0.05 
UNT – M3  0.854 18.93 0.728 0.066  1.188 3.191 0.773 0.05 
UNT – M4  0.809 19.21 0.787 0.045  0.893 2.852 0.865 0.022 
UNT – M5  0.964 18.95 0.871 0.02  1.200 2.933 0.840 0.029 
UNT – M6  0.393 19.64 0.821 0.034  1.072 3.109 0.869 0.021 
3% H2O2 – M1  0.867 18.07 0.991 0.001  1.066 2.652 0.859 0.023 
3% H2O2 – M2  1.002 18.82 0.967 0.003  1.250 2.856 0.822 0.034 
3% H2O2 – M3  0.865 18.60 0.999 0.001  0.954 2.565 0.852 0.025 
3% H2O2 – M4  0.962 18.65 0.987 0.001  1.069 2.617 0.852 0.025 
3% H2O2 – M5  0.989 18.29 0.994 0.001  1.045 2.654 0.844 0.027 
3% H2O2 – M6  0.741 17.79 0.909 0.012  1.004 2.511 0.815 0.036 
H2O2/CoCl2 – M1  0.502 17.78 0.733 0.064  0.867 2.628 0.807 0.038 
H2O2/CoCl2 – M2  0.863 18.45 0.946 0.005  1.027 2.706 0.853 0.025 
H2O2/CoCl2 – M3  1.454 23.53 0.951 0.005  1.437 3.881 0.792 0.043 
H2O2/CoCl2 – M4  1.231 22.06 0.954 0.004  1.377 3.746 0.843 0.028 
H2O2/CoCl2 – M5  0.968 22.13 0.981 0.001  1.277 3.534 0.887 0.017 
H2O2/CoCl2 – M6  1.069 19.88 0.949 0.005  1.097 2.936 0.872 0.02 
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Table 8-5: Storage stiffness (equation 4.1) and loss stiffness (equation 4.2) regression 
analyses of Chronosil 5% 80A.  
  k’  k’’ 
Specimen ID 
 
A B R² P Value 
 
C D R² P Value 
UNT – M1  1.065 10.79 1.000 0.001 0.663 2.340 0.916 0.011 
UNT – M2  1.766 13.81 0.991 0.001  1.349 3.446 0.869 0.021 
UNT – M3  1.536 16.07 0.978 0.001  1.406 3.941 0.853 0.025 
UNT – M4  1.102 10.74 1.000 0.001  0.715 2.183 0.889 0.016 
UNT – M5  0.897 9.90 0.989 0.001  0.662 2.083 0.828 0.032 
UNT – M6  0.937 11.47 0.983 0.001  0.704 2.374 0.863 0.022 
Real time – M1  1.490 15.22 0.999 0.001  1.329 3.620 0.920 0.01 
Real time – M2  1.237 14.24 0.982 0.001  1.074 3.197 0.896 0.015 
Real time – M3  1.292 12.46 0.984 0.001  0.959 2.719 0.876 0.019 
Real time – M4  1.352 12.46 0.978 0.001  0.914 2.664 0.961 0.003 
Real time – M5  1.105 12.22 0.923 0.009  0.718 2.357 0.875 0.02 
Real time – M6  1.219 13.45 0.959 0.004  1.004 2.917 0.866 0.022 
Accelerated – M1  0.953 10.95 0.924 0.009  0.670 2.210 0.895 0.015 
Accelerated – M2  1.083 12.06 0.991 0.001  0.820 2.608 0.883 0.018 
Accelerated – M3  1.417 13.32 0.977 0.002  1.020 3.102 0.886 0.017 
Accelerated – M4  1.233 12.23 0.917 0.01  0.773 2.675 0.848 0.026 
Accelerated – M5  0.809 10.32 0.979 0.001  0.625 2.065 0.798 0.041 
Accelerated – M6  0.867 7.135 0.999 0.001  0.470 1.360 0.916 0.011 
UNT – M1  1.133 11.46 0.959 0.004  0.867 2.558 0.885 0.017 
UNT – M2  0.649 10.38 0.792 0.043  0.609 2.092 0.899 0.014 
UNT – M3  0.531 11.22 0.684 0.084  0.666 2.336 0.868 0.021 
UNT – M4  0.846 11.09 0.873 0.02  0.787 2.364 0.887 0.017 
UNT – M5  0.859 9.990 0.997 0.001  0.681 2.076 0.895 0.015 
UNT – M6  1.249 12.25 0.949 0.005  1.042 3.042 0.920 0.01 
3% H2O2 – M1  0.966 12.09 0.917 0.01  0.814 2.395 0.917 0.01 
3% H2O2 – M2  1.090 11.73 0.991 0.001  0.770 2.441 0.931 0.008 
3% H2O2 – M3  0.901 13.75 0.964 0.003  1.103 2.947 0.883 0.018 
3% H2O2 – M4  0.715 9.155 0.942 0.006  0.658 1.790 0.865 0.022 
3% H2O2 – M5  1.259 14.44 0.954 0.004  1.147 3.129 0.802 0.04 
3% H2O2 – M6  1.032 13.51 0.967 0.003  1.048 2.919 0.859 0.024 
H2O2/CoCl2 – M1  1.094 12.29 0.976 0.002  1.013 2.877 0.861 0.023 
H2O2/CoCl2 – M2  0.747 8.717 0.962 0.003  0.537 1.742 0.905 0.013 
H2O2/CoCl2 – M3  1.038 11.91 0.960 0.003  0.923 2.771 0.881 0.018 
H2O2/CoCl2 – M4  1.446 17.02 0.976 0.002  1.556 4.379 0.816 0.036 
H2O2/CoCl2 – M5  0.876 11.21 0.977 0.001  0.684 2.114 0.878 0.019 
H2O2/CoCl2 – M6  1.005 11.09 0.990 0.001  0.728 2.300 0.853 0.025 
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8.6 Appendix F – Regression (DMA) 
Table 8-6: Storage stiffness (equation 4.1) and loss stiffness (equation 4.2) regression 
analyses of Quadrathane ARC 80A B20.  
  k’  k’’ 
Specimen ID 
 
A B R² P Value 
 
C D R² P Value 
UNT – M1  0.588 11.53 0.962 0.001 0.169 1.036 0.918 0.001 
UNT – M2  0.599 11.79 0.968 0.001  0.169 1.064 0.934 0.001 
UNT – M3  0.599 11.79 0.949 0.001  0.178 1.072 0.916 0.001 
Real time – M1  0.538 11.63 0.797 0.001  0.208 1.142 0.669 0.001 
Real time – M2  0.616 12.21 0.960 0.001  0.167 1.086 0.928 0.001 
Real time – M3  0.639 12.25 0.968 0.001  0.179 1.125 0.924 0.001 
Accelerated – M1  0.601 8.540 0.964 0.001  0.155 1.024 0.941 0.001 
Accelerated – M2  0.588 8.620 0.957 0.001  0.151 1.028 0.948 0.001 
Accelerated – M3  0.607 8.670 0.967 0.001  0.154 1.039 0.945 0.001 
UNT – M1  0.567 10.96 0.945 0.001  0.166 0.984 0.916 0.001 
UNT – M2  0.535 11.13 0.905 0.001  0.199 1.066 0.622 0.001 
UNT – M3  0.508 10.98 0.774 0.001  0.181 1.041 0.915 0.001 
UNT – M4  0.557 11.11 0.951 0.001  0.183 1.036 0.822 0.001 
UNT – M5  0.513 10.37 0.966 0.001  0.148 0.922 0.922 0.001 
3% H2O2 – M1  0.610 12.17 0.963 0.001  0.168 1.073 0.926 0.001 
3% H2O2 – M2  0.527 11.28 0.927 0.001  0.172 1.037 0.866 0.001 
3% H2O2 – M3  0.544 11.18 0.967 0.001  0.155 0.985 0.915 0.001 
3% H2O2 – M4  0.562 11.39 0.963 0.001  0.160 1.022 0.926 0.001 
3% H2O2 – M5  0.561 11.42 0.970 0.001  0.160 1.017 0.924 0.001 
H2O2/CoCl2 – M1  0.559 10.93 0.954 0.001  0.178 1.018 0.910 0.001 
H2O2/CoCl2 – M2  0.525 10.67 0.969 0.001  0.157 0.951 0.923 0.001 
H2O2/CoCl2 – M3  0.551 10.74 0.965 0.001  0.172 0.991 0.896 0.001 
H2O2/CoCl2 – M4  0.553 11.22 0.855 0.001  0.199 1.092 0.858 0.001 
H2O2/CoCl2 – M5  0.568 10.74 0.933 0.001  0.191 1.039 0.853 0.001 
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Table 8-7: Storage stiffness (equation 4.1) and loss stiffness (equation 4.2) regression 
analyses of Bionate II 80A.  
  k’  k’’ 
Specimen ID 
 
A B R² P Value 
 
C D R² P Value 
UNT – M1  0.752 16.01 0.944 0.001 0.301 1.480 0.888 0.001 
UNT – M2  0.870 17.18 0.954 0.001  0.349 1.670 0.897 0.001 
UNT – M3  0.838 17.04 0.957 0.001  0.334 1.639 0.901 0.001 
Real time – M1  0.948 18.06 0.889 0.001  0.445 1.957 0.880 0.001 
Real time – M2  0.754 16.73 0.687 0.001  0.409 1.762 0.792 0.001 
Real time – M3  0.962 18.71 0.946 0.001  0.393 1.832 0.890 0.001 
Accelerated – M1  0.864 14.64 0.945 0.001  0.320 1.663 0.869 0.001 
Accelerated – M2  0.796 13.49 0.940 0.001  0.288 1.497 0.797 0.001 
Accelerated – M3  0.901 15.18 0.956 0.001  0.312 1.656 0.863 0.001 
UNT – M1  0.957 17.73 0.945 0.001  0.389 1.825 0.898 0.001 
UNT – M2  0.866 17.56 0.957 0.001  0.346 1.695 0.897 0.001 
UNT – M3  1.064 17.90 0.919 0.001  0.484 2.049 0.832 0.001 
UNT – M4  0.975 17.52 0.950 0.001  0.421 1.907 0.887 0.001 
UNT – M5  1.004 17.76 0.949 0.001  0.429 1.958 0.897 0.001 
3% H2O2 – M1  1.015 18.10 0.943 0.001  0.425 1.947 0.892 0.001 
3% H2O2 – M2  0.841 18.32 0.626 0.001  0.448 1.986 0.812 0.001 
3% H2O2 – M3  0.981 18.90 0.950 0.001  0.388 1.865 0.889 0.001 
3% H2O2 – M4  0.966 18.24 0.941 0.001  0.384 1.797 0.881 0.001 
3% H2O2 – M5  0.815 18.48 0.462 0.001  0.441 1.980 0.822 0.001 
H2O2/CoCl2 – M1  0.978 18.29 0.952 0.001  0.384 1.847 0.906 0.001 
H2O2/CoCl2 – M2  0.936 17.72 0.958 0.001  0.370 1.794 0.906 0.001 
H2O2/CoCl2 – M3  0.972 18.08 0.953 0.001  0.386 1.832 0.901 0.001 
H2O2/CoCl2 – M4  0.933 17.38 0.943 0.001  0.385 1.800 0.895 0.001 
H2O2/CoCl2 – M5  0.917 17.40 0.949 0.001  0.387 1.803 0.888 0.001 
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Table 8-8: Storage stiffness (equation 4.1) and loss stiffness (equation 4.2) regression 
analyses of Quadrathane ARC 80A.  
  k’  k’’ 
Specimen ID 
 
A B R² P Value 
 
C D R² P Value 
UNT – M1  0.406 9.370 0.961 0.001 0.130 0.744 0.899 0.001 
UNT – M2  0.405 9.325 0.962 0.001  0.119 0.718 0.919 0.001 
UNT – M3  0.407 9.175 0.959 0.001  0.126 0.725 0.918 0.001 
Real time – M1  0.418 9.644 0.962 0.001  0.124 0.754 0.929 0.001 
Real time – M2  0.412 9.698 0.966 0.001  0.120 0.738 0.926 0.001 
Real time – M3  0.385 9.665 0.867 0.001  0.131 0.763 0.881 0.001 
Accelerated – M1  0.463 7.137 0.953 0.001  0.126 0.795 0.949 0.001 
Accelerated – M2  0.512 7.506 0.959 0.001  0.136 0.839 0.943 0.001 
Accelerated – M3  0.494 7.304 0.964 0.001  0.134 0.825 0.944 0.001 
UNT – M1  0.405 9.212 0.963 0.001  0.126 0.723 0.913 0.001 
UNT – M2  0.396 9.213 0.901 0.001  0.139 0.749 0.871 0.001 
UNT – M3  0.370 9.303 0.750 0.001  0.137 0.771 0.895 0.001 
UNT – M4  0.407 9.358 0.964 0.001  0.141 0.778 0.833 0.001 
UNT – M5  0.377 9.297 0.796 0.001  0.138 0.772 0.902 0.001 
3% H2O2 – M1  0.403 9.529 0.958 0.001  0.127 0.757 0.922 0.001 
3% H2O2 – M2  0.440 9.613 0.958 0.001  0.137 0.771 0.911 0.001 
3% H2O2 – M3  0.428 9.686 0.963 0.001  0.136 0.786 0.911 0.001 
3% H2O2 – M4  0.438 9.846 0.968 0.001  0.143 0.809 0.922 0.001 
3% H2O2 – M5  0.429 9.625 0.960 0.001  0.136 0.767 0.900 0.001 
H2O2/CoCl2 – M1  0.373 9.331 0.721 0.001  0.129 0.753 0.928 0.001 
H2O2/CoCl2 – M2  0.374 9.113 0.946 0.001  0.116 0.703 0.928 0.001 
H2O2/CoCl2 – M3  0.404 9.355 0.967 0.001  0.119 0.717 0.930 0.001 
H2O2/CoCl2 – M4  0.418 9.196 0.964 0.001  0.130 0.745 0.916 0.001 
H2O2/CoCl2 – M5  0.386 8.876 0.965 0.001  0.119 0.691 0.918 0.001 
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Table 8-9: Storage stiffness (equation 4.1) and loss stiffness (equation 4.2) regression 
analyses of ChronoFlex C 80A.  
  k’  k’’ 
Specimen ID 
 
A B R² P Value 
 
C D R² P Value 
UNT – M1  0.854 15.25 0.946 0.001 0.311 1.562 0.897 0.001 
UNT – M2  0.788 14.87 0.962 0.001  0.282 1.470 0.907 0.001 
UNT – M3  0.800 15.14 0.959 0.001  0.291 1.514 0.904 0.001 
Real time – M1  0.853 16.36 0.955 0.001  0.302 1.565 0.910 0.001 
Real time – M2  0.861 16.25 0.955 0.001  0.315 1.599 0.906 0.001 
Real time – M3  0.854 16.14 0.957 0.001  0.318 1.594 0.903 0.001 
Accelerated – M1  0.745 12.20 0.951 0.001  0.244 1.381 0.908 0.001 
Accelerated – M2  0.612 11.72 0.736 0.001  0.224 1.319 0.908 0.001 
Accelerated – M3  0.827 12.85 0.960 0.001  0.269 1.494 0.924 0.001 
UNT – M1  0.865 15.64 0.960 0.001  0.318 1.633 0.912 0.001 
UNT – M2  0.839 15.20 0.935 0.001  0.339 1.611 0.832 0.001 
UNT – M3  0.857 15.91 0.963 0.001  0.302 1.578 0.912 0.001 
UNT – M4  0.873 16.02 0.957 0.001  0.310 1.611 0.906 0.001 
UNT – M5  0.831 15.58 0.955 0.001  0.305 1.566 0.893 0.001 
3% H2O2 – M1  0.960 17.07 0.944 0.001  0.341 1.720 0.900 0.001 
3% H2O2 – M2  0.888 16.34 0.945 0.001  0.314 1.606 0.910 0.001 
3% H2O2 – M3  0.803 15.83 0.940 0.001  0.320 1.584 0.846 0.001 
3% H2O2 – M4  0.768 16.42 0.683 0.001  0.342 1.690 0.834 0.001 
3% H2O2 – M5  0.952 16.95 0.958 0.001  0.354 1.765 0.907 0.001 
H2O2/CoCl2 – M1  0.900 15.05 0.913 0.001  0.345 1.616 0.858 0.001 
H2O2/CoCl2 – M2  0.892 15.64 0.951 0.001  0.321 1.602 0.897 0.001 
H2O2/CoCl2 – M3  0.960 15.93 0.928 0.001  0.358 1.712 0.889 0.001 
H2O2/CoCl2 – M4  0.855 15.84 0.955 0.001  0.318 1.612 0.878 0.001 
H2O2/CoCl2 – M5  0.808 15.08 0.960 0.001  0.281 1.466 0.907 0.001 
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Table 8-10: Storage stiffness (equation 4.1) and loss stiffness (equation 4.2) regression 
analyses of Chronosil 5% 80A.  
  k’  k’’ 
Specimen ID 
 
A B R² P Value 
 
C D R² P Value 
UNT – M1  0.759 7.952 0.945 0.001 0.313 1.569 0.957 0.001 
UNT – M2  0.814 8.347 0.963 0.001  0.330 1.680 0.960 0.001 
UNT – M3  1.095 9.469 0.949 0.001  0.443 2.033 0.945 0.001 
Real time – M1  0.632 7.916 0.944 0.001  0.272 1.327 0.951 0.001 
Real time – M2  0.690 8.191 0.953 0.001  0.290 1.406 0.951 0.001 
Real time – M3  0.606 7.806 0.960 0.001  0.255 1.271 0.955 0.001 
Accelerated – M1  0.566 7.324 0.962 0.001  0.214 1.120 0.946 0.001 
Accelerated – M2  0.572 7.164 0.954 0.001  0.218 1.141 0.954 0.001 
Accelerated – M3  0.529 6.940 0.953 0.001  0.200 1.047 0.949 0.001 
UNT – M1  0.802 8.412 0.957 0.001  0.334 1.643 0.950 0.001 
UNT – M2  0.973 9.175 0.954 0.001  0.394 1.881 0.950 0.001 
UNT – M3  0.728 7.843 0.953 0.001  0.296 1.481 0.949 0.001 
UNT – M4  0.687 7.798 0.665 0.001  0.305 1.515 0.922 0.001 
UNT – M5  0.797 8.178 0.960 0.001  0.324 1.608 0.956 0.001 
3% H2O2 – M1  0.611 7..836 0.954 0.001  0.252 1.234 0.946 0.001 
3% H2O2 – M2  0.798 8.717 0.948 0.001  0.333 1.557 0.941 0.001 
3% H2O2 – M3  0.850 8.898 0.869 0.001  0.364 1.630 0.913 0.001 
3% H2O2 – M4  0.717 8.583 0.956 0.001  0.296 1.440 0.951 0.001 
3% H2O2 – M5  0.763 8.610 0.948 0.001  0.318 1.504 0.939 0.001 
H2O2/CoCl2 – M1  0.668 7.790 0.960 0.001  0.282 1.396 0.952 0.001 
H2O2/CoCl2 – M2  0.664 7.385 0.926 0.001  0.278 1.320 0.938 0.001 
H2O2/CoCl2 – M3  0.688 7.830 0.959 0.001  0.288 1.414 0.954 0.001 
H2O2/CoCl2 – M4  0.797 8.160 0.882 0.001  0.362 1.578 0.901 0.001 
H2O2/CoCl2 – M5  0.810 8.321 0.817 0.001  0.388 1.676 0.902 0.001 
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8.7 Appendix G – Savitzky Golay – in vitro biomaterial degradation 
(A)  (B)  
(C)  (D)  
(E)     
Figure 8-14: Savitzky Golay plots of untreated and in vitro oxidative degraded five 
biomaterials; (A) Quadrathane ARC 80A B20, (B) Bionate II 80A, (C) Quadrathane ARC 
80A, (D) ChronoFlex C 80A and (E) ChronoSil 80A 5%. (Black plot) Untreated, (red plot) 
3% H2O2 and (green plot) H2O2/CoCl2 oxidative degraded method 
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(A)  (B)  
(C)  (D)   
(E)     
Figure 8-15: Savitzky Golay plots of untreated and in vitro hydroltic degraded five 
biomaterials; (A) Quadrathane ARC 80A B20, (B) Bionate II 80A, (C) Quadrathane ARC 
80A, (D) ChronoFlex C 80A and (E) ChronoSil 80A 5%. (Black plot) Untreated, (red plot) 
real-time hydrolytic degraded and (green plot) accelerated hydrolytic degraded method   
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8.8 Appendix H – Matlab script to calculate viscoelastic properties  
%Viscoelastic Properties MATLAB File-Compression Cylinders 
 
%If you use this code or a section of this code for your own 
research, please cite this thesis as the source of where you 
got the code – thank you. 
 
%Authors: Mr. Bernard Michael Lawless, Dr. Spencer C. 
Barnes, Dr. David G. Eckold 
 
%Description: This script calculates the viscoelastic 
properties of a viscoelastic material. This material must 
have been evaluated on a BOSE (TA Instruments) 3200 DMA 
machine  
 
%% 
clc; 
clear all; 
 
%% Please define the following parameters 
% Definition of Cylindrical Parameters 
dcyl = 8; % Please state the diameter of the cylinder (in 
mm) 
hcyl = 1; % Please state the height of the cylinder (in 
mm) 
Wordbook = 'cartSub3 03162018 041643 v4.xlsx'; % state 
wordbook name and file eg.'Test1.xlsx' 
% Please ensure that in the spreadsheet; Time is in Column 
1, Displacement is in Column 2 and Load in Column 3. 
  
%% Importing of Excel File 
T = xlsread(Wordbook); % Read Wordbook (Excel File) 
Time = T(:,1); % Time Data in Column 1 
DisplacementData = T(:,2); % Displacement Data in Column 2 
LoadData = T(:,3); % Load Data in Column 3        
NumberOfRows = length(DisplacementData); % Count number of 
rows 
MeanDisplacement = mean(DisplacementData); % Calculate 
mean of displacement 
MeanLoad = mean(LoadData);% Calculate mean of load 
Blank ='  '; 
ResultsDivider = '--------------------------------------'; 
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%% FFT of Data 
% Creation of Fourier transforms of data 
nfft = 2^nextpow2(length(LoadData)); % Setting Data to the 
next power of 2 
dx = abs(Time(find(diff(Time),1)+1)-Time(1)); % Measuring 
the Time Step 
Fs = 1/dx; % Sampling Frequency 
f = Fs/2*linspace(0,1,nfft/2+1);  
  
fftDisp = fft(DisplacementData); % FFT of Disp Data 
fftLoad = fft(LoadData); % FFT of Load Data 
  
subplot(1,2,1), plot(f(2:end),2*abs(fftDisp(2:nfft/2+1))), 
ylabel('Amplitude'), xlabel('Freq'), title('Disp') % Plot 
of FFT Disp 
subplot(1,2,2), plot(f(2:end),2*abs(fftLoad(2:nfft/2+1))), 
ylabel('Amplitude'), xlabel('Freq'), title('Load') % Plot 
of FFT Load 
  
[MaxLoad, idx1]=max(abs(fftLoad(2:end))); % Finding the 
position of the peak of the fft of load 
[MaxDisp, idx2]=max(abs(fftDisp(2:end))); % Finding the 
position of the peak of the fft of disp 
  
r = abs(angle(fftLoad(idx1+1))-angle(fftDisp(idx2+1))); % 
Measure of phase angle in radians 
deg = r*180/pi; % Converting the phase angle to degrees 
  
disp(ResultsDivider) 
disp(Wordbook) 
  
if deg > 90 % If the phase angle is greater that 90 degree 
    disp(Blank) 
    disp('WARNING: THE PHASE ANGLE IS GREATER THAT 90 
DEGREES!') 
    disp(Blank) 
    disp('WARNING: THE DISPLACEMENT IS LEADING THE LOAD - 
CHECK THE NATURAL FREQUENCY OF THE MATERIAL') 
    degr=180-deg; 
else % if the phase angle is less than 90 degree 
    disp(Blank) 
    disp('THE LOAD IS LEADING THE DISPLACEMENT - NORMAL') 
    degr= deg; 
end 
  
ActualFrequency = f(idx1+1); % Measure of actual frequency 
from FFT 
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phaseangle=(-0.0667*ActualFrequency)+degr; % Calculation 
of actual phase angle with correction factor (see BOSE 
manual pg.14-10 for more information about the correction 
factor) 
phaseradians = (phaseangle*pi)/180; % Converting phase 
angle from deg to radians 
LossFactor = tan(phaseradians); % Loss Factor Calculation 
  
X1 = ['Actual Frequency (Hz):         ', 
num2str(ActualFrequency)]; 
X2 = ['Phase Angle (deg):             ', 
num2str(phaseangle)]; 
X3 = ['Loss Factor                    ', 
num2str(LossFactor)]; 
X4 = ['Time Step (s):                 ', num2str(dx)];  
X5 = ['Max Load and Disp Index:       ', num2str(idx1), ', 
' , num2str(idx2)]; 
disp(Blank) 
disp(X1) 
disp(Blank) 
disp(X2) 
disp(Blank) 
disp(X3) 
disp(Blank) 
disp(X4) 
disp(Blank) 
disp(X5) 
disp(Blank) 
  
%% Calculation of Cylinder Cross Sectional Area (CSA) and 
Shape Factor 
CylinderCSA = (pi*dcyl^2)/4; % Cylinder CSA 
ShapeFactor = (pi/hcyl)*((dcyl/2)^2); % Cylinder Shape 
Factor 
  
%% Calculation of angular velocity  
omega = 2*pi*ActualFrequency; % Angular velocity 
calculation 
Radian = omega*Time; % Radians (w*t) 
RadianLength = length(Radian); 
  
%% Calculation of X, F, Strain, Stress 
X = DisplacementData-MeanDisplacement; % Displacement 
around zero 
F = LoadData-MeanLoad; % Load around zero 
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Strain = X/hcyl; %Strain Calculation 
StrainLength = length(Strain); 
Stress = F/CylinderCSA; %Stress Calculation 
StressLength = length(Stress); 
  
XMax = max(X); % Maximum Displacement 
FMax = max(F); % Maximum Load 
StressMax = max(Stress); % Maximum Stress 
StrainMax = max(Strain); % Maximum Strain 
 
%% Graphs of Stress and Strain 
% Plot of time (s) vs Load (N) and Disp (mm) 
figure 
plotyy(Time,LoadData,Time,DisplacementData); 
xlabel('Time (s)'); 
ylabel('Load(N)'); 
title(Wordbook); 
legend('Load','Disp'); 
% Plot of time (s) vs Stress (MPa) and Strain 
figure 
plotyy(Time,Stress,Time,Strain); 
xlabel('Time (s)'); 
ylabel('Stress(MPa)'); 
title('Time (s) vs Stress/Strain'); 
legend('Stress','Strain'); 
% Plot of time (rads) vs Stress (MPa) and Strain 
figure 
plotyy(Radian,Stress,Radian,Strain); 
xlabel('Radians'); 
ylabel('Stress(MPa)'); 
title('Radians vs Stress/Strain'); 
legend('Stress','Strain'); 
 
%% Complex Stiffness (K*), Storage Stiffness (K') and Loss 
Stiffness (K'') 
ComplexStiffness = MaxLoad/MaxDisp; % Calculation of 
Complex Stiffness 
StorageStiffness = ComplexStiffness*cos(phaseradians); % 
Calculation of Storage Stiffness 
LossStiffness = ComplexStiffness*sin(phaseradians); % 
Calculation of Loss Stiffness 
  
StiffnessResult1 = ['Complex Stiffness (N/mm):      ', 
num2str(ComplexStiffness)]; 
StiffnessResult2 = ['Storage Stiffness (N/mm):      ', 
num2str(StorageStiffness)]; 
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StiffnessResult3 = ['Loss Stiffness (N/mm):         ', 
num2str(LossStiffness)]; 
disp(StiffnessResult1) 
disp(StiffnessResult2) 
disp(StiffnessResult3) 
disp(Blank) 
 
%% Complex Modulus (E*), Storage Modulus (E') and Loss 
Modulus (E'') 
  
ComplexModulusMPa = ComplexStiffness/ShapeFactor; 
%Calculation of Complex Modulus 
StorageModulusMPa = StorageStiffness/ShapeFactor; 
%Calculation of Storage Modulus  
LossModulusMPa = LossStiffness/ShapeFactor; %Calculation 
of Loss Modulus 
  
ModulusResult1 = ['Complex Modulus (MPa):         ', 
num2str(ComplexModulusMPa)]; 
ModulusResult2 = ['Storage Modulus (MPa):         ', 
num2str(StorageModulusMPa)]; 
ModulusResult3 = ['Loss Modulus (MPa):            ', 
num2str(LossModulusMPa)]; 
disp(ModulusResult1) 
disp(ModulusResult2) 
disp(ModulusResult3) 
disp(Blank) 
disp(Blank) 
disp('END OF RESULTS') 
disp(Blank) 
disp(ResultsDivider) 
  
%END 
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8.9 Appendix I – Savitzky Golay – Explanted BDyn components 
(A)  (B)  
(C)  (D)  
(E) (F)  
Figure 8-16: Savitzky Golay plots of untreated and explanted six PCU rings; (A) Explant 1, 
(B) Explant 2, (C) Explant 3, (D) Explant 4, (E) Explant 5 and (F) Explant 6. (Black plot) 
Untreated, (red plot) explanted component. 
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(A)  (B)  
(C)  (D)  
(E) (F)  
Figure 8-17: Savitzky Golay plots of untreated and explanted six silicone cushions; (A) 
Explant 1, (B) Explant 2, (C) Explant 3, (D) Explant 4, (E) Explant 5 and (F) Explant 6. 
(Black plot) Untreated, (red plot) explanted component. 
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8.10 Appendix J – Preliminary tests  
8.10.1 Force vs displacement graph of five PCU biomaterials (tension) 
8.10.1.1 Introduction 
Preliminary study to quantify the tensile force versus displacement response of the five long-
term implantable PCU biomaterials (section 3.1). 
8.10.1.2 Materials and methods 
The force versus displacement tension tests of the five PCU biomaterials were measured using a 
Bose ElectroForce 3300 testing machine running WinTest 4.1 DMA software (Bose 
Corporation, Electroforce Systems Group, Minnesota, USA; now, TA Instruments, New 
Castle, DE, USA). ASTM D1708 shaped specimens were used to keep consistency with the 
oxidation and hydrolysis studies. A displacement rate of 0.02 mm/s was applied to each tested 
specimen up to a displacement limit of 4 mm. All specimens were tested at room temperature 
and the sample size, of each biomaterial, was three (n = 3). The order of specimen testing was 
randomised by using the Excel Random Function (Microsoft, Redmond, Washington, USA). 
8.10.1.3 Results 
Figure 8-18 illustrates the force versus displacement curves for the five PCU biomaterials. 
(A)  (B)  
Figure 8-18: Force versus displacement of the five PCU biomaterials, (A) mean of the five 
PCUs and (B) mean ± standard deviation, at 0.5 mm intervals, of five PCUs 
8.10.1.4 Conclusion 
This preliminary study quantified the tensile mechanical behaviour (force versus displacement) 
of the five PCU biomaterials. 
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8.10.2 Force vs displacement graph of five PCU biomaterials (compression) 
8.10.2.1 Introduction 
Preliminary study to quantify the compressive force versus displacement response of the five 
long-term implantable PCU biomaterials (section 3.1). 
8.10.2.2 Materials and methods 
The force versus displacement compression tests of the five PCU biomaterials were measured 
using a Bose ElectroForce 3300 testing machine running WinTest 4.1 DMA software (Bose 
Corporation, Electroforce Systems Group, Minnesota, USA; now, TA Instruments, New 
Castle, DE, USA). Cylindrical disc shaped specimens with a height of 3 mm and a diameter of 
8 mm were used. A displacement rate of 0.02 mm/s was applied to each tested specimen up to 
a displacement limit of 1 mm. All specimens were tested at room temperature and the sample 
size, of each biomaterial, was six (n = 6). The order of specimen testing was randomised by 
using the Excel Random Function (Microsoft, Redmond, Washington, USA). 
8.10.2.3 Results 
Figure 8-19 illustrates the force versus displacement curves for the five PCU biomaterials. 
(A)  (B)  
Figure 8-19: Force versus displacement of the five PCU biomaterials, (A) mean of the five 
PCUs and (B) mean ± standard deviation, at 0.5 mm intervals, of five PCUs 
8.10.2.4 Conclusion 
This preliminary study quantified the compressive mechanical behaviour (force versus 
displacement) of the five PCU biomaterials. 
  
 234 
 
8.10.3 Force vs displacement graph of the BDyn device 
8.10.3.1 Introduction 
Preliminary study to quantify the force versus displacement response of the BDyn Implant. 
8.10.3.2 Materials and methods 
The force versus displacement of three BDyn 1 level devices (n = 3) were measured using the 
MTS Landmark Servo-Hydraulic testing machine running MTS Multi-Purpose Testware 
(MPT) on FlexTest 40 Station Manager Version 5.3B software (MTS Corporation, Eden 
Prairie, MN, USA). MTS 647 hydraulic wedge grips and MTS 647.02B jaws were used to 
clamp the mobile and fixed rods of the BDyn device (Figure 2-15). 
A custom testing procedure was created on the MTS MPT software. Firstly, a compressive 
displacement rate of 0.02 mm/s was applied to the silicone cushion of the BDyn device (see 
Figure 2-15 and Figure 8-20 (B)) until a load of -1250 N was recorded. Next, the hydraulic 
actuator moved at a displacement rate of 0.5 mm/s to -1 mm displacement position. Then, a 
tensile displacement rate of 0.02 mm/s was applied to the device until a tensile load of 1750 N 
was recorded (Figure 8-20 (C)); this device tensile load is a compressive load to the PCU ring in 
the BDyn device Titanium Alloy housing (see Figure 2-15). Once 1750 N was recorded, the 
hydraulic actuator moved at a displacement rate of 0.5 mm/s to 0 mm (the starting position) and 
the test ended.  
(A)  (B)  (C)  
Figure 8-20: Testing of the BDyn device in the MTS Landmark Servo-Hydraulic Test 
System; (A) at 0 N, (B) at -1250 N [compression of silicone cushion] and (C) at 1750 N 
[compression of PCU ring] 
All specimens were tested at room temperature.   
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8.10.3.3 Results 
Figure 8-21 illustrates the force versus displacement of (A) a BDyn device tested by the MTS 
MPT custom test procedure, (B) compression of the BDyn device (compression of the silicone 
cushion) and (C) tension of the BDyn device (compression of the PCU ring). The plots 
illustrated in Figure 8-21 (B) and (C) are mean average with standard deviation error bars. In 
tension, all three BDyn devices reached 1750 N while in compression, all three BDyn devices 
reached -1250 N. 
(A)  
(B)  (C)  
Figure 8-21: Force versus displacement of (A) a BDyn device tested by the MTS MPT 
custom test procedure, (B) compression of the BDyn device (compression of the silicone 
cushion) and (C) tension of the BDyn device (compression of the PCU ring). 
8.10.3.4 Conclusion 
This preliminary study quantified the compressive and tensile force versus displacement curves 
of the BDyn device. All three BDyn devices reached -1250 N in compression and 1750 N in 
tension. 
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8.10.4 Effect of ion treatment on the viscoelastic properties 
8.10.4.1 Introduction 
Preliminary study to investigate the effect of ion treatment on the viscoelastic response of the 
PCU ring and silicone cushion of the BDyn device. 
8.10.4.2 Materials and methods 
Twelve silicone and twelve polycarbonate urethane (PCU) components (Figure 5-1) were 
obtained from S14 Implants (Pessac, France). Six of these silicone cushions and six PCU rings 
were treated with a “full” ion treatment while the other six silicone cushions and six PCU rings 
were treated with a “weak” ion treatment; unfortunately, no specific parameters in relation to 
the ion treatment are known.  
The experimental methods such as applied sinusoidal load, investigated frequencies, machine 
fixtures used, etc. were kept consistent as the evaluation of the control, in vitro and in vivo 
degraded BDyn components (section 5.2.3).  
Wilcoxon rank sum tests were performed to compare the viscoelastic properties of the “full” 
and “weak” ion treated PCU rings and silicone cushions. 
8.10.4.3 Results 
Figure 8-22 and Figure 8-23 demonstrate the viscoelastic properties of the ion treated PCU ring 
and silicone cushion, respectively. 
(A) (B)  
Figure 8-22: (A) Storage stiffness and (B) loss stiffness of the ion treated (full and weak) 
PCU ring 
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(A)  (B)  
Figure 8-23: (A) Storage stiffness and (B) loss stiffness of the ion treated (full and weak) 
silicone cushion 
The storage and loss stiffness of the full and weak ion treated silicone components were 
significantly different for all frequencies range tested (p < 0.05) while the PCU component 
storage and loss stiffness were not significantly different for all frequencies tested (p > 0.05). 
8.10.4.4 Conclusion 
The silicone cushion viscoelastic properties are affected by the level of ion treatment while the 
PCU ring viscoelastic properties remain unchanged due to the level of ion treatment. 
